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1.INTRODUCTION: 
                Siddha medicine is of (some) 2500 years ago, Siddha means Siddhi, which 
means achievement in life arts such philosophy ,yoga,wisdom,alchemy,medicine and 
above all the art of longevity.The concept of siddha based on 96 principles which is the 
base of human life. 
              The persons who attained this siddhi are respectively called as siddhars who are 
also can be called as spiritual scientists. 
 In old days siddha system received petronage of Tamil Kings and general public 
all through.Yes it’s true it’s our medicine that is suitable for our climate,culture and so on. 
                        “kWg;gJ cly;Neha; kUe;njd yhFk; 
   kWg;gJ csNeha; kUe;njdr;rhYk; 
  kWg;gJ ,dpNeha; thuhjpUf;f 
   KWg; gJ rhit kUe;njdyhNk” 
                                                                        -jpU%yh; 
According to the above lines by Thirumoolar he states that medicine is, 
 That which cures the health problems 
 That which cures the psychic problems 
 Not only enriching physical and mental health and preventation of disease. 
 Medicine is that mankind from death.Paving way to holistic health. 
           The statement of Thirumoolar gives a clear and brief knowledge about what is 
Siddha system. 
            The ancient Dravidian’s science is applicable to the Mordern world also.This is 
evidence from WHO’s aims about holistic health. 
             In siddha system, SWASAM can be correlated with bronchial asthma.Despite the 
availability of wide range of drugs,the relief offered by them is symptomatic and shorts 
lives, more over these drugs produce side effects.Therefore,there is a desire need to 
identify effective and safe remedies to treat bronchial asthma.Herbal, medicines are being 
used by nearly about 80% of world populations.Primarily in Developing countries for 
primary health care.The herbo mineral drugs described inSiddha system have been, the 
basis of treatment of varies human disease. Selectionof scientific and systematic approach 
for the biological evaluation of herbal drug Formulations, based on their view in the 
traditional systems of medicine forms the  Basis for an ideal approach in the development 
of new drug from herbs. 
             Among several respiratory disease of man, Bronchial asthma is the most 
Common disabling syndrome. 
            Bronchial asthma is the most common allergic disease of human beingl leading to 
more complications.Bronchial asthma is an inflammatory disorders of the airways 
characterized by varies airway obstruction,airway inflammation and bronchial hyper 
responsiveness and is a global health problem that results from a complex interplay 
between genetic and environmental factors.Nearly 7-10% (300million) of the world 
population suffers from Bronchial asthma. 
 As of 2011.235-300 million people world wide are affected by asthma 
andapproximately 250,0 people die per year from the disease.Rates very between 
countries with prevalence between 1 and 18%.It is more common in developed than 
developing countries.One thus seen lower rates in Asia,Eastern Europe and Africa with in 
developed countries it is more common in those who are economically disadvantaged 
while in contrast in developing countries it is more common in the affluent. The reason 
for the differences is not well known,low and  middle income countries make up more 
than 80% of the mortality .While asthma is  twice as common in boys as girls severe 
asthma occurs at equal rates.In contrast  adult women have a higher rate of asthma than 
me and it is more common in the young than the old.  
 Global rates of asthma have increased significantly between the 1960,and 2008 
with it being recognized as a major public health problem since the 1970s.Rates of 
asthma have plate in the developed world since the mid 1990s with  recent increases 
primarily in the developing world.Asthma affects approximately 7% of the population of 
the United States and 5% of people in the United Kingdom  Canada, Australia and New 
zeland have rates of about 14-5%.  
 Mortality however is most common in low to middle income countries while  
symptoms were most prevelent (as much as 20%) in the united Kingdom, Austrelia, 
Newzealand, and Republic of Ireland, they were lowest (as low as 2-3%) in Eastern 
Europe, Indonesia,Greece,India. Here, I have taken there is a preparation called 
“Rajakesari chooranam” for its easy availability of drugs.Which is exclusively indicated 
for Eraippu Noi. (Bronchial asthma). 
2. AIM AND OBJECTIVES  According to the CDC (Council of Disease prevention and Control), more 
than 300 million peoples suffer with asthma today. Today number of synthetic 
bronchodilator, anti-spasmodic, anti-histaminic, anti-inflammatory drugs are 
available for symptomatic control of bronchial asthma. This synthetic drug may cause 
side effects. Therefore the modern world is searching for suitable traditional remedies 
because of without any adverse effect. In order to achieve this aim an attempt was 
made to establish the scientific validity for bronchodilator, anti-inflammatory, anti-
histaminic, & anti-spasmodic property of  RAJAKESARI CHOORANAM. 
OBJECTIVES: 
 The main objective of the present study is to high light the safety and efficacy 
of RAJAKESARI CHOORANAMon ERAIPPU NOI, the following methodology 
was adopted to evaluate the drugs and its standardization studies.  
 To collect the literature evidence regarding the trial medicine  Identification of 
the drugs in the RAJAKESARI CHOORANAM... 
 To prepare the trial medicine as per the text  
 Physico-chemical analysis of Test drug  
 Evaluation of the   toxicity of Test drug  
 Evaluation of Broncho dilator activity of test drug on Broncho-alveolar levage in 
mice. 
 Evaluation of Anti-spasmodic activity of test drug on Excised Rat Ileum.  
 Evaluation of Anti histaminic activity of test drug on Inbred Wister rat& guinea 
pigs. 
 Evaluation of anti-inflammatory activity of test drug on Albino rats. 
 
 
 
 
 
 
3. REVIEW OF LITERATURE 
3.1. thy; kpsF 
 PIPER CUBEBA. Linn… 
3.1.1. GUNAPADAM ASPECT 
 Other Names: 
 ‘mUspNdhk; Nuzpf nkd;Wk; NgU 
  mj;Juhjp tl;l nkd;wpjw;Fg; NgU 
 mUspNdhk; myq;fhH nkd;Wk; NgU 
  mNrhhpj nkd;wpjw;Fg; NgU z;lhr;R 
 kUspNdthk; J}yhjp vd;Wk; NgU 
  kfj;jhd jf;Nfhy nkd;wpjw;Fg; NgU 
 rUspNdhk; rJl;lNk nkd;wpjw;Fg; NgU 
   Rkj; jhfr; nrhy;yptpl;Nlhk; thy;kpsfpd; NgNu”           
- Panja kaviya Nigandu. 
 Asoritham 
 Thulathi 
 Thakkolam 
 Sathuttam 
HABITAT:- 
1. This climbing woody bush is indigenous to Java Sumatra &Malay Archipelago; but 
the dried full grown fruits of the shrub called cubebs.  
2. It also cultivated to a small extent in India especially in the Mysore state.                  
Parts used  - Dried immature full grown fruits called cubebs 
 Colour  - Greyish brown to black. 
 Odour    - Aromatic 
 Taste     - Pungent 
 Character  -     Veppam 
 Bio transformation -     Pungent 
ACTION:- 
 Stimulant 
 Carminative 
 Diuretic 
 Expectorant 
General Characters: (Pothu gunam) 
 ‘ thjgpj;j Iak; tapw;W typ jhfQ; 
  rPjk; gyNeha; rpijAq;fhz; - Nghj 
 mjpjP gdkhk; mzq;fuNr! ehSe; 
  Jjpthy; kpsfUe;jr; nrhy; 
 It cures vatha, pitha, kabha disease, ulcer, thirst. It increases appetide.  
     - Pathaartha Guna Sinthamani 
THERAPEUTIC USES:- 
 Small dose of cubeb improve digestion and increase the appetite.  
 Cubeb is said to increase the force and frequency of the heart. It is eliminated 
by the kidney, lungs and skin. 
 Dried cubebs internally for oral and dental disease, loss of voice, halitosis, 
fever and cough. 
 The paste of the cubeb berries externally on male and female genitals to 
intensify sexual pleasure during coitus.  
VAALMILAGU CONTAINING BRONCHIAL ASTHMA MEDICINES 
I.CHOORANAM:- 
1. Thalisapathri Chooranam 
Dose  -    Thirukadi 
Indication -      Bronchial asthma, Hiccough, Thirst. 
2. Kandankathiri Chooranam 
Adjuvant - Ghee 
Indication - Bronchial asthma, cough, tuberculosis 
II. YENNAI:- 
3. Korasanai Yennai: 
Dose  - Thuttalavu 
Adjuvant - Aloe vera juice 
Indication - Bronchial asthma, Cough. 
III. MAATHIRAI:- 
4. Kungumapoo Mathirai 
Dose  - Payaralavu 
Adjuvant - Honey 
Indication - Bronchial asthma, Cough Fever  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
thy; kpsF  
PIPER CUBEBA.Linn…  
3.1.2.BOTANICAL ASPECT  
Taxonomic Classification: 
 Kingdom -  Plant kingdom 
 Division - Spermatophyta 
 Sub division - Angiospermae 
 Class  - Dicotyledonae 
 Subclass - Monochlamydeae 
 Series  - Microembryeae 
 Family - Piperaceae 
 Genus  - Piper 
 Species - P.Cubeba 
Vernacular Names: 
 English - cubebs, tailed pepper 
 Hindi  - Kababcin 
 Mah  - Kankola 
 Malayalam - Valmulaku 
 Sanskrit - Kankolam 
 Tamil  - Vaalmilagu 
 Telugu - Calavamiriyalu 
Arab  : Kababh 
Distribution:- 
 Native of Indonesia, cultivated in Karnataka, yet large amount of fruit is imported. 
In India it is experimentally cultivated. Cultivated in java, Sumatra Ceylon and West 
Indies.  
Description:- 
 A perennial woody climber with ash grey climbing stems and branches, rooted at 
the joints, leaves simple, ovate – oblong, smooth, base, flowers small fruits subglobose 
berries.  
Parts used: -Dried unripe berries 
 
Phytochemical aspect:      
 Hignokenin 
 Dusin 
 Dihydrocubebin 
Oxygenated cyclohexanes: 
 Piperinol A 
 Piperinol B 
 The most characteristic constituent of cubeb is the essential oil (oil of cubeb) the 
proportion of which varies from 5 – 20%. In addition the fruits contain resinous matter, 
fixed oil, starch and nitrogenous substances. The resinous matter is made up of several 
acidic and neutral substances of undetermined composition including cubebin having a 
bitter taste.  
 The therapeutic value of the drug is said to be largely due to cubebic acid.  
 Other Terpene Alcohols: 
 - Sesquiterpenes mainly 1 – cadinene 
 - Sesquiterpene alcohols 
 Early investigation on chemical composition shows the presence of dipenten, 1 – 
terpene, 1 – cadinene azulence and so called cubeb camphor a sesquiterpene alcohol                           
Properties and uses:  
 The berries are acrid, bitter, thermogenic, aromatic, stimulant, anodyne, anti – 
inflammatory, anthelmintic, digestive, carminative, sedative, expectorant, 
rejuvenating, and diuretic.  
 They are useful in somatalgia, odontalgia, cephalalgia, halitosis, inflammation, 
wounds, ulcers, catarrh, anorexia, dyspepsia, flatulence, haemorrhoids.  
 It cures cough, asthma, bronchitis, amenorrhoea, dysmenorrhoea, cystitis, genito – 
urinary diseases like gonorrhoea & rheumatism.  
 The cubeb powder mix with rosewater to use externally for headache. 260mg of 
cubeb powder mix with milk to drink it cures throat infection.  
 
3.1.3.LATERAL RESEARCH: 
 Phytochemical Evaluation and Antioxidant activity of Piper cubeba. Gayatri 
Nahak and R.K. Sahu  
ABSTRACT:  
 Recent scientific research has established the presence of many active compounds 
in these spices that are known to possess specific pharmacological properties. Among 
the plants investigated to date, one showing enormous potential is the Piperaceae. 
Piperine is an alkaloid found naturally in plants belonging to the pyridine group of 
Piperaceae family, such as Piper cubeba. It is widely used in various herbal cough syrups 
and it is also used in anti inflammatory, anti malarial, anti leukemia treatment. So the 
present study was aimed to extract the phytochemical compounds in different solvent 
system in Piper cubeba.  
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2. rhjpf;fha; 
 MYRISTICA FRAGRANS. Houtt... 
3.2.1. GUNAPADAM ASPECT 
 Other names: 
 rhjpf;fha;  NgHjidNa rhj;jf; NfS 
  rhjpgyQ; rhjpr;rp aKkhFk; 
 khjpf;fha; fhYukh kjpgykh 
  kjrTz;lQ; rhjpfKkhFq; 
 fLf;fha; fg;gpypdpw Jwq;rpahFq; 
  fLf;fhapd; yfphpjhd; gytopfpahFQ; 
 #jpf;fha; jpwf;fpd; gpj;jdh rdpahFQ; 
  nrg;gpaNjhH rhjpf;fha; nraYkhNk. 
       - Pogar Nigandu 1200 
Saathichiyam, Saalooram, Athibalam, Saathigam, Kappilinira durachi, Lagithirakkani, 
Pithanaasini 
‘ey;ythjp kynkd;Wk;> rPyf;fhnad;Wk; 
 ey;ykhd thjpNuhja nkd;Wk; NgU 
nrhy;yf;Nfs; rptrpfpj nkd;Wk; NgUz;lhr;R 
 rPhpl nkd;wpjw;Fg; NgH nrg;gpNdhk; ehk; 
nrhy;y rpj nkd;wpjw;Fg; NgU 
 RNj tdhjp jnkdwpjw;F NgU 
my;ytq;fhu nkd;wpjw;Fg; NgU 
 mUspNdhk;> rhjpf;fhajw;Fk; NgNu.  
      - Panja Kaaviya Nigandu. 
Nallavaathi malam, Seelikkai, Vaathirothaiyam, Sivasikitham 
 Part used  - Fruit and aril 
 Taste   -          Astringent,Pungent 
 Character  - Veppam 
 Biotransformation  -           Pungent 
Action:- 
 Stimulant 
 Tonic 
 Carminative 
 Aphrodisiac  
 General Characters: (Pothu gunam) 
  “jhJ el;lk; Ngjp rUthrp lgQ;rpuNeha ; 
                XJth rq;fhrk; cl;fpuzp - NtNjh 
                 Vyf;fha; tpUk;gpzpNghk Vw;wikahy; gpj;jq ; 
                Fy;f;fh kUj;Jth;f;F $W” 
                                   -Pathartha Gunapadam  
 Jathikai cures oligospermia, Diaharrhoea, wheezing, cough, dysentry, then it cures 
abdominal pain, abdominal distension and indigestion 
Therapeutic Uses: 
 Useful in conditions of kapha and vata; inflammations, cephalalgia, helminthiasis, 
halitosis, dyspepsia, flatulence, colic, asthma, catarrh, Diarrhoea, vomiting, 
Amenorrhoea, dysmenorrhoea, ulcer, hepatopathy, spleenopathy, impotency, skin 
disease and general debility. 
SAATHIKKAI CONTAINING BRONCHIAL ASTHMA MEDICINE 
I. CHOORANAM:- 
 1. Thiratchathi Chooranam 
 Dosage : 1 Kaasadai 
 Indications : Cough, Pitham, Kaasam. 
 2.   Karpoorathi Chooranam 
 Adjuvant : Sugar or honey 
 Indications : sayam, ulcer 
 
II. YENNAI:- 
  3. Saathikai Yennai 
 Dosage  : 1 drop 
 Adjuvant : Mother milk or water 
 Indications : Cough, Kabam, vomit 
 
III. MAATHIRAI:- 
 4. Kaasakudaaram 
 Dosage  : 1 Pill 
 Adjuvant : water 
 Indications : Bronchial asthma, dysentery. 
IV CHENDURAM:- 
 5. Poorana Chandrothaiya Chenduram 
 Indications : Bronchial asthma. 
V. KIRUTHAM:- 
 6. Thoothulaiyaathi Kirutham 
 Dosage  : 2 thuttu edai 
 Indications : Cough, asthma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
rhjpf;fha; 
MYRISTICA FRAGRANS. Houtt... 
3.2.2.BOTANICAL ASPECT     
Taxonomic classification 
  Kingdom - Plantae 
  Order  - Magnoliales 
  Family  - Myristicaceae 
 Genus  - Myristica  
 Species - Fragrans 
Vernacular Names: 
 Eng  - Nutmeg tree, Mace tree 
 Hindi  - Jayphal 
 Kan  - Jajikayi 
 Mal  - Jati, Jatikkamaram 
 Sans  - Jati, Jatiphalah 
 Tam  - Jatimaram, Jatikkai 
 Telu  - Jajikaya 
 Burm  - Zadu – phu 
 French  - Musque 
Distribution: 
 Native of Malaya, Molukkas. It also cultivated in Srilanka.Cultivated in the hotter 
parts of India upto 750 with 150 – 300 cm per annum.  
Habit: 
 A moderate sized aromatic, evergreen greyish black bark having lenticular spots 
on the outside and red in the inner side, leaves elliptic, flowers creamy yellow fruits 
yellow, pesicarp fleshy, testa shiny, aril yellowish red; irregularly lobed.  
 Past used: Fruit and aril 
FRUITS: 
 Fruits are brown or greyish brown and reticulately furrowed.  
 A patch of lighter colour with brown lines surrounded by a ring is seen at one end of 
the fruit from this is a furrow runs to the chalaza at the opposite end of the kemal 
where there is a small depression.  
 In longtitudinal section a marble like lusterom appearance is given. The dark brown 
perisperm forming the outer tissue penetrates the light brown endosperm. 
Fibrovascular bundles are also seen in the perisperm.  
 The dried arillus is of bright red or corol colour section shows thick walled epidermis 
and large amount of parenchyma in which fibrovascular bundles and large oil cells are 
seen. 
 According to zandes, there are four grades of East Indlain nutmegs. 
1. The banda nutmegs. 
2. The siauw nutmegs. 
3. The Penang nutmegs.  
4. The papua nutmegs. 
PHYSIO – CHEMICAL PROPERTIES OF OIL OF NUTMEG 
Oil of nutmeg is a mobile, almost colourless or pale yellow liquid, possesing an 
odour and flavour characteristic of spice, especially a dilution. With the passage of time 
the oil takes up oxygen and partly resinifies, becoming more viscous.  
 CHEMICAL COMPOSITION OF NUTMEG AND MACE OIL  
 The presence of the following compounds 
1. Camphene 
2. β – pinene 
3. Dipentene 
4. P – cymene 
5. d – Linacool 
6. Borneol 
MYRISTIC ACID:- 
 M.P.540c present in the oil free and esterified. Depending upon the length of 
distillation and the steam pressure applied, smaller or larger amount of this acid and its 
esters occur in the oil. On evaporation of the oil, the acid remains in the residue. It large 
quantities are present the acid may separate from the oil in crystalline form. In the early 
literature, this crystalline deposit was called myristicin. It must not be confussed with 
true myristicin.  
USES OF NUTMEG AND MACE OILS: 
 It used widely for the flavouring of numerous food products, particularly baked 
goods cakes, cookies, custards, pudding, pickles etc.  
 Salway found, oils of nutmeg and mace are somewhat poisonous, the toxicity 
being caused presence of myristicin.  In pharmaceutical preparations the oil has been 
recommended for treatment of inflammation of the bladder & urinary tract large doses 
must be avoided.  
ACTION AND USES: 
 Anodyne, aphrodisiac, appetizer, astringent, carminative, narcotic, stimulant and 
stomachic.  
 Used in Anorexia, diarrhoea, dysentery, flatulence, headache, impotence, nausea, 
respiratory disorder, rheumatism, urinogenital disorders and vomiting. 
 Traditionally used extensively for diarrhoea of infants and pigmental disorders of 
the face. Ethnologically considered as on important item of toiletery.  
3.2.3. LATERAL RESEARCH: 
Journal of Pharmacognosy and pytochemicals histological and histo chemical 
Investigation of Myristica Fragrans. Houtt 
(www.phytojournal.com) 
 Myristica fragrans Houtt. Is an evergreen tree, native of the E. Moluccas and 
Cultivated throughout Malaya. It is found only as a specimen tree in Botanical  Gardens. 
The seed of the plant is known as “nutmeg” and the arillus of the seed is  Called “mace”. 
Both nutmeg and mace contain many volatile oils. These oil Constituents have a variety 
of individual pharmacological effects, some of which Oppose others (Jellin et al; 2005). 
The fruit contains ethereal oil-cells often with Phenolic and myristicin; the seed and the 
aril are used for flavouring food. Of the 72 Species of Myristica of global level 
distribution, five species are reported in S. India (Gamble, 1921). M. dactyloides Gaert. Is 
reported in the W.Ghats of Tamil Nadu (Mathew, 1999; Henry et al; 1987). The S. Indian 
species of Myristica are identified On the basis of inflorescence, leaf - venation, fruit 
shape and colour of the aril. The Main objective of the present study is to propose 
protocol of anatomical profile and Histochemical localisation of the ragrant compounds in 
the fruit including seed and Aril. Fragmentary account of the anatomical studies are 
available in the Pharmacognosy books (Wallis, 1985; Trease and Evans, 1978; Claus, 
1956; Kolammal, 1979) which give a superficial description of the fruit of Myristica. In 
the Present investigation it is proposed to provide detailed cellular organization and 
Histochemical aspect of the pericarp, seed and aril of the fruit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.  Nguuj;ij 
ALPINIA GALANGA, Wild. 
3.3.1. GUNAPADAM ASPECT 
 Other names: 
 ‘muj;ijapl ngaHjidNa miwaf; NfS 
 Mz;ikahk; uhrpdth krh rpahFkl; 
 cuj;ijahk; cj;juthk; rpNtq;fpahFk; 
 cz;ikah kh rhk ehir taj;jhkhFk; 
 jphpNjh\ thj fh rhf;fpdpahFk; 
 fue;ijahq; fgTjh ehrdp khFk; 
 fz;Liuj;j ngnuy;yh kuj;ijf; fhNk” 
      - Pogar Nigandu 1200 
 ‘Nfh\;lnkd;w nfe;j rhkjh ndd;Wk; NgU 
 nfhz;L nfe;j eduzp nad;Wk; NgU 
 Ml;lnkdw; rpjfk;gQ; Rujhf;Fjk; 
 mlthkr; nrUf; fk;g gtdnkd;Wk; NgU 
 ehl;lnkd;w jPj jPgnkd;Wk; ,jw;F NgU 
 ehj ehjhe;j nkd;Wk; ,jw;F NgU 
 Gfohfr; nrhy;yp tpl;Nlhk; Nguuj;ijapd; NgNu” 
  - Agasthiyar Yemathathuvam Ennum Panjakaviya Nigandu 
‘Jk;guh\;lfk;”-Saambasivampillai Mooligai Agarathy (220) 
 Habit   :   The plant is 6 – 7 height, bears the perennial 
rhizome.  
 Habitat  :    South India & Bengal 
 Parts used  : Rhizome 
 Taste   : Pungent 
 Character       : Veppam 
 Bio transformation : Pungent 
 Actions       : Expectorant 
Febrifuge 
Stomachic 
 
 
 
GENERAL CHARACTERS:  
 “njhz;ilapw; fl;Lq; fgj;ijj; J}uj;Juj;jptpLk; 
  gz;ilr;rPjj;ijg; gwf;fbf;Fk; - nfz;iltpop  
  kpd;Nd fug;gid Ntwhf;Fk; grpnfhLf;Fk; 
  nrhd;Ndhk; auj;ijr; Rfk;” 
      - Pathaartha Gunapadam  
 It cures cough, Asthma, Eczema, chest pain, oedema, tooth disorder, Nenju kozhai, and 
vathasuronitham. 
“ muj;ij fgj;ij apWf;Fq;fhy; Xl;LQ; 
  rpuj;jpy; cWk; <isar;rp ijf;Fk; - ,iuj;JtpLk 
  gpj;jNjh \j;ijg; gpwtypg;ig khw;wptpLk; 
  cw;wrHt ty;yp\k;Nghf;Fk;. 
      - Pathaartha Gunapadam 
 It cures Asthma, Kabam, pitha thosham, sarvavisham, vata kaeduppu, pain.  
Therapeutic uses:-  
 For the treatment of skin disease in powder (dose: 5 to 10 grains) or Tincture (1 in 
10); dose: ½ to 1 drachm paste made with any brand oil to apply locally in skin 
disease.  
 The rhizomes are useful in rheumatism and catarrhal affections. 
 Tubers and seeds are used as a fragrant adjunct to complex prescriptions.  
 It is a good remedy for impotence and nervous debility & respiratory ailments 
 The paste of Galanga in honey lessened the paroxysms of cough in children 
suffering from whooping cough.  
 The antispasmodic action of the drug may also prove useful in condition like 
asthma.  
It is useful for intestinal & biliary colic, diabetes mellitus, dyspepsia, fever, incontinence 
and destroy smell in mouth &other parts of the body & used to improve the voice in 
throat infection.  
 
PERARATHAI CONTAINING BRONCHIAL ASTHMA MEDICINES 
I. NEI:- 
1. Thoothuvalai Nei 
 Indication - Bronchial asthma, Tuberculosis. 
II. RASAYANAM:- 
2. Thippili Rasayanam 
 Indication - Bronchial asthma, Cough, Tuberculosis. 
III. LEGIUM:- 
3. Sarapangavilvathi legium 
 Dose  - 1 ¼ Varaganedai. 
 Indication - Sayam, ulcer, dysentery. 
OTHER MEDICINE 
1. Panjamoola Chooranam. 
2. Amukkara Chooranam. 
3. Karunkozhi Chooranam. 
4. Narasimma legium. 
5. Nilappanai Kirutham. 
6. Nanthi Nei 
7. Yeranda Thailam. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nguhj;ij 
ALPINIA GALANGA, Wild. 
3.3.2.  BOTANICAL ASPECT 
Taxanomic Classification: 
 Kingdom - Plantae 
Order         -  Zingiberales 
Family     - Zingiberaceae 
Subfamily - Alpinioideae 
Genus        - Alpinia 
Species     -     Galanga 
Vernacular Names: 
       Tamil  - Perarathai  
 Sans  - Dhumbarastma 
 Hindi  - Barakalinjan 
 Marathi - Koshtkulinjan 
 Malayalam - Peraratha 
 Gujarat - kolinjan 
 Portuguese - Galanga 
 Telugu  - rash – trakam 
 English - Greater galangal 
HABITAT: 
 Distributed throughout the topics, Java, Sumatra, South India, and Bengal. 
 Widely distributed mainly in the Eastern Himalayas and South West India. 
Parts used: Rhizome 
Actions: 
 Aromatic, Stimulant, Bitter, Stomachic, Carminative.  
Distribution:Throughout the Western Ghats are curtivated 
 RHIZOME: 
 The rhizomes are cylindrical, irreqularly branched and often bent like knee size 5 -
10cm long upto 20 cm. 
 Brownish red externally pale brown internal surface marked with five annuli of 
lighter colour than the general surface.  
 Aromatic odour 
Taste: Characteristic spicy, aromatic, pungent. 
DESCRIPTION 
 The leaves are 23 – 45 by 3.8 – 11.5 cm long. Simple arranged distichously and 
having sheathing leaf bases and ligules, lanceolate with a strong mid rib and numerous 
ascending parallel veins 
Types of galangal Rhizome: 
 Alpinia calcarata – Rose Substitute for Alpinia galangal cultivated in Honghong. 
 Alpinia officinarum Hance (or) lesser galangal  Native of China. 
CONSTITUENTS:- 
 According to chemist Jahus, galanga root contains these three different 
compounds campheride, galangin and alpinin. From the green rhizomes, a pale 
yellow volatile essential oil with a pleasant odour can be obtained on distillation. 
The oil contains 48% of methyl cinnamate, 20 to 30% of cincole; camphor and 
probably d – pinene.  
Phytochemistry:- 
 Isolation of 1 – acetoxy chavicol acetate, 1 – acetoxy eugenol acetate and 1 – 
hydroxy chavicol acetate, new diterpenes, galangal A and galangal B and characterised 
isolation of new compound di – (p – hydroxyl – cis – stryl), methane along with 17 – 
hydroxy cinnamol dehydrate from rhizomes. 
Medicinal Uses:- 
 Rhizome is used to treat asthma, diabetes mellitus, bronchitis, rheumatic arthritis, 
and nervine tonic.  
 The tubers & seeds are said to possess carminative properties may be used in 
producing a reflex increase in the bronchial secretion. 
 It improves appetide, taste, voice and used in head ache, chest pain, sore throat, 
burning sensation of liver, disease of kidney. 
 The rhizomes are bitter, acid, thermogenic, aromatic,nervine tonic, stimulant, 
carminative, stomachic, disinfectant, aphrodisiac, expectorant, bronchodilator, 
febrifuge, anti – inflammatory and tonic.  
 They are useful initiated conditions of vata & kapha, RA inflammation, 
Stomatopathy, cough, asthma, hiccough, dyspepsia and intermittent fever. 
3.3.3. LATERAL RESEARCH: 
 Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ (25–35) 
induced amnesia in mice. 
J.C. Hanish Singha, V. Alagarsamyb, Prakash V. Diwana, S. Sathesh 
Kumarc, J.C. Nishad, Y. Narsimha Reddye. 
AIM OF THE STUDY 
 This investigation is designed to screen cognitive improvement of Alpinia galanga 
(AG) fractions in Alzheimer's type of amnesia in mice induced by Aβ(25–35). 
MATERIALS AND METHODS 
 Alzheimer's disease induced mice treated with fractions (n-hexane, chloroform 
and ethyl acetate) of AG in 200 and 400 mg/kg. Neurotoxicity was induced by 
intracerebroventricular injection of Aβ(25–35) on the 14th day of 21 days drug treatment. 
Open field and water maze were carried to determine habituation memory and 
hippocampal memory. Na+/K+-ATPase, acetylcholinesterase (AChE) and antioxidant 
enzymes (SOD, GPx, catalase and vitamin C) were determined in brain tissue 
homogenate to estimate the brain biochemical changes and its anti-amnesic potential with 
intensity of oxidative stress signaling. Further bioactive (chloroform) fraction was eluted 
through column chromatography to identify the lead molecules. 
RESULTS 
 Increased habituation memory and decreased escape latency in behavioral 
parameter are the indicative of the cognitive enhancement after treatment with Alpinia 
galanga fractions. Increment in Na+/K+-ATPase and antioxidant activity depicts brain 
membrane integrity improvement and free radical scavenging property. AChE level was 
decreased to improve the cognition by enhancing cholinergic transmission. 
 
 
 
 
 
 
 
3.4. jpg;gpyp 
PIPER  LONGUM. Linn... 
1.4.1. GUNAPADAM ASPECT: 
 Other names: 
 ‘jpg;gpypapd; NgHjidNa nrg;gf; NfS 
  jPl;rz jz;LyfkhF ... khFk; 
 gg;gpypghshf;fp ahk; rgykhFk; 
  ngUj;j rTz;brpakhKgFy;ypa khFk; 
 tg;gpypahk; itanjf;f Nfhydhkk; 
  thjFd;kj; jphpNjh\ ehrdpAkhFk; 
 fg;gpypahq; Nfhdbjid aWf;Few; #jd; 
  fUjpaNjhH jpg;gpypapd; ehkkhNk”. 
      - Pogar Nigandu  1200 
Aarkathi, Unsaram, Uluvainaasi, Kaaman, Kudaari, Kolagam, Koli, Saram, Saadi, Ambu 
 ‘trdpj;j rykhd rydhq; nfd;Wk; 
 tykhd fhzhtjp nad;Dk; NgU 
Jrdpj;j Njtdhjp nad;Wk; NgU 
 Jjpahd fhzpnad;W kpjw;Fg; NgU 
jrdpj;j ntypthhp nad;Wk; NgU 
 fUthd Ntfhe;j nkd;wpjw;Fg; NgU 
rdpj;j Nghjf nkd;wpjw;Fg; NgU 
 trdpj;Njhe; jpg;gpypf;fp mjPjg; NgNu” 
     - Agasthiyar Panjakaaviya Nigandu 
 
 Parts Used   -  Roots, Dried spikes.  
 Colour    - Brownish grey 
 Odour   - Aromatic 
 Taste   - Sweet 
 Character   - Veppam 
 Biotransformation- Sweet 
Actions: 
 Stimulant 
 Carminative  
GENERAL CHARACTER : 
“,Uky; Fd;kk; ,iug;G fag;nzp 
 <is ghz;Lre; epahrk; mNuhrfk; 
 nghUky; Cij rpug;gpzp %Hr;irNeha; 
 G+hpf;FQ; ry Njh\k;gp yPfKk; 
 tUkUg; ngUf; NfhL kNfhjuk; 
 thjk; MjpKj; Njh\e; Ruq;FspH 
 ngUk iyg;Ghp Nkfg; gplfKk; 
 NgUe; jpg;gpypg; Nguq; Fiuf;fNt”. 
     - Pathaartha guna sinthamani  
 It cures cough, ulcer, bronchial asthma, and Anemia, Headache, Fever, vaatham, 
Nose and ear disease. 
 ‘MrdNeha; njhz;ilNeha; Mtuz gpj;jKjy; 
 ehrptpop fhjpitNeha; ehl;GONeha; - tPrpUtp 
 aq;fyhQ;r dQ;rpijAk; mk;gha; moptpe;Jk; 
 nghq;fyhQ;r eq;ifaH Nfhl;Nghy;”. 
     - Theraiyar Gunavagadam 
It reduces cough, throat infections and it cures nose, eye, and ear diseases. 
THERAPEUTIC USES OF PIPER LONGUM 
 Thippili powder along with betal leaf juice and honey is used for expectoration, 
cough and fever. 
 Thippili and Tran powder is used for menorrhagia and leucorrhoea. 
 Thippili powder is mixed with honey to take one month for tinea versicular infection. 
 Useful for gout, lumbago, dyspepsia, stomachalgia spleenopathy. 
 It cures anorexia, epilepsy, fever, gonorrhoea, hiccough, asthma, bronchitis, 
hemorrhoids.  
 THIPPILI CONTAINING BRONCHIAL ASTHMA MEDICINES 
I. CHOORANAM:- 
1. Thippiliyaathi Chooranam 
 Dosage  : 1 – 2 gram 
 Adjuvant : Honey 
 Indications : Cough, Kabam, headache. 
II. THAILAM:- 
 2. Nochi thailam 
 Dosage  : Kaasalavu   
Internal / External 
 Indications : Bronchial asthma, Tuberculosis 
III. VADAGAM:- 
 3. Nelli Vadagam 
 Dosage  : Kottai pakkalavu 
 Indications : Cough, Eelai 
IV. NEI:- 
 4. Thasamoolaathi Nei 
 Dosage  : Karandi alavu  
 Adjuvant : Milk 
 Indications : Bronchial asthma 
V. LEGIUM 
5.Sandamaarutha leg 
 Dosage  : Thaanrikkai alavu 
 Indications : Bronchial asthma, TB, Cough 
jpg;gpyp 
PIPER  LONGUM. Linn... 
3.4.2. BOTANICAL ASPECT 
Taxonomic  classification      
 Kingdom -    Plantae 
Order  - Piperales 
Family - Piperaceae 
Genus  - Piper 
Species -       longum 
Vernacular Names: 
 English - Indian long pepper 
 Hindi  - Papal, Pipli 
 Kannad - Hipli 
 Malay  - Tipli 
 Marathi - Pimpali 
 Sanskrit - Pippali 
 Tamil  - Thippili 
 Telugu - Pippallu 
HABIT 
 Stems creeping below; young shoots downy; branching prostrate or creeping with 
broad leaves, flowering shoots erect; lower leaves 5 – 7.5 cm often rounded ovule, petiole 
2.5 – 7.15 cm, upper leaves much narrower with often unequal basal lobes; male spikes 
2.5 – 7.5cm, female 1.25 – 2cm, fruits about 0.22cm.  
 The mature spikes collected sand dried from the commercial from of pippali, roots are 
known as pippalimulam 
Distribution:Throughout India, in evergreen forest; often cultivate. 
FRUITS 
1. In transaction of the fruiting spike are seen one seeded fruitlets arranged in a circle 
on the main axis. The pericarp of the fruit has zones of epicarp, mesocarp and 
endocarp. 
2. The secretory cells are present in the outer part of epicarp and round and oval type 
cells of sclerenchyma mesocarp has thin walled collapsed parenchymatous cells. 
Endocarp is ovary and filled with dark brown contents.  
3. Sometimes the outer end of endocarp forms a dome like structure covering a few 
cells of endosperm and embryo. The major portions of the fruit under endocarp 
consists of perisperm, the cells of which alternative, digestive, febrifuge, stimulant 
and tonic. It used in abdominal distension, ascities, colic, consumption, cough, 
emaciation, fever, piles, weakness and worms.  
CHEMISTRY 
 The main chemical constituents of long pepper are major alkaloid piplartine which 
is isolated by Atal. Initially its structure was thought to be a piperidide of trimethoxylin 
cinnamate acid but the some chemical appears to have been reisolated subsequently given 
the name piper longumine. 
 The fruit contains 
 n – Cicosane 
 D -hydro stigmestesol 
 n – Heneosane 
 Piperine 
 Alpha – thyene.   
THE LEAVES OF PIPER LONGUM CONTAINS 
 Hentriacontane 
 Triacentanol 
 Betal sitosterol 
 USES 
1. Piper longum in specifically used in bronchial asthma. To evaluate this action its 
antihistaminic effects were seen. Piper longum did not showed any significant 
effect on total quantity of histamine in lungs. 
2. The petroleum ether extract of piper longum produce respiratory stimulant effect 
in smaller doses. Fruit decoction exhibits a potent anti inflammatory 
activity.It also has an anti bacterial, anti tubercular, Anti – fertility activity. 
3. Inhibitory effect of essential oils of Allium sativum and Piper longum on 
spontaneous muscular activity of liver fluke, Fasciola gigantic 
 
 
3.4.3. LATERAL RESEARCH: 
Thakur Uttam Singh, Dinesh Kumar, Surendra Kumar Tandan, Santosh 
Kumar Mishra 
Abstract 
 Effects of essential oil of Allium sativum (garlic) and Piper longum (Indian long 
pepper) were evaluated on muscular activity of whole Fasciola gigantica and its strip 
preparation. The whole flukes and longitudinal strip preparations of the flukes were 
isometrically mounted to record the spontaneous muscular activity (SMA) and to evaluate 
effects of cumulative doses (0.1, 0.3, 1.0 and 3.0 mg/ml) of the plant essential oils. Whole 
flukes and the strip preparations exhibited continuous SMA without any significant 
difference in its baseline tension, frequency and amplitude for 2 h. Essential oil of A. 
sativum produced significant reduction in the frequency and the amplitude of the SMA of 
whole fluke at 1 and 3 mg/ml concentrations. It caused complete paralysis of the fluke 
after 15 min of administration of 3 mg/ml concentration. Similar to whole fluke, essential 
oil of A. sativum (3 mg/ml) also produced flaccid paralysis in the strip preparations of the 
flukes. Essential oil of P. longum firstly induced marked excitatory effect and then there 
was flaccid paralysis of the whole fluke following 15 min exposure at 3 mg/ml 
concentration. Complete flaccid paralysis of the strip preparation was also ensued after 15 
min of administration of 3 mg/ml concentration of P. longum. In both the essential oils, 
the whole fluke and strip preparations did not recover from paralysis following 2–3 
washes. In conclusion, the observations demonstrated irreversible paralytic effect of 
essential oils of A. sativum and P. longum on F. giganticain vitro which might possibly 
help to developing herbal-based anthelmintic. 
  
3.5. f];J}hp 
MOSCHUS MOSCHIFERUS.Linn.. 
3.5.1.GUNAPADAM ASPECT  
Other names: 
“f];J}hp NgHjidNa fUjf; NfS 
 fhsfj;jpw; fhkpUfq; NfhkpUfkhUQ; 
 ej;J}hp ehgpkpU fhz;lkhFk; 
 eykhd kfr;rhuk; Ntj Kf;fpar;  
 kj;J}hp kjnfe;jk; ntspfhthk; 
 kfj;jhd fU\;zpahk; thjehrdpAkhFk; 
 rpj;J}hp tf;fpu rhug;gpakhFk; 
 rpl;rpahq; f];J}hpg; NgUkhNk”. 
  - Pogar Nigandu1200 
 Kanagathiraga mirugam, Sumatho mirugam Magaccharam, Vethamukkiyasam, 
Mathagantham, Karushni, Vaathanaasini, Vakkira Saarappiyam. 
“trdpj;jf; fypKjis ifar;nrhyhjp nad;Wk; 
  tskhd re;jd Jiugjhjp nad;Wk; NgU 
  trdpj;j nte;jyhfk; tpWthJb nad;Wk; NgU 
  tpjpjpnkd;w kUkhypir nad;Wk; NgU 
  mrdpj;j thWKiw kjpnad;Wk; NgU 
  mlthd epfhpy;yhg; NgUkijr; nrhy;Nthk; 
  Jrdpj;j nrq;fjpH thopnad;Wk; NgU 
  jq;ifnaDq; f];J}hp thrkjpd; NgNu” 
 - Agasthiyar Panchakaviya Nigandu 
Maargam; Maarchaari, Maanmatham, Naabi, Miruganaabi 
     - Gunapadam Thaathu Jeevam 
 Colour : Pazhupudan koodiya Karupu niram 
 Taste  : Bitter 
 Character : Veppam 
Distribution: -America, Europe, Asia, China, Kashmir, Assam, Russia 
Types: 
 Kaamruba 
 Nepali 
 Kashmiri 
 
Action: 
 Stimulant 
 Tonic 
 Anti spasmodic 
General characters: (Pothu gunam) 
‘nrhy;yUk; trpaq; fhe;jp 
 RfKjy; mZFk; gpd;Dk;  
 nky;ypahH jkf;F ehjk; 
 tphpj;jpahk; jiyNeh NaFk; 
 gy;Y}W fgKk; jPUk; 
 gfnuhzhg; gyKk; cz;lhk; 
 ky;ylh re;ep &l;ir 
 khWq;f]; J}hpf; nfd;Nd”. 
Theraperctic uses: 
 It mix with betal leaf to use alterative.  
 It add in the Mahaaraja mirugaangam, Poornasanthirothaiyam and 
Aphrodisiac medicines. 
 It cures cough and reduces heart disease. 
 It cures vomit, headache, sinusitis, fever 
 It curves bronchial asthma, vaatham, stomach disorders, and ulcers.  
 KASTHURI CONTAINING BRONCHIAL ASTHMA MEDICINES 
I. YENNAI:- 
1. Santhanaathi Yennai 
External application (Head bath) 
 Indication - Eye disease, Sinusitis. 
II. MAATHIRAI:- 
2. Kasthuri Maathirai 
 Dose  -  1 Pill 
 Adjuvant - Mother’s Milk 
 Indication - Kabarogam, fever, Epilepsy. 
      3. Amurthasanjivi Kuligai 
 Dose  :  1 Pill 
 Adjuvant : Piper betle leaf 
 Indication : Cough, Sanni. 
 
 
III. MELUGU 
4. Kasthuri Melugu 
 Dose  :  Payiralavu 
 Adjuvant : Honey. 
 Indication : Fever, Kabam, Vatham. 
IV. KARUPPU 
5. Kasthuri Karuppu 
 Dose  :  ½ - 1 Kunrimani 
 Adjuvant : Honey. 
 Indication : Bronchial asthma. 
 
 
  
 f];J}hp 
MOSCHUS MOSCHIFERUS.Linn...  
3.5.2.ZOOLOGICAL ASPECT  
Taxonomic Classification: 
 Scientific  - Classification 
 Kingdom - Animalia 
 Phylum - Chordata 
 Class  - Mammalia 
 Order  - Artiodactyla 
 Suborder - Ruminantia 
 Infraorder - Fecora 
 Family - Moschidae 
 Genus  - Moschus 
 Species - Moschus moschiferus. 
Vernacular Names: 
 Sam  - Kasturi, Mrigumadha  
 Eng  - Musk 
 Arab E pers  - Mishu 
 Hind 
 Ben 
 Guj 
 Mah   Kanturi  
 Leon  
 Can 
 Tamil 
 Mal 
 Duk  - Mushk 
 Sinh  - Urula 
 Burma  - Kado 
 
 
 
 
 
SOURCE  
 Musk Producing animal (musk – deer) is found generally in china, Russia, Assam, 
central Asia, and pine forests and the inaccessible differ above 8000 feet of Himalayas. 
Russle his found in their animals only in the rutting season and undoubtedly for 
the purpose of attracting the female. 
Chinese traders say that the best kind of musk in not obtainal from euchred 
animals, but is gathered from the favorite hands of the deer, after the retting season, when 
the animals break the gland in the hoof and empher the contents on the ground. Nussle of 
this cind in therefore, rarely seen on the market. 
SIZE 
 A little creature not more than 20in. (50cm) high at the shoulder, slightly higher at 
the croup. 
DISTINCTIVE CHARACTERS 
 The musk Dear holds a place between the deer and the antelopes. It is regarded as 
an undeveloped form of deer which has not progressed with the rest of its family. But is 
hornless and has no face glands. These are generally present in all dear, and it has a gall 
bladder which no deer possesses. In some ways it has taken a special line of development 
of its own. This is seen in its possession of a caudal gland and a musk gland. The tail of a 
musk deer is peculiar. It is completely buried in the loin hairs of the anal region and is for 
the most part naked except for a large tuft at the tip and a tuft at the base which covers its 
upper surface and sides. The lateral surface of the tail bears in its flaccid skin a narrow slit 
which is the opening of the caudal gland. The musk gland situated beneath the skin of the 
abdomen of the males. When fresh its secretion has an unpleasant, pungent, urinary 
Adour; when dry it acquires the scent of musk. Valued as a commercial product, it 
induces the persecution of the species. From the great development of the caudal and 
musk glands, it is inferred that in this deer the females seek out the males in the breeding 
season. Finally, musk deer have especially mobile feet, the long pointed central hooves 
and unusually large lateral hooves being well adapted to give it a foothold on showy 
slopes and slippery rocks. The absence of horns is compensated for by the great 
development of the canine teeth, particularly in the males. 
 The musk Deer wears a comet of thick and bristly hairs, almost pithy in structure. 
The general cooler is a shade of rich dark brown speckled with grey. 
 
DISTRIBUTION 
 Musk Deer range over a wide area in central and north eastern Asia. The 
typical form M...Moschiferus is found in Kashmir, Nepal and Sikkim. 
HABITS 
1. Musk Deer Live singly or in pairs and are generally met with in birch forest above 
the zone of the pines; at times they come down to lower levels, but always keep in 
thick cover. They scrope out a shallow form in which they lie concealed and come 
out to feet in the morning and evenings. 
2. The breeding season is believed to be in January and the young are born in June.   
3. Which is milky, and bag an unpleasant small. A full grown back gives about two 
ounces, but specimens containing one - third to one - half of an ounce of must are 
common. “The odour of musk is so strong that it can be perceivedat a distance 
when the animal is shot and it is said that the hunters very frequently suffer from 
the strong odour emanating from the fresh musk as it acts deleteriously on the 
nervous system eye - sight and hearing. 
ACTION  
 According to Ayurveda, musk is a diffusible stimulant, anodyne, antispasmodic, 
cardiac, expectorant diaphoretic, and diuretic, laxative, antiseptic and aphrodisiac. It acts 
principally on the heart and the nervous system. It exhilarates the mind and stimulates the 
brain, spinal cord ant the peripheral nerves. It improves the circulation and raises arterial 
tension. It is a stimulant of the urino - genital orgens. It is also reputed to stimulate the 
respiratory centre.  
 It is eliminated in the urine, sweat and milk. When taken, its first effects are to 
stimulate the vascular system and the brain. After a time it acts as a narcotic or soporoific. 
Uses: 
 Musk is largely used in perfumery, its aroma being very lasting and holding more 
evamescent perfumes with it “perfumers use musk for imparting an odour to scaps, 
powders, and mixing liquid perfumery”. In indigenous medicines of India musk is used 
as nerve sedative in epilepsy, hysteria and convulsions in children, and as an 
antispasmodic and anodyne in low fevers, chronic cough, general debility and 
impotence.  Its fame as a cardiac stimulant is so great that it is almost the last resort 
when everything else has failed to support the heart. In western medicine as a diffusible 
stimulant it is used in various adynamic fevers as typhoid, typhus, and typho - remittent 
fevers and in all. Typhoid conditions as collapse of delirium tremors, coma, typhoid, 
pneumonia; as an antispasmodic it is given in “gout, in lock - jaw or tetanus, 
hydrophobia, epileptic form and hysterical attacks, chorea, whooping cough, hiccup, 
asthma, colic, laryngismus stridulus, etc.. Musk externally applied to the body acts 
through the pores as a rejuvenator. In palpitation of the heart it is useful. “It is prescribed 
sometimes alone and sometimes in combination with ‘Makaradhwaja’ (insoluble 
sulphide of mercury) and sida cordifiolia”.  
ADULTERATION OF MUSK AND THEIR TESTS FOR GENUINENESS  
 On account of the great demand and the difficulty of obtaining it musk is very 
frequently adultered with inert substances such as dried blood, liver, etc. Vegetable 
products such as beans, wheat grains, barley grains, etc., are also mixed with the 
commercial article at the time of preparing.Whenever any doubt exists; a few grains are 
extracted from the pod and placed in water.It these remain gravy the musk is genuine, and 
if these malt the musk is the false or adulterated.Nothere test is to place a few grains on a 
live piece of charcoal. If these melt and bubble, the musk is pure if they at once harden , it 
is adulterated.Genuine musk even when buried does not change its odour, luhile impure 
or adulterated musk gives out an entirely different smell.Aduterated musk can also be 
detected by touch. Genuine musk is soft and adulterated musk is stuff to the touch.An 
interesting popular test for musk has been reported from the Punjab. A thread is passed 
through asafetida and then through the must pod. If after this, the smell of asafoetide 
remains the music is not genuine. 
 
 
 
 
 
 
 
 
 
 
 
 
3.6.mjpkJuk;       
GLYCYRRHIZA GLABRA. Linn. 
3.6.1.GUNPADAM ASPECT: 
 “mjpkJuk; NgHjidNa mwpaf; NfS 
  ml;bf kJfkhq;fptp jfKkhF 
 kjpkJu khJukh kJuhfpu khFk; 
 ty;ypnad;w kJfkh klrp kakhFe; 
 jpjpkJuQ; rpwpjrpH NkhtaKkhFQ; 
 rpwg;ghd fh\nkd;w kJukhFk; 
 gpjpkJuk; gpj;jdh rdpAkhFk; 
 NgrpaNjh ujpkJuk; NgUkhNk”. 
 Madhugamangi vithagam, Maathurama, Mathurasiam, Mathugama, 
Madasimayam, Kaashamathuram, Pithanaasini. 
DISTRIBUTION  
 Cultivated in Punjab and the sub – Himalayan tracts. 
The Plant:- 
 A tall perennial under – shmb about 1m high; leaves compound; leaflets 4 – 7 
pairs; flowers violet in racemes; pods, oblong to linear, flattened; seeds reniform. 
 The liquorice of commerce is the dried underground stem and roots. Its outer 
surface in pale chocolate brown in colour, flexible and fibroces and intemally has 
a light yellow colour. It has a characteristic pleasant sweet taste. 
Description:- 
 Perennial small spreading herb with pinnate compound leaves; purple flowers. 
Medicinal Parts:- 
 Root, underground stem; leaves; Taste: Sweet. 
 Chemical constituents: 
 Glycyrrhizin; glyciyrrhizic acid, It is 50 times sweeter than the normal sugar. 
Alyeosides, steroids, glucose; sucrose; resin; starch and essential oil. 
 Medicinal properties:- 
 Anti – emetic  
 Anti – inflammatory 
 Aphrodioiac 
 Appetizer 
 Blood purifier 
 Cooling 
GENERAL CHARACTERS: 
“fj;jpahp Kg;gpzpahy; tUGz; jsfq; 
 fz;Nzhapcd; khjk; tpf;fy; typntz;F\;lk; 
 gpj;jhYk; GUf;fpfphpr; ruk; M tHj;jk; 
 gpj;jkj %Hr;irtpl ghfk; ntg;gep 
 jj;jptU thjNrh zpjq;fh khiy 
 rUttplq; fhkpaNeha; jhJel;lq; 
 &j;jpUky; Mrpaq;fk; ,jo;Neha; ,e;J 
 Fgg; GzkpNghk; kJ}f;nkdf; $Wq;fhNy” 
                                 It cures eye disease, cough, tongue disease, pitham. 
 
 “Gj;jpf;F tpj;jhFQ; re;jhge; jPHf;Fk; 
 Gife; jjLf;FQ; Nrl;Lkj;ijg; gpj;jNuhfj;ij 
 mj;jpg;gw; epdNkfe; jd;idth jj;jpid 
 tWj;jpLk;tr; rpunk d;gh ejpkJue;jidNa” 
- Fzghlk; %ypif tFg;G 
Traditional Uses 
 It is cooling, tasty, induces heaviness useful in opththalmia, deranged bile, 
oedema, removes pimples and dermal ulcers, decreases thirst and is used in treatment of 
hairs.  
ATHIMATHURAM CONTAINING BRONCHIAL ASTHMA MEDICINES 
I. CHOORANAM 
1. Athimathura Chooranam 
Dosage  : 5 – 15 Kunri alavu 
Adjuvant : Honey 
Indications : Asthma, Cough, fever. 
2. Madhurathi Chooranam 
Adjuvant : Honey 
Indications : Asthma, Cough, Tuberculosis, Kabam. 
 
 
 
II. MAATHIRAI 
 3. Amirthathi Kuligai 
 Dosage  : 1 – 2 pills 
 Adjuvant : Honey 
 Indications : Asthma, fever, Maantham. 
III. VADAGAM 
4. Athimathura Vadagam 
 Dosage  : 2 pills 
 Indications : Asthma, Cough. 
IV. ELAGAM 
5. Kandangathiri elagam 
 Dosage  : 5 gram 
 Indications : Asthma, Cough, Kabam. 
V. THAILAM 
6. Athimathura thailam 
 Dosage  :  External use  
 Indications : Cough, Kabam, Headache 
VI. KIRUTHAM 
7. Aswaganthi Kirutham 
 Dosage  : 5 gram 
 Indications : Asthma, Kabam, Elaippu. 
VII. KASAYAM 
8.Athimathura Kasayam 
 Adjuvant : Thippili Chooranam 
 Indications : Asthma, Cough. 
 
 
 
 
 
mjpkJuk; 
GLYCYRRHIZA GLABRA                                                                                      
3.6.2.BOTANICAL ASPECT:                                                                                 
Taxonomic classification: 
 Kingdom - Plantae 
 Order  - Fabales 
Family - Fabaceae 
 Subfamily - Faboideae 
 Genus  - Glycyrrhiza 
Species - G. glabra:                     
 Vernacular names:  
English            - Licorice 
 Hindi  - Mulhathi 
 Karnad - Testhamadhu 
 Marathi - Testhamadha 
 Malayalam - Trattimadhuram 
 Sanskrit - Yashtimadhu 
 Tamil  - Atimaturam 
 Telugu - Atimadhuramu 
 THE PLANT 
 A genus of perennial herbs and under shrubs distributed in the sub tropical and 
warm temperate regions of the world, chiefly grown in the mediterranean countries and 
china. It is hardy herb attaining a height upto six feets, leaves are multi folate,  flowers 
are in axillary spikes, papilionaceous, lavender to violet in colour, pods are compressed, 
containing reinformed seeds. The licorice of commerce is the dried under ground stems 
and roots. Its outer surface is pale chocolate brown in colour, flexible and fibrous and 
internally has a light yellow colour. It has a characteristic pleasant sweet taste.  
NUTRITIONAL CONSTITUENT 
 B1 B2 B3, B5, B6 inositol biotin 
 Minerals 
 Phosphorus 
 Manganese 
 Iodine 
 Chromium 
 Zinc 
CHEMICAL COMPOUNDS 
 Saponins 
 Liquritic acid 
 Glycrrhetol 
 Glabrolide 
 Isoglabrolide 
 Licoric acid. 
FLAVONOIDS AND ISOFLAVONOIDS:  
The flavonoids impart the yellow colour to licorice. The main flavonoid is liquid other are  
 Isoliquritin    
 Liquritingenin    
 Glycerin 
 Glycerol 
 Glycrrhetic acid 
 Glycrrhetol 
 Glycrrhizic acid 
 Glycyrrhizine 
 Glyzaglabarin 
 Some of the above properties are confirmed by extensive research on licorice. It 
has been proved to be oestrogenic, demulcent, anti oxidant, anti inflammatory, demulcent, 
anti oxidant, anti inflammatory, anti ulcer, anti allergic, anti spasmodic and expectorant.  
Medicinal Uses:- 
 cholera; cough; epilepsy, haematemesis; heart disease; micturition of urine; skin 
disease;  vomiting; wound, healing.In vitro and in vivo neuroprotective effect and 
mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra  
3.6.3. LATERAL RESEARCH: 
ABSTRACT 
 Stroke is a life-threatening disease characterized by rapidly developing clinical 
signs of focal or global disturbance of cerebral function due to cerebral ischemia. A 
number of flavonoids have been shown to attenuate the cerebral injuries in stroked 
animal models. Glabridin, a major flavonoid of Glycyrrhiza glabra (licorice), possesses 
multiple pharmacological activities. This study aimed to investigate whether glabridin 
modulated the cerebral injuries induced by middle cerebral artery occlusion (MCAO) in 
rats and staurosporine-induced damage in cultured rat cortical neurons and the possible 
mechanisms involved. Our study showed that glabridin at 25mg/kg by intraperitoneal 
injection, but not at 5mg/kg, significantly decreased the focal infarct volume, cerebral 
histological damage and apoptosis in MCAO rats compared to sham-operated rats. 
Glabridin significantly attenuated the level of brain malonyldialdehyde (MDA) in 
MCAO rats, while it elevated the level of two endogenous antioxidants in the brain, i.e. 
superoxide dismutase (SOD) and reduced glutathione (GSH). Co-treatment with 
glabridin significantly inhibited the staurosporine-induced cytotoxicity and apoptosis of 
cultured rat cortical neurons in a concentration-dependent manner. Consistently, 
glabridin significantly reduced the DNA laddering caused by staurosporine in a 
concentration-dependent manner. Glabridin also suppressed the elevated Bax protein and 
caspase–3 proenzyme and decreased bcl–2 induced by staurosporine in cultured rat 
cortical neurons, facilitating cell survival. Glabridin also inhibited superoxide production 
in cultured cortical neurons exposed to staurosporine. These findings indicated that 
glabridin had a neuroprotective effect via modulation of multiple pathways associated 
with apoptosis. Further studies are warranted to further investigate the biochemical 
mechanisms for the protective effect of glabridin on neurons and the evidence for 
clinical use of licorice in the management of cerebral ischemia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.7.Vyk;  
ELETTARIA CARDAMOMUM, Maton. 
3.7.1.GUNAPADAM ASPECT: 
vl;lhd jpUtzpje; jpUfq;fe;J}b  
 ,ay;ghd thyhsp nad;Wk; NgU 
 Fl;lhd $dnkd;Wk; kpjw;Fg; NgU 
 $whd ehyhl;L ahgby nkd;Wk; NgU 
 el;lhd khjehyp nad;Wk; NgU 
 eykhd rpq;fhu nkd;wpjw;Fg; NgU 
 fl;lhd fl;lnkd;W kpjw;Fg; NgU 
 fUthd Ntyhprp mjw;Fg; NgNu. 
     -Pogar nigandu 
 Vyj;jpd; NgHjidNa apak;gfp NfS 
 vaj;jNakj;jpu trfhNjtkhFe; 
 J}ykhQ; #lfk; Nfhyfk; 
 Jy;ypah jpwpGlh jpwpjp NtH JbA 
 thykhk; tf;fpunfQ;j urkhFk; 
 tskhd gpNwhr;rpa Njrgj;jpiu 
 fhykhq; fhwzp fhr;rg;GlhT khF 
 fhhpakh Nkyj;jpd; fzf;Fkh 
     -Pogar nigandu 
Habitat:- 
Cultivated for its fruit in many parts of western & southern India (forests of 
Kanada; Mysore; Coorge;  Cochin); Ceylon & Burma.  
Parts used:  Dried ripe seeds; oil from fruits. 
Action:- 
 Powerful aromatic; stimulant; carminative; stomachic; digestive. These properties 
due to the essential oil contained in the seeds. 
 
 
 
 
 
 
GENERAL CHARACTERS 
“njhz;il tha;fTs; jhY Fjq;fspy; 
 Njhd;Wk; Neha;mjp rhuk;gd; Nkfj;jhs; 
 cz;ilNghy; vUq; fl;b fphPr;ruk; 
 coiy the;jprp ye;jptp \Q;Ruk; 
 gz;il ntf;iftp jhfNeha; fhrKk; 
  ghrQ; Nrhgg; gpzptpe;J el;lk; cs; 
  Mz;il aPdstd; gpj;jk; ,itf;nfy;yhk; 
  Mykhq;fko; VykUe;Nj”. 
It cures throat infection, mouth disease, Ear diseases, vomit, fever, asthma, anemia, 
tuberculosis                                                                                                                                    
ACTION AND USES 
 Aromatic, cardiotonic, carminative, cooling, diuretic, expectorant, 
stimulant and stomachic.  
 Used in consumption difficulty in micturition, piles, respiratory diseases 
and in retarded mental faculties. 
 Useful in Asthma; bronchitis; haemorrhage;  renal and vesical calculi; 
halitosis; cardiac tonic, Anorexia, dyspepsia; gastropathy; burning 
sensation; debility and vitiated condition of vata. 
Therapeutic uses:- 
 Swasam; kasam; mootrakiricharam; impotency.  
ELAM CONTAINING BRONCHIAL ASTHMA MEDICINES 
CHOORANAM:- 
1. Elathy Chooranam 
Dosage  : 1 ½ Varaganedai 
Adjuvant : Honey 
Indications : Bronchial asthma, Pitham. 
MAATHIRAI:- 
2. Korosanam Maathirai 
Dosage  : 1 Pill  
Adjuvant : Mother milk 
Indications : Cough, Kabam. 
 
 
NEI:- 
3. Thasamoola Nei 
Dosage  : 2 Kasalavu 
Indications : Bronchial asthma, ulcer. 
THAILAM:- 
4.Asanavilvathi thailam 
Dosage  : External 
Indications : Kaasam, Eelai, B. asthma. 
LEGIUM:- 
5.Nira Abaiyathi Legium 
Dosage  : Kazharchi kayalavu 
Indications : Bronchial asthma, cough. 
KIRUTHAM:- 
6. Swasakasa kirutham 
Indications : Bronchial asthma, cough, TB. 
VADAGAM:- 
7. Elathi vadagam 
Dosage  : Kazharkiyalavu 
Indications : Stomachpain, pitham. 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
Vyk;: 
ELETTARIA CARDAMOMUM, Maton. 
3.7.2.BOTANICAL ASPECT: 
Taxonomic classification: 
                    Kingdom     - Plantae 
                         Order     - Zingiberales 
                         Family    - Zingiberaceae 
                         Genus    - Elettaria 
             Species   - E.cardamomum 
Vernacular names: 
San  - Ela; truti; kapita 
Eng  - Cardamom; malorbar cardamom 
Hind  - Elachi 
Ben  - Garale; Chotielachi; chota Elachi 
Mah  -  Elachi 
Tel  - Elakkaya 
Tam  - Elakaya; Ella – kay; Elam; Elakgai 
Can  - Elakki 
Burm  - Palah; Bala 
Mal  - Raputage – Plnvar 
Pers  - Kakilahe – Khurd 
Habit:-   
 A leafy dense herb with leafy stem attaining a height of 2 – 3m with thick 
horizontal perennial rootstock; leaves 60 – 75cm long 2.5 – 5 x 7.5cm wide. Pubescent 
beneath; panicles several to one leafy stem. 2.5 – 5cm bracts linear, oblong, persistant, 
3.75 – 5; calyx 1.25cm; cordla tube shortly exserted, segments 1.25cm lip longer than 
the corolla segments white sheathed and violet, capsule sub – globose or oblong marked 
with many five vertical ribs. 
Seed: 
 Seed outer most epidermal layer is testa. The epidermal cells are fusiform. 
Beneath this is a single layer of small flattened parenchyma and long rectangular cells 
and oil cells. The inner seed coat has the beak shaped polygonal prisms and the lumen 
filled by a noddle of silica. The inner layer appears as a hyaline band. In hilum region a 
vaneul trace is visible with a few cells of xylem and a small group of phloem cells. The 
perisperm following the inner coat is parenchymatous cells are circular or polyhedral 
with starch grains along with crystals. Next to perisperm is endosperm containing a 
hyaline yellowish mass sand devoid of starch grains. The embroyo is placed at the centre 
of the seed constituting simple parenchymatous cells. 
Distribution:- 
 Malabar in the western ghats from coorg. Southwards extensively cultivated in the 
country upto 1500 m.a.s.l. 
Description: 
 A tall herbaceous perennial with  brankling root stock 1.5 – 5m in height, leaves 
subsessile; elliptic or lanceolate with sheating base flowers in panicles which are many 
for a plant arising from the base the vegetative shoots; upright first and becoming 
prostrate; lip of the corolla streaked with violet; fruits triloculor; subglobose capsules; 
marked with many vertical ribs; seeds 15 – 20 per pod; brownish black covered by a thin 
mucilaginous membrane.  
Parts used: Seeds: oil 
Properties:- 
 Aromatic (seeds)    Stomachic 
 Acrid      Diuretic 
 Sweet      Cardiotonic 
 Cooling     Abortifacient 
 Expectorant 
Constituent:- 
 Fixed oil; essential oil; volatile oil of the seeds the active principle 4 to 8 p.c and 
contains a considerable amount of terpinyl acetate; cincole; free terpinol; and propably 
also limonene are present. The following figures may be taken as covering most pure 
sample specific gravity O. 923 to O. 945; optical station: 240 to  480 refractive index 
1.4620 to 1.4675; acid value 1 to 4 ester value 90 to 150; potarsh & salts; starch; 
hitrogenous mucilage; yellow colouring matter ligneous fiber & ash containing 
manganese 
Uses:- 
 Cardomomum seeds; have a fragrant taste & aromatic odour; are generally used as 
masticatory (as a spice & as a flavouring agent). Cardomoms are employed to a small 
extent in Europe for flavouring sweetmeats. They are valuable in many stomach 
complaints. An oil extracted from the fruits is used both in pharmacy & perfumery. It is 
used as carminative is convalescence after diarrhoea.  In the form of tincture of powder; 
cardamoms are used in both in Eastern & western system of medicine, a frequent adjunct 
to other stimulant bitters & purgatives. A decoction of cardamom together with their 
pericarp & Jaggery added in a popular home remody to relieve giddiness caused by 
biliousness. A compound powder containing equal parts of cardamom seeds; ginger; 
cloves  in a good stomached in ½ drachm doses in atric dyspepsia.Antioxidant and 
antimicrobial activities of essential oil and various oleoresins of Elettaria cardamomum 
(seeds and pods)† 
3.7.3. LATERAL RESEARCH: 
Gurdip Singh1,*, Shashi Kiran1, Palanisamy Marimuthu1, Valery Isidorov2 
andVera Vinogorova2 
BACKGROUND:  
 This paper describes the chemical analysis of the essential oil and various oleoresins 
of Elettaria cardamomum (seeds and pods) by gas chromatography (GC) and gas 
chromatography/mass spectrometry (GC/MS) techniques. It also compares the effects of 
the different extraction solvents used (chloroform, methanol, ethanol and diethyl ether) on 
the antioxidant and antimicrobial activities of the essential oil and oleoresins. 
 
RESULTS:  
 The essential oil was found to contain 71 compounds. The major components 
were α-terpinyl acetate (44.3%), 1,8-cineole (10.7%), α-terpineol (9.8%) and linalool 
(8.6%). The chloroform and methanol oleoresins both contained α-terpinyl acetate (21.8 
and 25.9% respectively) as the main component, while 5-hydroxymethylfurfural (28.9%) 
was the most abundant compound in the ethanol oleoresin. However, very few 
components (total 0.61%) were found in the diethyl ether oleoresin. The antioxidant 
activities of the essential oil and oleoresins, studied in mustard oil by monitoring the 
peroxide value of the oil substrate, were comparable to those of the synthetic antioxidants 
butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) at 0.02% 
concentration. The essential oil exhibited strong antibacterial activity against the micro-
organisms Staphylococcus aureus, Bacillus cereus, Escherichia coli and Salmonella typhi 
at 3000 ppm by the agar well diffusion method. Antifungal activity was tested against the 
food-borne fungi Aspergillus terreus, Penicillium purpurogenum, Fusarium graminearum 
and Penicillium madriti. The methanol and ethanol oleoresins gave the best results against 
A. terreus at 3000 ppm by the poison food method. 
 
3.8.fpuhk;G  
SYZYGIUM AROMATICUM.  Merrill & Perry 
3.8.1.GUNAPADAM ASPECT. 
mjw;Fg; NgH jphprhthjp nad;Wk; NgU 
mlthd jpUfhje;jU khjpiu nad;Wk;  
mjw;Fg; NgH tUthzpjnkd;wjw;Fg; NgU 
  thUd nkd;wpjw;Fg; NgujPjkhr;R 
 mjw;Fg; Ngulh Urp nad;Wk; NgU 
  kfj;jhd m\;l fjw;f nkd;Wk; NgU 
 nrjw;Fg; NgH rptuhd nkd;Wk; NgU 
  rPuhf nrhy;yptpl;Nlhk; ytq;fg; g+tpd; NgNu.  
                        - mf];jpaH gQ;rf; fhtpa epfz;L  
thrnkd;w ifaywp aq;fq; nfhz;lhftd  
tUFrf KiwneQ;rjpNy kfj;jhk; NgU 
fhrnkd;w jwpnfe;J}u nkd;Wk; NgU 
 YNfhNfhr; rhpG+lf nkd;Wk; NgU 
jhrnkd;wtJ ehbNt nud;Wk; NgU 
 jayhd ttuq;fuiz nad;Wk; NgU 
gPrnkd;w tpilRfe;j nkd;Wk; NgU 
 F\hjpr; fpuhk;gpdPl tPjPjg; NgNu. 
Habit:- 
 Small handsome evergreen tree attaining a height of 8 – 10 metres; leaves short; 
petiolate, elliptic, obovate, sub – acute at both ends 6.8 x 2.5.4cm coriaceous; venation 
district beneath; cyme terminal; panicle corymbose; flowers in umbellules, small; calyx X 
0.3cm long obscurely lobed; corolla calyptrate. 
Distribution:- 
 Cultivated in Western Ghats and kerala. 
 Part used :   Flower bud. 
Properties: 
 Taste   :   Pungent 
 Character  :   Veppam 
 Bio-transformation :   Pungent 
 
General characters: 
 gpj;j kaf;fKWk; NgjpnahL the;jpAk; NgU 
  Rj;jftpuj; jf;fLg;Ge; Njhd;WNkh – nkd;W 
 ,ytq;fq; nfhz;ltUf; Nfw; RfklhU 
  kykq;Nf fl;Lnkd tho;j;J 
-gjhHj;j Fz gy;nahUs; tpsf;fk; 
Action: 
 Anti – Spasmodic 
 Carminative  
 Stomachic  
 Anaesthetic  
 anodyne  
 antispasmodic  
 antiseptic 
 aphrodisiac,  
 aromatic, carminative, circulatory stimulant, expectorant, rubifacient and 
stimulant.  
Therepeautic Uses: 
 It is also used to relieve the presence of excessive gas in the digestive tract, 
Various form of gastric irritability colic dyspepsia and increase the flow of 
saliva. 
 Lavangathi chooranam made of cloves dry ginger, black pepper and fried borax 
 Taken in equal measure is useful in bronchitis. 
 Cloves heated over flame and kept in the mouth Juice swallowed improves the 
Breathe and relieves sore throat and strengthens the gum. 
 Clove stops puss formation 
 Used in aches, colic, cough, indigestion, pain, respiratory disorders, sore throat, spasm 
and weak eye sight. 
Lavangam Containing Bronehial asthma medicines 
Vadagam:- 
1. Lavangapathri Vadagam 
Dose  :  Nellikkaiyalavu 
Adjuvant : Honey. 
Indication : Bronchial asthma, fever. 
Yennai:- 
2.Lavangaathi Yennai 
Dose  :  1 drop 
Adjuvant : Water, Breast milk. 
Indication : Bronchial asthma. 
Chooranam:- 
3. Kukkulu Chooranam 
Dose  :  Verukadi alavu 
Indication : Bronchial asthma. 
4. Piraai Marunthu 
Indication : Bronchial asthma. 
Nei:- 
5. Poosani Nei 
Dose  :  3 Kalanchu 
Adjuvant : Milk 
Indication : Bronchial asthma, Hicough. 
 
6. Thasamoola Nei 
Dose  :  2 Kaasalavu 
Indication : Bronchial asthma. 
Legium:- 
7. Koozhpaanda Legium 
Dose  :  Yelumichai alavu 
Indication : Cough, Kabam, Tuberculosis. 
 
8. Poosanikkai Marunthu 
Dose  :  Yelumichai alavu 
Indication : Cough, Kabam, Tuberculosis 
 
 
 
 
 
 
 
 
 
 
 
fpuhk;G 
SYZYGIUM AROMATICUM.Merrill & Perry.     
3.8.2.BOTANICALASPECT                                                                                                                                 
Taxonomic classification 
 Kingdom - Plantae 
 Order  - Myrtales 
 Family  - Myrtaceae 
 Genus  - Syzygium 
 Species  - Aromaticum 
Vernacular names: 
Vern  - Laung 
Bengali - Laung 
English - clove 
Gujarathi - Lavang 
Hindi  - Laung 
Kannada - Laung 
Malayalam - Krambu 
Marathi - Laung 
Sanskrit - Lavang 
Tamil  - Krambu 
Telugu - Lavangalu 
Parts Used: - Dried flower bud with peduncle. 
Taste: Bitter–Acrid. 
Description:- 
 The tree is slender evergreen which grows to a height of 15 to 20m medium Sized,  
straight with semi erect branches and brittle limb, bearing bushy and greyish bark. 
Leaves: 
 Leaves posses plenty of oil glands on its lower surface, obovate oblong to Elliptic. 
6-13 cm X 3.6 cm opposite simple, glabrous, coriaceous and shining with 
Short reddish petioles. 
Flower: 
 The flowers produced in terminal corymbose, trichotomus, panicle shorty, 
Pendunculated and branched from the base with 3-20 flowers per panicle Flowers born at 
the terminal ends in small bunches are hermaphrodite in nature the stem and Bulbous 
head for sale “As whole clove” it is essential for the buds to be intack but this Is not 
important when they are required for grinding.  
 
Major constituents of clove oil 
 Eugenol: 48.05% 
 Eugenyl acete: 24.26 
 Iso caryophyllene: 14.89 
 Alpha Caryophyllene: 3.75 
Flower bud: 
Microscopically it shows the epidermis of the hypanthium and calyx teeth 
composed of straight walled cells with large stomata, the tetra hydral polen grains, the 
Fibrous layer of the anther walls, the schizolysigenous oil glands founds in all parts of the 
drug, occasional isolated pericyclic fibres, the spongy tissue of the hypanthiam, bi – 
colleteral vascular bundles arranged in ring, the central parenchymatous columella, the 
cluster crystals of calcium oxalate, the absence of store– cells, starch and prismatic 
crystals of calcium oxalate. 
Chemical Constituents:-  
 Dried flower bud contain Beta – caryophyllene, Eugenol, Acetate, Methyl 
salicylate, N – Amylcarbinol, Benzyl alcohol, Furfural, Furfury alcohol, Vanillin, 
Eugenitine, Eugenon, Galactose, Glucose, Fructose, Rhamnose, Sucrose, Gallotanic acid.  
Properties:- 
 Anthelmintic 
 Aromatic 
 Appetizer 
 Carminative 
 Stimulant 
 Stomachic 
Medicinal uses:  
 Dried flower bud – Anthelmintic, asthma, blood purifier, cold, colic, cough, 
diuretic, flatulence, tuberculosis.asthma; blood purifier, cloves – Anti – 
fertility. 
 Clove stem oil and leafoil are useful for isolation of eugenol 
 For the manufacture of vanillin. 
 Clove bud oil is a widely used in food products and in pharma ceuticals. 
 
  
3.8.3 LATERAL RESEARCH: 
Gastro protective activity of essential oil of the syzygium aromaticum and its 
Major component eugenol in different models: 
 Syzygium aromaticum, a medicinal plant commonly known as clove, is used to 
treat toothache, respiratory disorders, inflammation, and gastrointestinal disorders. From 
the flower buds of S. aromaticum, it is possible to obtain an essential oil comprised of a 
mixture of aliphatic and cyclic volatile terpenes and phenylpropanoids,Being eugenol as 
the main component.  
The aims of this study were:  
 (1) to extract theEssential oil of the flower buds of S. aromaticum,  
 (2) to identify and quantify the main component of the essential oil, and  (3) to 
evaluate its antiulcer activity using different 
 Animal models. Assays were performed using the following protocols in rats: 
 Indomethacin-induced and ethanol/HCl-induced ulcer model. Both essential oils 
from S. aromaticum and eugenol displayed antiulcer activities in the rat models of 
Indomethacin- and ethanol-induced ulcer. Studies focusing on the possible Mechanisms 
of gastroprotection were also undertaken using the following Experiments: evaluation of 
gastric secretion by the pylorus-ligated model, Determination of mucus in gastric content, 
participation of nitric oxide (NO) and Endogenous sulfhydryl in gastric protection. The 
results show that there was no Significant effect on the volume of gastric juice and total 
acidity. However, the Quantification of free gastric mucus showed that the clove oil and 
eugenol were Capable of significantly enhancing mucus production. With regard to the 
NO and Endogenous sulfhydryls, the results demonstrated that the gastroprotection 
induced by Clove oil and eugenol are not related to the activities of the nitric oxide and 
Endogenous sulfhydryls. No sign of toxicity was observed in the acute toxicity study. 
 In conclusion, the results of this study show that essential oil of S. aromaticum, as 
Well as its main component (eugenol), possesses antiulcer activity. The data suggest that 
the effectiveness of the essential oil and eugenol is based on its ability to stimulate the 
synthesis of mucus, an important gastroprotective factor. However, further 
pharmacological and toxicological investigations are required to enable its use for the 
treatment of gastric ulcer.                                                      
 
 
3.9. ,ytq;fg;gl;il  
CINNAMOMUM VERUM. Presl. 
3.9.1.GUNAPADAM ASPECT: 
 G+thdj; jphpNfhzkhyp nad;Wk; Ng 
   G+uzkh khpatdhjp nad;Wk; NgU 
 Mthd ttpw;rhjpnad;Wk; NgU 
   mq;f gdwehjp nad;Wkjw;Fg; NgU  
 Njthd nfhz;ly;t;t nkd;Wk; NgU 
   $wpNdhk; thuhd kpjw;Fg; NgU 
 Vthd Ntiuahl;L gapnud;Wk; NgU 
   ,ak;gpNdhk; yTq;fg;gl;ilajPjg; vd;dk; NgNu 
Habitat: 
 Indigenous to Ceylon, Southern India and growing in a wild state in the Western 
Ghats from the konkan southwards, and in the forests of Tennasserion.  
Part used: 
 Dried inner bark of the shoots from funcated statues and essential oil.   
Properties & uses:- 
 The bark is acrid, bitter, sweet, aromatic, astringent, aphrodisiac, deodorant, 
stimulant, and alexeteric, and expectorant, febrifuge, diuretic and carminative.                                                          
General characters: 
‘rd;d ytq;fg;gl;il jhd; FspHr;rp Az;lhf;F 
 kpd;D kpuj;jf; fUg;ig kPHf;Fq;fhz; Kd;dKW 
 Ke;jpf; fLg;gfw;W Kz;%yH Gz;NghfpUq; 
 je;jkpF G+q;FoNy fhz;” 
jhJel;lk; Ngjp rUttpl khrpaNeha; 
 kPjfpuQ; rpye;jpg; G+r;RtplQ; rhjptpl 
 khl;Lkpiug; NghbUk;g yhjpaNeha;f; $l;lkw 
 Nthl;L kpyq;fj;Jhp. 
                                             It cures Brochial asthma, poisons, vaatham. 
 
 
 
 
 
Lavangapattai Containing Bronchial asthma medicines 
Chooranam:- 
1. Pathira Chooranam 
Dosage  : Verukadi alavu 
Adjuvant :             Honey 
Indications : Cough, Asthma, fever. 
Vadagam:- 
2. Thaalisathi vadagam 
Dosage : Kottaipakkalavu 
Indications : Kabam, Vaatham, Cough. 
Rasayanam:- 
3. Thippili rasayanam 
Indications : Asthma, Vaatham, Cough. 
Elagam:- 
4. Sarabanga Vilvathi elagam 
Dosage : 1 ¼ Varaganedai 
Indications : Elaippu, Cough. 
Thailam:- 
5. Arakku thailam 
Dosage : External 
Indications : Asthma, fever, Cough. 
Maathirai:- 
6. Kukkulathi Maathirai 
Dosage : Elanthakottai Alavu 
Indications : Asthma, ulcer, piles. 
 
 
 
 
 
 
 
 
3.9.,ytq;fg;gl;il 
CINNAMOMUM VERUM, Presl 
3.9.2.BOTANICAL ASPECT:-                                                                                                                 
Taxonomic classification:                                                                                                                                                                                       
  Clas  - Dicotyledons 
 Subclars - Moncotyledons 
 Series  - Rciphnales (Dor R) Confusion 
 Family - Lauraceae 
 Genus  - Cinnamomum 
 Species - Zeylanicum 
 Vernacular names: 
 Eng  - Cinnamon 
 Hin  - Dallini, Darucini 
 Kan  - Dalcini 
 Mal  - Ilavangam, Elavangam 
Sans  -          Darusita 
 Tam  - Ilavangam, Karuva 
 Tel  - Dasini Cekka, Dalcini 
Distribution: West coast tropical evergreen and Semi – evergreen frrests. 
Description:                                                                                                                                                                            
 A moderate sized evergreen tree, 8 – 18m in height and 50cm in diameter with 
reddish broken soft bark, having numerous small warts, leave, ovate or elliptic – ovate, 
shiny above, 3 – 5 ribbed from a little above the base the side ribs ending about three 
fourths up, the base usually rounded, flowers small in anxillary or sub – terminal cymes 
or panicles; fruits ovoid berry, dark purple in colour having persistent perianth.  
 Part used: - bark, oil. 
Constituents: 
 Volatile oil, 2 percent cinnamon acid, rests, tannin, sugar,starch, mucilage, ash 
etc. Oleum cinnamomum B.P. in distilled from the cortex and consists chiefly of 
cinnamic aldehyde oxidizing into resin and cinnamon acid; also cinnamyl acetate and 
hydro – carbon and small quantities, of phellandrene, pinene, linalol, caryophyllene, 
eugenol etc, also exist. The British pharmacopoea limits the amount of aldehydes to 55 – 
65% but aoil may contain as much as 75%. 
Cinnamon Oil:- 
 Stomachic 
 Carminative 
 Emmenogogue 
 Styptic 
Bark: Carminative, antispasmodic, aromatic, stimulant, hemostatic, and astringent, 
antiseptic, stomachic. 
Uses:- 
 Bronchial asthma, cephalalgia, odontalgia, cardiac disease, diarrhoea, neuropathy, 
nausea and vomiting, flatulence, fever, halitosis and restoring normal skin colour on the 
face.  
3.9.3. LATERAL RESEARCH:                                                                                          
 The abundant use of anti-infective agents resulted in the emergence of drug-
resistant bacteria, fungi, and viruses. To overcome the increasing resistance of 
pathogenic microbes, a variety of medicinal plants have been screened worldwide for 
their antimicrobial properties. The aim is to find new, effective antimicrobial agents 
with novel modes of actions. Essential oils derived from aromatic medicinal plants 
have been reported to exhibit exceptionally good antimicrobial effects against 
bacteria, yeasts, filamentous fungi, and viruses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.10.khrpf;fha;                  
QUERCUS INFECTORIA, Olivier                                                                                                            
3.10.1.GUNAPADAM ASPECT 
General characters: 
mf;fuq;fs; Nghf;fptpLk; Mwhj ntg;ghw;Wk; 
 nkaPf;FWjp ghrpf;fha; nkd;NkYe; - jf;fnjhU 
 ghyHfz NehaPNghf;Fk; gd;Nkf Ke;njhiyf;Fk;  
 Ntyida fz;zha; tpsk;G 
     -Pogarnigandu 
It cures eye disease,mouth disorders,asthma. 
 khrpf;fha;r; Ritf; \ha kUtpa jpf;j K\;zk; 
 Ngrpa fLtp ghfk; ngUQ;rPj uj;jj; NjhLk; 
 VRWkjp rhuk; gpd; vOKis uj;j ntl;if 
 MRW %y kd;wp abj;js;sy; fz;l Nuhfk; 
Distribution:- 
 Native of Greece; Asia Minor; china and Iran; also found in Kumaun, Gahwal and 
Bijnor forests.  
The plant:- 
 A small tree or shrub 2 – 5 m in height with grey bark leaves riged, 4 – 6cm long; 
dendate yellowish in colour, the galls arise as excrescences on the young twigs; consque 
to the deposition of eggs by a small hymenopterous insect known as Adeleria gallae – 
tinctoriae. 
 The galls are spherical or pear shape a smooth and shining surface bearing spinous 
projections. It is chestnut brown in colour the galls collected before the emergence of the 
insects are best such galls have inner soft tissue of & deep greenish yellow colour those 
collected after the escape of insects will have perforations. The galls generally vary in 
size; colour and appearance.  
Past Used  :   galls 
Taste   :  Astringent.                                                                                                                  
Properties :  Astringent, Acrid, Cooling, haemostatic, Constipating, Vulnerary, 
expectorant, Tonic. 
 
 
 
Uses: 
 Useful for dysentery diarrhoea; stomatitis; cough; bronchitis; dyspepsia; fever; 
gonorrhoea; diabetes; tonsillitis; hyperhidrosts; leucorrhoea and general debility. It is very 
useful for blackening of the hair and in the antitodal treatment in cases of poisoning by 
aconite datura; nux – vomica and antimony. 
Maasikkai containing Bronchial asthma medicines 
Kuligai:- 
  1. Maruthuva amirtha kuligai 
Dosage  : 2 
Indications : Bronchial asthma, Kabam. 
 2. Amirthaathi Kuligai 
Dosage  : 1 Pill  
Adjuvant : Mother milk 
Indications : Cough, fever. 
 Legium:- 
 3. Venpoosani legium 
Dosage  : Punnai kkaiyalavu  
Indications :  Anemia. 
Melugu:- 
4. Kiragani Kabaada Melugu 
Dosage  : 5 to 10 grams  
Indications : Diarrhoea, dysentery. 
5. Rasaganthi Melugu 
Dosage  : Sundai alavu  
Indications : Kuttam, Kiranthi, Soolai 
Maathirai:- 
6. Katturaathi maathirai 
Indications : diarrhoea 
 
 
 
 
 
khrpf;fha;  
3.10.2.QUERCUS  INFECTORIA,  Olivier                                                                                   
BOTANICAL ASPECT                                                                                                                         
Taxonomic classification: 
 Phylum  - Angiospem 
 Sub – phylum - Dicotyledons 
 Division - Lignosae 
 Order  - Fagales 
 Family  - Fagaceae 
 Genus  -  Quercus 
 Species - Infectoria 
Vernacular names: 
Eng  - Sak gall; Dyer’s sak gall 
 Hind  - Majuphal; muphal 
 Kan  - Macike 
 Mal  - Masikka; Mayakku 
 San  - Kaisika; Mayaphalah 
 Tam  - Masikkai; Macakkai 
 Tel  - Maslkaya  
 Part used: Galls 
Properties: Astringent, Styptic, Tonic.  
Formation of oak gall:- 
Galls are pathological outgrowth formed on the twigs of the Dyer’s oak, Quercus 
infectoria Oliver, family – Fagaceae. These excrecences arise in consequence of the 
deposition of an egg by a small hymenopterous insect Alleria gallo tinctoriae Oliver 
(cyrnips galloctinctoriae hastig) Family – cynipidae, often known as the gall – wasp. 
On emerging from the egg, the group pieces the delicate epidermis near the 
growing point of the twig, where the egg was deposited, and a secretions from its jaws 
stimulates a rapid growth of tissue which quickly envelops the grub and forms a spherical 
excrescence. If the egg fails to hatch, no gall is produced and galls ceases. The grub 
develops at the centre of the gall, charges into pupa and finally the image, or perfect 
insect, emerges from the pupa and bores a tunnel about 2 to 2.5mm. In diameter to 
outside of the gall and escape as a small four winged flying insect. The eggs are laid in 
spring or early summer and the insect escapes after five to six months.  
 Gallo – tannic acid, the ‘Tannic Acid’ of commerce is a pale yellow, amerhous 
substance yielding bluish – black precipitates with solutions of ferric salts. It an aqueous 
solution darkens when exposed to the air with simultaneous formation of gallic acid and 
sometimes also of ellagic acid. 
 These galls which arise as excrescences on the young twigs are caused by the 
deposition of egg by a small hymenopterous insect. Adleria Gallae Tinctoriae Oliver. The 
female fly lays the egg anor in the cambium of a young shoot. The egg develops into a 
larva and gets surrounded by tissues of the developing gall. The galls are collected before 
the escape of the insect and are well dried. They are spherical or pear shaped and 
measures 5 to 6 mm in diameter.  
Constituents: 
 The principal chemical constituents of galls in Tannin or Tannic acid (Galls – 
tannic acid) 50 – 60 or 70% and 30% of gallic acid. Oak bark contains upto 
16% of tannic acid to which it owes its effect.  
 Alleppo galls contains 50 to 60% of tannis.  
 Chinese galls contains 70% of tannins. 
 Tannic acid is found to the largest extent in galls, though it occurs in a 
moderate amount in numerous plants. Main constituent of tannis in 
petadigalloglucose  
  Galls contain on principal constituents from 50 to 70% of tannis, which yields 
gallo tannic acid. They contains also a little Gallic acid (2 to 4%) ellagic acid, 
cyclogallipharic acid sugar & starch. 
Chemistry or chemical compounds:- 
 Proto catechuic acid ester  
 Infecoryl aster (M+196, C10H12O4) 
 2, 6 dimethyl proto catechuic acid methyl ester 
 Phenolic – quarcanaphthalene (C12H12O6) 
 Ellagic acid glycoside – quercoside (C32 H36 O22) 
    
 
 
 
Gallic acid:- 
 The tannis react with T – proteins to produce typical tannin effect, 
medicinally. 
 Bleeding disorders – including functional bleeding haematochezia (blood in 
stool) ulceration, topically for bleeding wounds, bleeding piles.  
 Indestinal disorders – diarrhoea, dysentery, haemorrhoids, intestinal parasites, 
rectal peolapse. 
 Excessive discharge such as enuresis, frequent urination, hyperhidrosis 
(excessive sweating) leucorrhoea, night sweating involuntary seminal 
expression.  
Characters: 
 Pure gallic acid assures the form of white or nearly colourless feathey crystals 
of a beautiful silky lusture.  
 When it’s strongly heated, the gallic acid in converted, into metagallic acid.  
 It is soluble in alcohol, sparlingly in ether.  
Uses:- 
 Gall nut is used externally for its astringent effect, it is used ointments from the 
treatment of piles and in plasters. The tannic and Gallic acids extracted from the galls are 
often used in dysentery and diarrhoea . The galls are said to find extensive applications in 
tanning, dyeing and in the manufacture of ink. 
3.10.3. LATERAL RESEARCH: 
Antiinflammatory evaluation of alcoholic extract of galls ofQuercus infectoria 
Abstract 
 Galls of Quercus infectoria Olivier (Fagaceae) possess pleiotropic therapeutic 
activities, with particular efficacy against inflammatory diseases. The present study was 
undertaken to evaluate the effect of alcoholic extract of Q. infectoria galls on various in 
vivo and in vitro experimental models of inflammation. Oral administration of gall extract 
significantly inhibited carrageenan, histamine, serotonin and prostaglandin E2 (PGE2) 
induced paw oedemas, while topical application of gall extract inhibited phorbol-12-
myristate-13-acetate (PMA) induced ear inflammation. The extract also inhibited various 
functions of macrophages and neutrophils relevant to the inflammatory response. In vitro 
exposure of rat peritoneal macrophages to gall extract ameliorated lipopolysaccharide 
(LPS) stimulated PGE2 and nitric oxide (NO) production and PMA stimulated superoxide 
(O2 −) production in a dose dependent manner. Gall extract also scavenged NO and O2 −. 
Probing into mechanism of NO inhibition in macrophages revealed gall extract to 
ameliorate the induction of inducible NO synthase (iNOS), respectively without any 
inhibitory effect on its catalytic activities even at higher concentrations. Gall extract also 
significantly inhibited formyl-Met-Leu-Phe (fMLP) stimulated degranulation in 
neutrophils. These results suggest that alcoholic extract of galls of Q. infectoria exerts in 
vivo antiinflammatory activity after oral or topical administration and also has the ability 
to prevent the production of some inflammatory mediators. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.11. Rf;F  
ZINGIBER   OFFICINALE, Rosc.                                                                                                       
3.11.1.GUNAPADAM ASPECT: 
Other names: 
  mUf;fd;> mjfk;> Muj;ufk;> cgFy;yk; 
 cyHe;j ,Q;rp> fLgj;jpuk;> Rf;F> Rz;b> nrhz;b> 
 nrsgd;dk;> nfstHzk;> etRW> ehfpuk;> knescuja;> 
 tprtNg\[k;> tpl%ba mkpHjk;> NtHf;nfhk;G 
           - Fzghlk; %ypif tFg;G 
  
Rf;Fz;lg; NgH jidNa nrhy;yf; NfS 
 fz;bahq;fhy; tPjk; tpRtkhFk; 
 Kf;FDl jhfkhk; Ngr\KkhFk; 
 Kf;fpukhq; fw;gj;jpuQ; rpWq;fpd; 
 ef;fpDl jhfjphpgQ; rhjfKkhFk; 
 rhq;fkh Awg;Gkhq; frg;GkhFk; 
 gf;fpdplj; jpwpNjh\ khdpahFk; 
 ghpghi\ehknky;yhQ; Rf;Ff;fhNk. 
- Pogar Nigandu – 1200 
Sundi, Kaalveetham, Visuvam, Nagam, Pesham, Kasapu, Urappu. 
 
Habit:- 
 A herbaceous, rhizomatous perennial, reaching upto 90cm in height under 
cultivation. Glabrous herb root stock perennial bearing many sessile tubers, leafy stem 1 – 
1.3m, leaves 15 x 35 x 2.5cm spike 5.75 x 2.5cm diameter peduncle 1.25 to 2.50cm bracts 
about 2.25cm, corolla segments lanceolate stamen dark purple as long as the lip vary 
rarely flowers and never seen in seed. 
The Plant: 
 A slender, perennial rhizomatous herb, leaves linear, sessile, glabrous, flowers 
yellowish green in oblong, cylindrical spikes, unsheathed in a few scarious glabrous 
bracts, fruits oblong capsules. The rhizomes are white to yellowish white in colour 
irregularly branched, somewhat annulated and laterally flattened. The growing tips are 
covered over by few scales. The surface of the rhizome is smooth and if broken a few 
fibrous elements of the vascular bundles projects out from the cut ends. 
General Character  
Fiyke;j neQ;nrhpg;G Njh\Nkg;gk; koh 
 %ykpiug;gpUkd; %f;FePH – thyfg 
 Njh\ kjprhue; njhlHthj Fd;kePHj; 
 Njh\ khkk; Nghf;FQ; Rf;F 
 
 thjg; gpzptap Wjw; nrtpaha; 
 typjiy typify typapU tpOePH 
 rPjj; njhLtU Ngjpg; gyNuh 
 rpfkyp Kfkf Kftpb fgkhH 
 rPjr; Ruk;tphp Ngjr; RuNeha; 
 njwpgL nkdnkhop FtHGtp jdpNy 
 aPJf; FjT aPJf;Fjth njzk;tpjp 
 apiy et RWFzKsNt Rf;F 
- gjhHj;j Fz gy;nghUs; tpsf;fk; 
It cures vaatham, ear disease, dysentery, fever, headache. 
 Rawe ginger is acrid, thermogenic, carminative laxative and digestive. It is useful 
in anorexia, vitiated condition of vata and kapha. Dry ginger is acrid, thermogenic, 
appetizer, and laxative, appetizer, laxative, aphrodisiac and carminative.  
Therapeutic Uses of dried Ginger 
 Ginger possesse Anti- Oxidant Properties and may be added to edible oils and fats 
to protect them against oxidative rancidity. This is due to phenolic constituents of 
ginger. 
 Ginger also prevents lipid oxidation due to shogaol and zingerone. 
 Ginger is valued is medicine as a carminative and stimulant to the Gastro-
intestinal tract. It is used in home for flatulence and Colic. Ginger contains anti 
histaminic factor. 
 It is include among anti depressents and it forms and ingredient of some anti-
narcotic preparations 
 An extract of ginger is used as an adjuvant to many tonic and stimulating 
remedies. Externally ginger is used as local stimulant and rubefacient. 
 Alcoholic extracts of spice have been found to stimulate the vasomotor and 
respiratory centres of anaesthetized cats they also stimulate the heart. 
 In veterinary practice, ginger is used as a stimulant and carminative in atonic 
indigestion of horses and cattle. 
 The rhizome has been found to be a new source of proteolytic enzyme. 
 
Chukku containing Bronchial asthma medicines 
Thailam: 
1. Chukku thailam 
Dosage  : External 
Indications : Cough 
Chooranam: 
2.Chukku Chooranam: 
Dosage  : 3 viral alavu  
Adjuvant : Honey 
Indications : Bronchial asthma 
Kiyazham:- 
3. Thiratchathi Kasayam 
Indications : Bronchial asthma 
Maathirai:- 
4. Kaasa kulaanthaga maathirai 
Adjuvant : Ginger juice 
Indications : Bronchial asthma 
Rasayanam:- 
5.Thippili Rasayanam 
Indications : Bronchial asthma, Couga 
Kirutham 
6. Swasa Kaasathirku Kirutham 
Dosage  : 1 Spoon 
Indications : Bronchial asthma 
 
 
 
 
 
 
Rf;F 
ZINGIBER   OFFICINALE.Rosc. 
3.11.2.BOTANICAL ASPECT 
Taxonomic classification: 
 Kingdom - Plantae 
 Order  - Zingiberales 
 Family  - Zingiberaceae 
 Genus  - Zingiber 
 Species - officinale 
Vermacular Names:- 
 Tamil  - Dried – shukku, Chukku, Fresh – inji 
 English  - Ginger. 
 Sanskrit  - Sranga Vera, Sringa – beram;   
 Hindi  - Adrak, ada 
 Ger  - Ingwer 
 Kannad  - (Dried) – Vona – shunti 
 Malayalam - Chukka 
 Telugu  - Dried – Sonti      
Distribution:- 
 Widely cultivated in tropical Asia. Ginger is cultivated in many parts of India, and 
on large scale in the warm, moist regions, chiefly in Madras, Cochin and Travancore,  
 It is an underground rhizome. 
Habit: 
 An herbaceous, rhizomatous perennial, reaching up to 90cm in height under 
cultivation. 
Root: 
 Adventitious 
Leaves:  
 Narrow, Sub-sessile, linear – lanceolate, 17.0 cm x 1.8cm, dark green, evenly 
narrowed to form a slender tip with stem –clasping sheaths. 
 
Parts used: Rhizomes (raw as well as) 
 
 
Properties:- 
    Raw ginger   Dry ginger 
 Acrid   - Acrid 
 Thermogenic   Thermogenic 
 Carminative   Emollient 
 Laxative   Appetiser 
 Digestive   Laxative 
Vitamins:- 
 Thiamine - 0.06 mg / 100 gm 
 Riboflavin - 0.03 mg / 100 gm 
 Niacin  - 0.60mg / 100 gm 
 Vit C  - 6.0 mg / 100 gm 
 Carotene - 40 mg / 100 gm 
Chemistry: 
 The major chemical constituents are oleoresin – 5.3 to 8.6% comprising of non – 
volatill pungent principles. Gingerol mainly 6 – gingerol, non – pungent substances and 
volatile oil containing sequiterpene hydrocarbon namely alpha – zingiberene,  
Action and uses:- 
 used in abdominal distention cholera, colic, diarrhoea, eye disease, dypepsia, 
fever, flatulence, heart disease, hysteria, nausea, nervous disease, tympanitis. 
 Used extensively in traditional medicine for its specific action in rheumatism and 
inflammation of liver.Useful for Dropsy; Otalgia, Cephalalgia; asthma; cough; colic; 
diarrhoea; flatulence; anorexia; dyspepsia;  pharyngopathy; cholera; nausea; vomiting 
elephantiasis and inflammation. 
Used to treat Indigestion hyperacidity, cough, Asthma, dyspepsia, Polyuria, ascites, 
diarrhoea, oedema, stomach disordes, anemia, disease of kapham, cardiac diseases. 
3.11.3. Lateral Research  
The use of Ginger (zingiber officinale Rose) as a potential anti – inflammatory and 
anti thrombotic agent.   -Thomsan M. et al  
 The effect of an aqueous extract of Ginger (Zingiber officinale) on serum 
cholesterol and triglyceride levels as well as platelet thromboxane B (2) and prostaglandin 
Ec2 production was examined. A raw aqueous extract of ginger was administrated daily 
for a period of 4 weeks, either orally or intraperitoneally to rat. Fasting blood serum was 
investigated for thromboxane – B (2), prositaglandin – ECX2), cholesterol and 
triglycerides A low dose of ginger (50mg l kg) administrated eightr orally or I.P. did not 
produce any significant reduction in the serum thromboxane – Bc2) levels when 
compared to saline treated animals.  However, ginger administered orally caused 
significant changes in the serum PGR(2) at this dose High doses of ginger (500mg 1kg) 
were significantly effective in lowering serum PGE(2) when given either orally or IP. 
However, TXB (2) levels were significantly lower in rats given 500mg1kg ginger orally 
but not ID A signiticant reduction in serum cholesterol was observed when a higher dose 
of ginger (500 mg 1 kg) a significant reduction in the serum cholesterol was observed 
only when ginger was administered levels were observed upon administration of either 
the low or high dose of ginger there an cholesterol lowering anti thrombotic, and anti – 
inflammatory agent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.12. DISEASE REVIEW 
Iraippu Noi (Bronchial asthma)  
3.12.1.SIDDHA ASPECT 
Other names:   
 Izhuppu noi, Swasam, Thoivu, Eelai, Swasakaasam.  
Nature of the disease:  
Swasakasam not comes under any perfect cause. It produces chest pain as if 
the chest is tightened. There will be breathlessness with difficulty in expiration as 
well as inspiration. The expiratory noise will makes a sound of musical instruments 
such as flute, lute and veenai. Further, even if attempt is made for expectorating the 
sputum it does not come out easily.  
Genesis of the disease:  
fhy; ngUf;FzTnghUs; jz;zPh;khwy;   
fUjpUky; kpfy;the;jp Fsph;e;jfhw;W   
khy; nra;Jehs;NjhWk; tUj;Jq;fha;r;ry;   
ke;jd Kaph;epiy apybf;jhq;fs;   
Vy; rPjNgjp tplghz;L Giffs;  
 ,yfpa ney;yhjpkzpr; RizAl;nry;yy;  
 Nky; topapw; rpythpDkpiug;ghk; NehA  
 Kdpth;fs; tpsk;gpdhNu  
It is considered that the disease may develop due to the following factors:  
 The body natural protection power is reduced because of unwanted foods and 
behaviours. In such condition the disease develops when food which can 
aggravate the activity of kapha are taken or by any other act which aggravate 
the same.  
 As a result of allergy due to grass, plant, rice and ragi, may also triggers the 
disease.  
 By smelling some foul smelling substances which are not good to the body to 
develop the episodes of disease.  
Other factors affecting the disease:  
 Eating foods which will induce excessive kapha.  
 Exposure to chill air.  
 Living in the mountains.  
 
Prodromal symptoms:  
  Generally, those who have suffered from this disease chronically can 
recognize the Prodromal symptom and also the intensity of the disease allergic to them. 
The patient on smelling the food and air which are allergic to him, will develop watery 
discharge from the nose, sneezing, chest pain as if the chest constricted. Blockage of 
natural respiration, pain at the region of ribs with breathlessness distension of abdomen 
and sweating of body are other symptoms of the disease.  
 In ancient Tamil book, the disease has not been mentioned separately. But it has 
been mentioned as two separate entities, viz. under cough disease as ‘Swasa kasa’ and 
under fire disease as ‘Swasa pitta’. The signs and symptoms of these two have also been 
mentioned.  
Types of Swasakasam:  
 Vali iraippu (Sitriraippu)  
 Iya iraippu (Periraippu)  
 Iyavali iraippu (Thinaraliraippu)  
 Mukktra iraippu (Manthara iraippu)  
 Melnokku iraippu (meliraippu) 
Signs and symptoms:  
“tdi;kahaf; Nfhioflb ,Ukp tPOk;        
  khehfk NghyNt thqF;Q Rthrk;        
jpzi;kahar; ;nrUkYzl;h kbf;f bfF;Q;          
 rPuz kpyhkNy tapW %Jk;        
edi;kaha ;ehrpaJ jzyN;gh yhFk;          
 eypeJ;lkG; tww;p tUq ;FuYq ;fkK;k;       
 czi;kah Az;zhf ;fpY}Wq ;Nfzp  
          AoeJ;Nk Rthrfh rjj;p ndhgN;g”.  
        -a+fpitj;jpa rpe;jhkzp 
 
Vali iraippu noi (or) Arpa Swasam(or) Soothira suvaasam:  
The activity of vatha dhosha gets aggravated due to, intake of food which is 
not digested easily, wandering in the hot sun rays, eating of substances such as tubers. 
The patient may feel a sensation as if nothing is inside the chest. Inspite of all these 
effects, the disease does not cause severe hardship to the patient.   
 
Iya iraippu noi (or) Manthara swasm (or) Thamaraga suvaasam: 
The disease is caused by the excessive activity of kapha, foods which aggravate 
the kapha and also on exposure to rain and chill air. The excessive activity of kapha in the 
body also affects in the head, causes nasal obstruction and watery discharge from the 
nose. But these symptoms will subside within few hours. The other clinical features are:  
 The patient will have a sensation of constriction type of chest pain with 
difficulty in expiration. Sometimes patient may fear that may even die in 
view of his inability to breath. When the patient coughs a bit and mucus is 
expectorated out, he may have relief. If the patient does not cough and there 
is no expectoration of sputum, patient will experience severe difficulty in 
expiration and he may not be even in a position to lie on the bed and stand.  
 There will be also sweating over the forehead, blackening of face, chillness 
of limbs. The eyes may appear as if swollen due to breathlessness. Dryness 
of tongue, shivering of body, dyspnoea and inability to sleep in the bed are 
other features of the disease. 
Iyavali iraippu (or) Perirappu (or)Vichinna suvaasam:   
In this disease, as the kapha and vatha dosha are deranged together, the signs and 
symptoms will be severe. In addition to the signs and symptoms of Iraippu noi, the 
following clinical features may be seen due to the derangement of vatha dosha and its 
association with udhana vaayu: inability breath in and breath out with intermittent 
dyspnoea, distension of due to retention of stool and urine, dryness of tongue, congestion  
eyes with pain, pain at the region of reproductive organs, sweating, incoherent talk, 
feeling sad, occasional behavioral disturbance, giddiness, sensation of rotation of body, 
etc.   
Mukkutra iraippu noi (or) Thinaraliraipu (or) Maghaa suvaasam: 
 In this disease, all the three will aggregate together. In view of this the upward 
directional and downward directional, diffuse directional and central directional factors 
are deranged one by one. In addition, the severe body structures will also be reduced in 
strength and these results in severe Iraippu noi. The prodromal symptoms are dyspnoea, 
astonishment, shivering of the body and feeling sad. Later, wheezing may develop. The 
breath sounds will be similar to a big cows sound. The other features of the disease pain 
in the chest is tied tightly, giddiness occurs frequently, retention of urine and with 
distention of abdomen, incoherent talk, perplexion, decreased activity of five senses, pain 
throughout the body, excessive sweating in the forehead.   
Melnokkuiraippunoi: 
 If any of the disease mentioned above continues for many days without response 
to treatment, becomes upward directional the udhana vaayu loses its strength and be in 
such a situation, expiration may not be possible. The patient will develop dysnoea and his 
eyeball will be prominent. There may be dryness of mouth. Patient may be unable to 
speak; he may appear astonished and will not lie down on the bed; he may look upward 
as if the mouth opened; he may also attempt to exhale. If proper treatment is given at this 
juncture he may survive. Otherwise, he may fall unconscious with darkening of face and 
may die with mouth open.  
Pulse examination:  
 “fgky;yhJ fhrRthrk; thuhJ”  
 Kabanadi,   
 VathakabaNadi,   
 Kapha pitha naadi are the classical pulse for Swasakasam.  
Some other factors in the genesis of disease:  
Sputum: 
 If the sputum is found excessive in quantity, light weight and foamy, it is 
considered that the disease developed due to kaphadosham.  
 If the sputum is black in color, hard and with smell of flesh, it will denote 
kaphadosham.  
 If it is found white like pus and mixed with yellow color, it will denote 
pithadosham. 
 
 
 
 
 
 
 
 
 
 
 
 
ERAIPPU NOI (BRONCHIAL ASTHMA) 
3.12.2.  MODERN ASPECT  
Definition:  
  Asthma is a chronic reversible inflammatory disease of the airways 
characterised by recurrent paroxysmal attacks of dyspnoea chiefly expiratory in nature 
accompanied by wheeze which may subside spontaneously or with treatment.  
Aetiology and pathogenesis:  
              Asthmatic patients are having a hyper-reacting bronchial tree and numbers of 
factors may produce obstruction ,namely spasam of the bronchial smooth muscle 
,oedema of the bronchial mucosa ,and presence of mucus in the bronchial 
lumen.Bronchoconstriction may be due to varies factors,known and unknown .Known 
substences are Histamine ,slow reacting substence of Anaphylaxis,Platelet activating 
factor ,Eosinophil chemotactic factor of Anaphylaxis ,Bradykinin,Prostoglandins,5-HT 
and other unidentified substences liberated from the mast cells.The factors responsible for 
releasing these mediators are allerge,infection,exercise,psychological factors,change of 
temperature and humidity ,smoking etc.  
Allergy:  
           Allergens may be inhaled or ingested.Inhaled allergens are house 
dust,pollens,dander,kapok,and feathers.The antigen in the house dust is derived from 
feathers ,mite,dermatophytes which live in bedding and mattresses and fungus like 
A.Fumigatus .Ingested allergens include various substences such as 
egg,fish,crab,chocolate,aspirin,penicillin,iodide,etc.This type of allergic asthma develops 
in atopic individuals mediated by antibodies.These antibody belong to a type of 
immunoglobulin called IgE this is called hypersesitivity reaction.Air-borne pollution of 
the environment produces so called “Tokyo –Yokohma “ or “New Orleans” asthma .Meat 
wrappers asthma ,Barkers asthma,wood workers asthma are other examples .Asthma may 
also develop by type III hypersensitivity mechanism mediated by IgG.  
Infection:  
         Infection of the bronchial mucosa causes airway obstruction due tooedema of the 
mucosa and overproduction of mucous .Apart from this ,bacterial antigen may produce an 
allergic response .Streptococcus pneumoniae ,H.influenza and viruses are responsible for 
infection .Asthma in children and middle aged people are mainly due to this.  
 
Exercise:  
 It may precipitate asthma or may worsen the asthmatic state .This is called 
exercise induced asthma.  
Psychologicalfactors:  
         Various psychological factors particularly stress may precipitate an attack.                             
 Temperature and humidity:  
 Changing temperature and humidity may cause obstruction to the airways in the 
asthmatic subjects. 
Smoking: Cigarette smoking also causes airway obstruction. 
INTRINSIC AND EXTRINSIC ASTHMA:  
Asthma can be divided into extrinsic and intrinsic varieties.  
 The main points of distinction are given below:  
 Points       Intrinsic Asthma  Extrinsic Asthma              
1.  Precipitating allergin              Nil    Present and external  
2.  History  of allergy               Absent  Present  
3.  Family history of  
Asthma,Eczema,    hay  
fever,urticaria             
Usually present    Usually present  
4.  Age of onset                       Middle age    Childdood  
5.  Allergic skin tests               Negative      Positive  
6.  IgE level                                Normal     Raised  
Table 1 
 
Clinical Features:  
During attack  
          Attack usually stars in the late hours of the night or in the early hours of the 
morning.Onset is sudden and may be preceded by a feeling of tightness of the 
chest.Patient becomes very much dyspnoeic and feels as if there is less air in the 
room.He rushes to the window, opens it and pants for breath .After sometimes he 
coughs and brings out a little phlegam and gradually the attack subsides within an 
hour or so.  
Signs:  
      General survey:Facies is anxious ,decubitus-patients sits upright or in stooping 
forward posture, accessory  muscles of  respiration are very much prominent 
,expiratory wheeze is present ,central cyanosis may be present ,respiration rate is 
hurried 25-40 per minute ,expiration is prolonged and laboured ,pulse rate is rapid,BP 
shows systolic elevation of  pressure .Temperature is usually normal .Sweating is 
present.  
           Chest is held in a state of full inspiration but as the diaphragmatic function is 
preserved the lower ribs normally move outward .During inspiration the skin over the 
chest is sucked inside.Vocal fremitus is slightly increased unless there is pre-exsistent 
emphysema .Expiratory rhonchial fremitus is present .Percussion shows hyper-
resonant note .Wheezing is polyphasic and though heard in both phases of respiration 
yet they are more prevalent during expiratory phase.  
Status asthmaticus (Acute severe asthma):  
Severe asthma is diagnosed by the following features:  
 Severe breathlessness.  
 Inability to speak with one breath  
 Restlessnes and anxiety.  
 Presence of large amount of bronchial secretion.  
 Prominent central cyanosis.  
 Pulse rate more than 130 per minute.  
 Pulsus paradoxus.  
 Diminished level of consiousness.  
 Severe hyperinfaltion of the chest.  
 Markedly diminished breath sound with practically absence of rhonchi.  
Specialinvestigations:  
 Blood: Slight eosinophilia is present but the absolute count is less than 
1000/mm3. Other blood changes are elevated IgE and rarely elevated SGOT, 
SGPT, LDH, CPK, OTCand ADH.  
 Sputum shows eosinophils, Charcot-Leyden crystals, Curschmanns spirals and 
Laennec’s pearls and creolas bodies apart from the infective agents.        
 X-ray of chest shows overinfection of lungs in acute attack but may show 
emphysematous changes in late stages.  
 Pulmonary function test: The degree of airway obstruction can be measured by 
FEV1 and FEV1/FVC ratio both of which are reduced and improves after use 
of bronchodilators .The diffusing capacity is usually normal.  
 Blood gas analysis shows diminished PaO2 and raised PaO2in status 
asthmaticus but normal in mild attacks .In earlier status respiratory alkalosis is 
present but in severe late stages respiratory in acidosis results.  
 Skin test: By prick test hypersensitivity reaction to various antigens can be 
obtained.  
 ECG  shows  normal  features  except  Tachycardia.But 
sometimes  
 P.pulmonale, Right axis or RBBB pattern   may be observed   
 Bronchial provocative test with methadolin or histamine may be of help in 
presence of uncertain diagnosis.  
Complications:  
 Status Asthmaticus   
 Secondary infection –Bronchitis, Tuberculosis.  
 Emphysema of lungs   
 Bronchiectasis.  
 Pneumothorax,pneumo mediastinum  
 Right heart failure in late stages called chronic cor pulmonale.  
Clinical diagnosis  
 Episodic asthma: Paroxysms of wheeze, dyspnoea and cough, asymptomatic 
between attacks.  
 Acute severe asthma: Upright position, use accessory respiratory muscles, 
can’t complete sentences in one breath, tachypnea > 25/min, tachycardia > 
110/min, PEF < 50% of pred or best, pulsus paradoxus, chest hyperresonant, 
prolonged expiration, breath sounds decreased, inspiratory and expiratory 
rhonchi, cough.  
 Life-threatening features: PEF < 33% of pred or best, silent chest, cyanosis, 
bradycardia, hypotension, feeble respiratory effort, exhaustion, confusion, 
coma, PaO2 < 60, PCO2 normal or increased, acidosis (low pH or high [H+]).  
 Chronic asthma: Dyspnea on exertion, wheeze, chest tightness and cough on 
daily basis, usually at night and early morning; intercurrent acute severe 
asthma (exacerbations) and productive cough (mucoid sputum), recurrent 
respiratoryinfection, expiratory rhonchi throughout and accentuated on forced 
expiration.  
Physiological diagnosis  
 Demonstration of variable airflow obstruction with reversibility by means of 
FEV1 and PEF measurement (spirometer and peak flow meter).  
 FEV1 < 80% of pred – PEF < 80% of pred.  
 Reversibility: A good bronchodilator response is a 12% and 200ml 
improvement in FEV1 20 min after inhalation of 200ug salbutamol (2 puffs).  
 Diurnal peak flow variation: Normal variation: Morning PEF 15% lowers 
than evening PEF. With asthmathis variation is > 15% (morning dipping). 
 Provocation studies:  
     (a) Exercise:  A 15% drop in FEV1 post exercise indicates exercise induced 
asthma.  
Differential Diagnosis:  
 Cardiac Asthma  
 Chronic bronchitis  
 Obstruction of trachea and bronchus  
 Uraemic asthma  
 Bronchopneumonia 
 Tropical eosinophilia  
 Allergic aspergillosis  
 Pulmopnary embolism  
 
 
 
 
 
 
 
 
 
 
 
3.13. PHARMACEUTICAL REVIEW 
CHOORANAM 
Chooranams are fine powders of drugs .The term chooranam may be applied to the 
powder of a single drug or a mixture of two or more drugs, which are powderd 
seperately prior to their being mixed to homogenity.  
Equipment required:   
 1. A mortar and pestle  
 2. A fine sieve or fine cloth of close mesh.  
 Note:  In large scale manufacture, in factores comminutors, pulvirisers and ball mills are 
employed for powdering.Sieving is performed by mechanical sifters which handle large 
quantities of drugs in a short time.  
Process of preparation:    
              The drugs enumerated in the recipe are clean and in well dried state.               
The drugs which are to be used in the preparations should be taken from recently 
collected material.  
              However, drugs like licorice, long pepper, tail pepper, nutmeg, clove, greater 
galangal, sukku are prepared from fairly aged stock, provided they are not intested with 
pests, deteriorated or spoiled or developed rancidity.  
              In general the aromatic drugs are slightly fried, in order to enhance their aroma 
and milling properties.Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection.  
              The chooranam should be so fine as to be called amorphous and should be 
never damp.The fineness of the sieve should be 100 mesh or still finer.  
Storage:  
            The prepared dry powder should be allowed to cool by spreading and mixing, 
prior to packing.They should be stored in tightly stoppered glass, polythene or tin 
contains, or in polythene or cellophane bags and sealed.These bags should in turn be 
enclosed in card board boxes.  
          The powder (chooranam) is said to retain its potency for two months and then 
gradually deteriorate .However, if properly packed and stored they keep good for a year.  
          The chooranam to facilitate easy handling and to assure exact dosage of 
administration, could be pressed in to tablets with the addiction of a suitable 
binder.These tablets could be packed in bottles or tubes made either of glass or plastics 
or packed in strips  
of metal foil or plastic sheets.  
          In Industry, the tablets are made, counted and packed by electronic devices.  
4. MATERIALS AND METHODS  
4.1. PREPARATION OF THE DRUG 
 Materials:  
 RAJAKESARI CHOORANAM has been selected from the siddha 
literature’’ANUBOGA VAITHIYA BRAMMA RAGASIYAM”.  
 Ingredients:    
1. Vaalmilagu    (piper cubeba) Linn 
2. Thippili               (Piper longum) Linn 
3. Perarathai                 (Alpinia galanga) Wild           
4. Chukku   (Zingiber officinale) Rose 
5. Maasikkai   (Quercus infectoria) Olivier 
6. Saathikkai   (Myristica fragrans) Houtt 
7. Kasthuri    (Moschus moschiferus) Linn 
8. Elam    (Eletteria cardamomum) Maton     
 9.Kirambu                  (Syzigiyum aromaticum) Merrill & Perry                                  
10.Lavangapattai       (Cinnamomum verum) Presl                                                         
11.Athimathuram       (Glycyrrhiza glabra) Linn                                                                                                         
 
Collection of the raw Drugs and Authendication:  
1) Vaalmilagu:  
It was bought from the Gobal aasan store, Nagercoil. The raw material was 
identified and authenticated by PG Gunapadam department, Govt.Siddha Medical 
College, Palayamkottai, Tamilnadu.   
 
2) Thippili: 
It was bought from the Gobal aasan store, Nagerkovil. The raw material was 
identified and authenticated by PG Gunapadam department, Govt.Siddha Medical 
College, Palayamkottai, Tamilnadu.  
3) Saathikkai:  
            It was bought from the Gobalaasan store, Nagercoil. The raw material was 
identified and authenticated by botanist and PG Gunapadam department, Govt.Siddha 
Medical College, Palayamkottai, Tamilnadu.   
 
 
4) Chukku:   
It was bought from the Gobalaan store, Nagarcoil. The raw material was 
identified and authenticated by botanist and PG Gunapadam department,  
Govt.Siddha Medical College, Palayamkottai, Tamilnadu 
5) Perarathai:  
It was bought from the Gobaalan store, Nagarcoil.Palayamkottai. Thrikadugu, 
and karunabi was taken and purification process was the raw material was identified and 
authenticated by botanist and PG Gunapadam department, Govt.Siddha Medical 
College, Palayamkottai, Tamilnadu.   
6) Kasthuri:  
          It was collected from Gobaalan store, Nagarcoil. The raw material was identified 
and authenticated by botanist and PG Gunapadam department, Govt.Siddha Medical 
College, Palayamkottai, Tamilnadu.  
7) Maasikkai:  
       It was collected from Gobaalan store, Nagarcoil.The raw material was identified and 
authenticated by botanist and PG Gunapadam department, Govt.  
Siddha Medical College, Palayamkottai, Tamilnadu.  
:8) Athimaduram 
       It was collected from Gobaalan store, Nagarcoil.The raw material was identified and 
authenticated by botanist and PG Gunapadam department, Govt.  
Siddha Medical College,Palayamkottai,Tamilnadu 
9)Elam:       
  It was collected from Gobaalan store,Nagarcoil.The raw material was identified 
and authenticated by botanist and PG Gunapadam department, Govt. Siddha Medical 
College,Palayamkottai,Tamilnadu                                                                    
10)Lavangapattai:                                                                                                                                                                              
 It was collected from Gobaalan store,Nagarcoil.The raw material was identified 
and authenticated by botanist and PG Gunapadam department, Govt.  
Siddha Medical College,Palayamkottai,Tamilnadu  
11)Kirambu                                                                                                                                                        
 It was collected from Gobaalan store,Nagarcoil.The raw material was identified 
and authenticated by botanist and PG Gunapadam department, 
GovtSiddhaMedicalCollege,Palayamkottai,Tamilnadu 
A.Purification                                                                                                                              
l.Athimathuram: 
 Wash in pure water and remove the skin and cut into small pieces and   dryit.                                                
2. Lavangapattai: Dry in the sunlight.                                                                                                         
3. Vaalmilagu: Remove thestalk then dry in the sunlight   
4. Kasthuri: Remove the hair particles 
5. Sukku: 
 Fry the dry ginger with limestone 1:2 ratio.After 9 hours wash                                              
it and dry then remove the external skin                     
6. Thippili: Sock in 24minutes in kodiveli leaf juice and dry in the sunlight.                       
7. Yelam:Clean the dust and dry in the sunlight. 
8. Maasikkai: Fry in the cow’s ghee. 
9. Jathikkai:Remove the outer skin and it dried with sunlight. 
10. Kirambu: Remove the dust particles and dry in the sunlight.                                                  
11. Perarathai: Remove the skin and dry in the sunlight.                                                                                     
C.Process of preparation 
Sukku, Thippili, Kirambu, Lavanga Patti, Elam, Kasthuri, Val Milagu, Athimaduram, 
Maasikkai, Perarathai, Saathikai are taken and powdered in Stone mortar  individually  
and filtered to obtain a fine powder (Vasthirakayam Process) and thoroughly mixed. It is 
a Rajakesari Chooranam.  
D.Indication: Kasam, swasam, kshayam (Respiratory disorders)                                                                                                       
E.Dosage:    1/2 varagan (2.1gram) 
F.Adjuvant : Honey, piper betle juice  
G.Shelf life  :3months   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2. STANDARDIZATION OF THE DRUG 
  The identification of the drugs an authenticated by P.G.Gunapadam Department & 
Herbal Botany Dept. GSMC, Palayamkottai.  
Standardization of drugs helps in confirming it’s identify and determination of its quality 
and effectiveness. Standardisation of herbomineral drug is based on qualitative and 
quantitative analysis through physico-chemical properties and instrumental studies. 
Physico-chemical analysis and elemental analysis of this herbomineral formulation will 
be been done in Govt. Siddha medical college, Palayamkottai. IITM (FTIR in Dept of 
Chemistry) and SEM in Dept of mechanics, Chennai.  
 Organoleptic character   
 The organoleptic characters of the sample drug were evaluated.1gm of the test 
drug was taken and the colour, odour, taste, texture, particle size and other morphology 
were viewed by naked eye under sunlight. Then the result is noted.  
4.2.1. PHYSICO CHEMICAL ANALYSIS  
 Physicochemical studies of the trial drug have been done according to the WHO 
guidelines.  
 Determination of Ash Values  
 Total Ash  
3g of the test drug was accurately weighed and incinerated in a crucible dish at a 
temperature not exceeding 450oC until it was free from carbon. It was then cooled and 
weighed. The % w/w of ash with reference to the air-dried powder was calculated.  
Water Soluble Ash  
The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled with 25ml of water for 5mins. The insoluble ashes were collected using 
filter paper. It was then washed with hot water and transferred to the silica crucible. It 
was then ignited for 15minutes at temperature not exceeding 450oC. For determination 
of weight of the water soluble ash the silica crucible and residue were weighed until 
constant weight was attained. The weight of the water soluble ash is determined by 
subtracting the weight of insoluble ash from the weight of total ash.  
Acid insoluble Ash 
The total ash was obtained as the above method for preparation of total ash. The ash was 
boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes were collected using filter 
paper and washed with hot water. It was then transferred to the silica crucible and 
ignited for 15minutes at temperature not exceeding 450oC.  
The silica crucible and residue were weighed until constant weight is attained.  
Determination of Extractive Value  
 Alcohol Soluble Extractive Value  
3g of test drug powder was weighed and macerated with 100ml of ethanol in a closed 
container for 24 hours. The resulting solution was shaken continuously for 6 hours. It is 
then allowed to stand and soak for 18 hours. The solution is filtered and evaporated of 
the filtrate in a flat bottomed shallow dish and dried at 105oC. Then the content was 
cooled and weighed.  
Water soluble Extractive value  
3g of test drug powder was weighed and macerated with chloroform and water, 
respectively, at 80oC for 24 hrs. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hrs then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105oC then cooled and weighed.  
Loss on Drying  
 The powdered drug was taken and dried in the oven at 100- 105°C to constant weight. 
The result was noted.   
 Thin-layer chromatography 
             Thin-layer chromatography (TLC) is a chromatographic technique that is useful 
for separating organic compounds. Because of the simplicity and rapidity of TLC, it is 
often used to monitor the progress of organic reactions and to check the purity of 
products.TLC is a simple, quick and inexpensive procedure that gives how many 
components are in a mixture.TLC is also used to support the identity of a compound in a 
mixture when the Rf of a compound is compared with the Rf of a known 
compound(preferably both run on the same TLC plate).Chromatography works on the 
principle that different compounds will have different solubilities and adsorbtion to the 
two phases between which they are to be partitioned. As the solvent rises by capillary 
action up through the adsorbent, differential partitioning occurs between the components 
of the mixture dissolved in the solvent stationary adsorbent phase. The more strongly a 
given component of a mixture is adsorbed on to the stationary phase, the less time it will 
spend in the mobile phase and the more slowly it will migrate up the plate.  
 
 
4.2.2. CHEMICAL ANALYSIS  
Preliminary Basic and Acidic radical studies  
Preparation of the extract: 
  5 gms of the drug was weighed accurately and placed in to a 250 ml clean 
beaker.Then 50 ml of distilled water is added and dissolved well.Then it is boiled well 
for about 10 minutes.It is cooled and filtered in a 100ml volumetric flask and made up to 
100ml with distilled water.This fluid is taken for analysis.  
QUALITATIVE ANALYSIS FOR BASIC RADICALS.  
Test for Calcium:  
  2ml of the above prepared extract is taken in a clean test tube. To this add 2ml of 
4% Ammonium oxalate solution.No Formation of white precipitate.   
Test for Iron (Ferric):  
  The extract is acidified with glacial acetic acid and potassium ferro cyanide.  
No blue colour is formed.  
Test for Iron (Ferrous):  
 The extract is treated with concentrated Nitric acid and ammonium thiocyanate 
solution. Formation of blue red colour.   
QUALITATIVE ANALYSIS FOR ACIDIC RADICALS.  
Test for Zinc:  
 The extract is treated with potassium ferro-cyanide.No Violet precipitate is 
formed.  
Test for Sulphate:  
 2ml of extract is added to 5% barium chloride solution. Formation of white 
precipitate.   
Test for Chloride:  
 The extract is treated with silver nitrate solution.No Formation of white 
precipitate.   
Test for Phosphate:  
 The extract is treated with ammonium molybdate and concentrated nitric acid. No 
yellow precipitate.   
Test for Carbonate:  
 The substance is treated with concentrated Hcl.No Brisk effervescence is formed 
 
 Test for Starch:  
 The extract is added with weak iodine solution. Formation of blue colour.   
Test for Albumin: 
 The extract is treated with Esbach`s reagent. No yellow precipitate.   
Test for Tannic acid:  
 The extract is treated with ferric chloride. Bluish black precipitate is formed.   
Test for unsaturation:   
  The extract is treated with potassium permanganate solution.It gets  
Decolourised.  
Test for the Reducing sugar:  
 5ml of Benedict`s qualitative solution is taken in a test tube and allowed to boil 
for 2 minutes and added 8-10 drops of the extract and again boil it for 2 minutes. No 
colour change is occurs.  
Test for Amino acid:  
           One or two drops of the extract is placed on a filter paper and dried it well. After 
drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation of violet 
colour.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.3. INSTRUMENTAL ANALYSIS  
Scanning Electron Microscope (SEM)  
Principle:  
              Another important feature of the SEM is the three-dimensional appearance of 
the specimen image, which is a direct result of the large depth of field. The SEM is also 
capable of examining objects at very low magnification. This feature is useful in 
viewing particle size and shape of any composition at various stages of preparation in 
siddha system as well as other fields. The large depth of field available in the SEM 
makes it possible to observe 3- dimensional objects in stereo. Today, a majority of SEM 
facilities are equipped with X-ray analytical capabilities. Thus topographic 
crystallographic and compositional information can be obtained rapidly, efficiently and 
simultaneously from the same area.  
Scanning Electron Microscope (SEM)  
 
              Figure No: 1- Scanning Electron Microscope 
 The microstructure of the powders was examined using a Hitachi S 3000H 
scanning electron microscope (Fig). The scanning Electron Microscope is one of the 
most versatile instruments available for the examination and analysis of the micro 
structural characteristics of solid objects. The primary reason for the SEM’s usefulness 
is the high resolution which can be obtained when bulk objects are examined; values of 
the order of 5nm (50degreeA) are usually quoted for commercial instruments. Advanced 
research instruments have been described which have achieved resolutions of about 
2.5nm (25 degree A). Any solid material can be studied.  
 Sample size is limited to specimens less than about 10μm in diameter. An electron 
beam passing through an evacuated column is focused by electromagnetic lenses onto 
the specimen surface. The beam is then rastered 0ver the specimen in synchronism with 
the beam of a cathode ray tube display screen. In eleastically scattered secondary 
electrons are emitted from the sample surface and collected by a scintillator, the signal 
from which is used to modulate the brightness of the cathode ray tube. In this way the 
secondary electron emission from the sample is used to form an image on the CRT 
display screen. (Goldstein, et. al., 1992).  
               Differences in secondary emission result from changes in surface topography. 
If (elastically) back-scattered electrons are collected to form the image, contrast results 
from compositional differences. Cameras are provided to record the images on the 
display screen. Since an electron is a charged particle, it has a strong interaction with the 
specimen (due to coulomb interaction). When an electron beam images on a specimen, it 
is scattered by atomic layers near the surface of the specimen. As a result, the direction 
of electron motion changes and its energy is partially lost. Once an incident electron 
(primary electron) enters a substance, its direction of motion is influenced by various 
obstructions (multiple scattering), and follows a complicated trajectory which is far from 
a straight line. Also, when electrons with the same energy are incident on the specimen 
surface, a portion of electrons is reflected in the opposite direction (back scattered) and 
the remainder is absorbed by the specimen (exciting X- rays or other quanta in the 
process). If the specimen issufficiently thin, the electron can pass all the way through the 
specimen (transmitted electrons, scattered or non-scattered).  
 The depth at which various signals are generated due to electron beam – specimen 
interaction indicates the diffusion area of the signals in the specimen in addition to the 
local chemistry of the specimen. Secondary electrons mainly indicate information about 
the surface of a specimen. Since secondary electrons do not diffuse much inside the 
specimen, they are most suitable for observing the fine-structures of the specimen 
surface. That is to say, sharp scanning images with high resolution can be expected from 
secondary electrons, because of the smaller influence on resolution by their diffusion.   
As the incident electron energy increases, the probability of incident electrons  
colliding with elemental components of the specimen and releasing secondary electrons  
also increases. In other words, as the incident energy increases, the emission of electrons 
from the specimen also increases. However, as the energy increases beyond a certain 
level, the incident electrons penetrate deeper into the specimen with the result that the 
specimen derived electrons use up most of their energy to reach the specimen surface. 
Consequently, the electron emission yield decreases. Therefore, the peak secondary 
electron emission yield occurs at a specific entry level of the incident electrons.  
In order to verify the existence of a substance and recognize its shape, the image contrast 
must be well defined. In other words, even if a system boasts extremely high resolution, 
if image contrast is poor, it would be extremely difficult to determine the existence of a 
substance, let alone recognize its shape.   
 
Fourier Transform - Infra red Spectroscopy (FT-IR)  
 
Figure No:2-FTIR Machine 
 
 
 
 
 
 
 
  
Schematic diagram:  
 
 
Figure No: 3- Schematic diagram 
Introduction  
  Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational modes of 
the molecule. The various functional groups present in the molecule can be assigned by 
a comparison of the spectra with characteristic functional group frequencies. As the 
positions of the bands are directly related to the strength of the chemical bond, a large 
number of investigations including intermolecular interactions, phase transitions and 
chemical kinetics can be carried out using this branch of spectroscopy.   
             In IR spectroscopy, the resonance absorption is made possible by the change in 
dipole moment accompanying the vibrational transition. The Infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies are a 
kind of fingerprint of the compounds.   
             This property is used for characterization of organic, inorganic and biological 
compounds. The band intensities are proportional to the concentration of the compound 
and hence qualitative estimations are possible. The IR spectroscopy is carried out by 
using Fourier transform technique.   
Principle  
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of 
the nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and 
electronic structure of the substance and with intra- and inter molecular interactions.  
Source: Nernst Glower  
Beam splitter    :    It is made up of a transparent material. Thin films of     Silicon  
           deposited on  Potassium bromide  (KBr)  
Bromide (KBr) Detectors   :  Deutrated TriGlycine Sulphate (DTGS).  
MIR Range   :  4000 to 450 cm-1  
Resolution      :   4.0 cm-1  
Sampling Techniques  
 There are a variety of techniques for sample preparation depending on the physical form 
of the sample to be analyzed.  
Solid    :  KBr or Nujol mull method.  
Liquid     :  Csl / TIBr Cells  
Gas    :   Gas cells  
KBr Method  
 The sample is grounded using an agate mortar and pestle to give a very fine 
powder.  
 The finely powder sample is then mixed with about 100mg dried KBr salt.  
 The mixture is then pressed under hydraulic press using a die to yield a 
 transparent disc  and measure about 13mm diameter and 0.3mm in thickness.  
Nujol Mull Method  
 The sample is ground using an agate (natural quartz) mortar and pestle to give a 
 very fine  powder.  
 A small amount is then mixed with nujol oil to give a paste and this paste is then  
          applied between two sodium chloride plates.  
 The plates are then placed in the instrument sample holder ready for scanning.  
 Liquids  
 Viscous liquids can be smeared in the cell and directly measured.  
 For dilute solutions, liquid cells and variable path length cells are employed.  
Measurements Techniques  
The procedure for recording the %T or %A is as follows:  
 Air is first scanned for the reference and stored. The sample is then recorded and 
finally  the ratio of the sample and reference data is computed to give required %T     or 
%A at  various frequencies.  
 Study of substances with strong absorbance bands and weak absorbance bands 
 aswell as  possible.  
 Small amount of samples are sufficient  
 High resolution is obtained.  
Procedure  
 Preparation of samples for infrared measurements and infrared spectra 
Typically,1.5 mg  of protein, dissolved in the buffer used for its purification, were 
centrifuged in a 30 K  Centric on micro concentrator (Amicon) at 3000_g at 4oC until a 
volume of  approximately 40 Al.  
 Then, 300 Al of 20 mM this buffer, prepared in H20 or 2H0, pH or p2H 7.2, were 
added  and the sample concentrated again. The p2H value corresponds to the pH meter 
reading +  0.4. The concentration and dilution procedure was repeated several times 
in order to  completely replace the original buffer with the Tris buffer.  
 The washings took 24 h, which is the time of contact of the protein with the  
2H20  medium prior FT-IR analysis. In the last washing, the protein was 
concentrated to fine a volume of approximately 40 Al and used for the infrared 
measurements.  
 The concentrated protein sample was placed in CaF2 windows and a 6 Am tin 
spaceror a  25 Am Teflon spacer for the experiments in H20 or 2H20, respectively. FT-
IR spectra  were recorded by means of a Perkin-Elmer Spectrum-1 FT-IR 
spectrometer using a  deuterated triglycine sulfate detector.  
At least 24 h before, and during data acquisition, the spectrometer was  
continuously purged with dry air at a dew point of 40oC. Spectra of buffers and 
samples were acquired at 2 cm_1 resolution under the same scanning and 
temperature conditions. In the thermal denaturation experiments, the temperature 
was raised in 5oC steps from 20 to 95oC.  
 Before spectrum acquisition, samples were maintained at the desired  
temperature for the time necessary for the stabilization of temperature inside the cell 
(6 min).Spectra were collected and processed using the SPECTRUM software from 
Perkin  -  Elmer. Correct subtraction of H20 was judged to yield an approximately 
flat baseline   at 1900-1400 cm_ 1, and subtraction of 2H20 was adjusted to the 
removal of the2H20   
bending absorption close to 1220 cm_ 1  
 
Inductively coupled plasma optical emission spectrometry (ICP-OES),  
 
 
Figure No:4- ICP-OES 
 Inductively coupled plasma optical emission spectrometry (ICP-OES)is an 
analyticaltechnique used for the detection of trace metals. It is a type of emission 
spectroscopy thatuses the inductively coupled plasma to produce excited atoms and ions 
thatemit electromagnetic radiation at wavelengths characteristic of a particular element. 
Theintensity of this emission is indicative of the concentration of the element within the 
sample.  
Mechanism  
 The ICP-OES is composed of two parts: the ICP and the optical spectrometer. 
TheICP torch consists of 3 concentric quartz glass tubes. The output or “work” coil of 
the radiofrequency (RF) generator surrounds part of this quartz torch. Argon gas is 
typically usedto create the plasma.  
When the torch is turned on, an intense electromagnetic field is created within thecoil by 
the high power radio frequency signal flowing in the coil. This RF signal is createdby 
the RF generator which is, effectively, a high power radio transmitter driving the 
“workcoil” the same way a typical radio transmitter drives a transmitting antenna. The 
argon gasflowing through the torch is ignited with a Tesla unit that creates a brief 
discharge arcthrough the argon flow to initiate the ionization process. Once the plasma is 
“ignited”, theTesla unit is turned off.  
  The argon gas is ionized in the intense electromagnetic field and flows in a 
particularrotationally symmetrical pattern towards the magnetic field of the RF coil. A 
stable, hightemperature plasma of about 7000 K is then generated as the result of the 
inelastic collisionscreated between the neutral argon atoms and the charged particles. A 
peristalticpump delivers an aqueous or organic sample into a nebulizer where it is 
changed into mistand introduced directly inside the plasma flame. The sample 
immediately collides with theelectrons and charged ions in the plasma and is itself 
broken down into charged ions. Thevarious molecules break up into their respective 
atoms which then lose electrons andrecombine repeatedly in the plasma, giving off 
radiation at the characteristic wavelengths ofthe elements involved.  
Within the optical chamber(s), after the light is separated into its differentwavelengths 
(colors), the light intensity is measured with a photomultiplier tube or tubesphysically 
positioned to “view” the specific wavelength(s) for each element line involved, or, in 
more modern units, the separated colors fall upon an array of semiconductor 
photodetectors such as charge coupled devices (CCDs). In units using these detector 
arrays, theintensities of all wavelengths (within the system’s range) can be measured 
simultaneously, allowing the instrument to analyze for every element to which the unit is 
sensitive all atonce. Thus, samples can be analyzed very quickly.  
 The intensity of each line is then compared to previously measured  intensities of  
known concentrations of the elements, and their concentrations are then computed by 
Interpolation along the calibration lines. In addition, special software generally corrects 
for interferences caused by the presence of different elements within a given sample 
matrix.Examples of the application of ICP-OES include the determination of metals, 
arsenicpresent in Traditional medicines, and trace elements bound to proteins. ICP-OES 
is widelyused in minerals processing to provide the data on grades of various streams, 
for theconstruction of mass balances.  
        The author used ICP-OES for elemental identification and quantitative 
compositional information of the RAJAKESARI CHOORANAM.  
 
 
 
 
 
 
 
 
4.3.TOXICOLOGICAL  ANALYSIS 
4.3.1.ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO 
EVALUATE TOXICITY PROFILE OF  RAJAKESARI CHOORANAM 
OBJECTIVES 
 The aim of this Study is to evaluate the toxicity of the test substance 
RAJAKESARI CHOORANAM, when administered orally to Female Wister Ratswith 
different doses, so as to provide a rational base for the evaluation of the toxicological risk 
to man and indicate potential target organs. 
Guidelines followed: 
(a)  OECD Guidelines No. 423, 
Study Design and Controls: 
1) Female Wister Ratsin controlled age and body weight were selected 
2) RAJAKESARI CHOORANAM was administered at 5 mg/kg,50 mg/kg,300 
mg/kg,1000 mg/kg, and  2000 mg/kg body weight as (Water) as suspension 
along with blank. 
3) The results were recorded on day 0, with single oral dosing period of 14 days.  
EXPERIMENTAL PROCEDURE 
1. ANIMALS  
1.1. Supply 
        A total of 15 Female Wister Rats with an approximate age of 6 weeks and purchased 
from M/s.Venkateshwara Enterprises  Pvt. Ltd, Bangalore. On their arrival a sample of 
animals was chosen at random and weighed to ensure compliance with the age requested. 
The mean weights of Female Wister Rats were 100-150 g respectively.  The animals were 
housed in metabolic cages (55 x 32.7 x 19 cm), with sawdust litter, in such a way that 
each cage contained a maximum of 3 animals of the same sex. 
All animals underwent a period of 20 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, the 
animals were inspected by a veterinary surgeon to ensure that they fulfilled the health 
requirements necessary for initiation of the Study. 
1.3. Housing 
The Female Wister Rats were housed in metabolic cages (55 x 32.7 x 19 cm), 
placed on racks. From the week before initiation of the treatment, each cage contained a 
maximum of 6 mice of the same sex and treatment group. 
 Each cage was identified by a card, color coded according to the dose level. This 
card stated the cage number, number and sex of the animals it contained, Study number, 
test substance code, administration route, dose level and Study Director's name, date of 
the arrival of the aanimals and initiation of treatment. 
The temperature and relative humidity were continuously monitored. Lighting was 
controlled to supply 12 hours of light (7:00 to 19:00 hours) and 12 hours of dark for each 
24-hour period. 
The cages corresponding to each experimental group were distributed on racks in 
such a manner that external factors, such as environmental conditions, were balanced as 
far as possible. 
2. DIET 
   All the rats had free access to a pelleted rat diet. The diet was analyzed by the   
manufacturer to check its composition and to detect possible contaminants. 
2.1. Water 
The water was offered ad libitum in bottles.  
3. ADMINISTRATION ROUTE AND PROCEDURE 
The test substance was administered orally. The Female Wister Rats belonging to the 
control group were treated with the vehicle (Water) at the same administration volume as 
the rest of the treatment groups. 
3.1 Numbering and Identification 
The animals were marked on body with picric acid solution prepared in water. The 
marking within the cage was as below. 
 
 
 
 
 
Table-2 Numbering and Identification 
 
 
 
 
 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals  
 
Table-3 Numbering and Identification 
 
 
3.2 Doses 
The doses for the study were selected based on literature search and range finding 
study. Following the period of fasting, the animals wereweighed and then drug was 
administered orally as single dose using a needle fitted onto a disposable syringe of 
approximate size at the following different doses. 
                                                 
                   GROUP DOSE 
 
GROUP DOSE 
Group-I 5  mg/kg 
Group-II 50  mg/kg 
Group-III 300  mg/kg 
Group-IV 1000  mg/kg 
Group-V 2000  mg/kg 
 
Table-4 Doses 
 
The test item was administered as single dose. After single dose administration 
period, all animals were observed for day 14. 
 
Cage No Group No Animal Marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
Dose Preparation 
RAJAKESARI CHOORANAM was added in distilled water and completely 
dissolved to form oral for administration. The dose was prepared of a required 
concentration before dosing by dissolving, in distilled water. It was mixed well. The 
preparation for different doses was vary in concentrations to allow a constant dosage 
volume. 
3.3 Administration 
The test item was administered orally to each Female Wister rats as single dose 
using a needle fitted onto a disposable syringe of appropriate size at the following 
different doses. The concentration was adjusted according to its body weight. The volume 
was not exceeding 10 ml/kg bodyweight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
3.4 Observation period 
All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, were 
recorded for approximately 1.0, 3.0 and 4.0 hours post-dose on day of dosing and once 
daily thereafter for14 days. Animals in pain or showing severe signs of distress were 
humanely killed. The cageside observation was included changes in skin, fur, eyes and 
mucous membranes, occurrence of secretions and excretions. Autonomic activity like 
lacrimation,  piloerection, pupil size and unusual respiratory pattern, changes in gait, 
posture, response to handling, presence of clonic or tonic movements, stereotypes like 
excessive grooming and repetitive circling or bizarre behavior like self-mutilation, 
walking backwards etc were observed. At the 14th day, sensory reactivity to stimuli of 
different types (e.g. auditory, visual and proprioceptive stimuli) was conducted. Auditory 
stimuli responses were measured by clicker sound from approximately 30 cm to the rats; 
visual stimuli response were measured with the help of shining pen light in the eye of rats 
and placing a blunt object near to the eye of rats. Response to proprioceptive stimuli was 
measured by placing anterior/dorsal surface of animals paw to the table edge. The 
responses of reactions for these three exercises were normal in animals belonging to both 
the controls as well as drug treatment dose groups. 
4 Mortality and Morbidity 
All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0 and 4.0 hours post dose on day of dosing and twicedaily (morning 
and afternoon) thereafter for 14 days. 
4.3.2 Sub-Acute Toxicity Study inWister rats to Evaluate Toxicity 
Profile of  RAJAKESARI CHOORANAM  
1. Objective 
The objective of this ‘Sub-Acute Toxicity Study of RAJAKESARI 
CHOORANAM ON Wister Rats’ was toassess the toxicological profile of the test item 
when treated as a single dose. Animals should be observed for 28 days after the drug 
administration. This study provides information on the possible health hazards likely to 
arise from exposure over a relatively limited period of time.  
2. Test Guideline Followed 
OECD407Method- Sub-Acute Toxic Class Method (Repeated Dose 28-Day Oral 
Toxicity Study in Rodents) 
3. Test Item Detail 
Name: RAJAKESARI CHOORANAM  
4. Test System Detail 
The study was conducted on 5 male 5 female Wister rats. These   animals were 
selected becauseofthe recommendedrodent species for oral studies as per followed 
guideline and availability of Animals 8-12 weeks old male and female rats were selected 
afterphysical and behavioral examination.The body weight range was fallen within ± 20% 
of the mean body weight at the time ofRandomization and grouping. The rats were 
housed in standard laboratory condition inPolypropylene cages, provided with food and 
water adlibitumin the Animal at M/s. SreeVenkateshwaraEnterprises Pvt. Ltd, Bangalore. 
The experimental protocol was approved by Institutional AnimalEthical Committee as per 
the guidance of Committee for thePurpose of Control and Supervision ofExperiments on 
Animals (CPCSEA), Ministry of Environment and Forest, government of India. 
5.  Acclimatization 
The animals were selected after veterinary examination by the veterinarian. All 
the selectedanimals were kept under acclimatization for a week. 
6.  Randomization & grouping 
One day before the initiation of treatment (days 0- last day of acclimatization), the 
selectedanimals were randomly grouped into three different groups containing minimum 
6 maleanimals per group.  
 
 
7.  Numbering and Identification 
The animals were marked on body with picric acid solution prepared in water. The 
markingwithin the cage was as below. 
Table-5 Numbering and Identification 
The group no., cage no., sex of the animal and animal no. were identified as 
indicated below  using cage label and body marking on the animals: 
 
Table-6 Animal Marking 
 
 
 
Group No Animal Marking 
1. CONTROL H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
2. LOW DOSEOF RAJAKESARI 
CHOORANAM 300mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
3. MIDDLEDOSE OFRAJAKESARI 
CHOORANAM 600mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
4. HIGH DOSEOF RAJAKESARI 
CHOORANAM 900mg/kg. 
H,B,T,HB,NM (MALE) 
H,B,T,HB,NM (FEMALE) 
Cage  
No 
Group No Animal Marking Sex 
1 1. CONTROL H,B,T,HB,NM                  
H,B,T,HB,NM 
Male 
Female 
2 2. LOW DOSEOF RAJAKESARI 
CHOORANAM 300mg/kg. 
 H,B,T,HB,NM                   
H,B,T,HB,NM  
Male 
Female 
3 3. MIDDLEDOSE OFRAJAKESARI 
CHOORANAM 600mg/kg. 
 H,B,T,HB,NM                   
H,B,T,HB,NM 
Male 
Female 
4 4. HIGH DOSEOF RAJAKESARI 
CHOORANAM 900mg/kg. 
 H,B,T,HB,NM                   
H,B,T,HB,NM  
Male 
Female 
8. Husbandry 
8.1 Housing 
The Wister rats were housed in standard polypropylene cages with stainless steel 
top grill. Paddyhusk wasused as bedding. The paddy husk was changed at least twice in a 
week.From the week before initiation of the treatment, each cage contained a maximum 
of 6 mice of the same sex and treatment group. 
8.2 Environmental conditions 
The animals were kept in a clean environment with 12 hour light and 12 hour dark 
cycles.The air was conditioned at 22±30C and the relative humidity was maintained 
between 30-70% with 100% exhaust facility. The cages corresponding to each 
experimental group were distributed onracks in such a manner that external factors, such 
as environmental conditions, were balanced as far as possible. 
8.3 Feed & feeding schedule 
 ‘SaiDurgaAnimal Feed, Bangalore.Feed was provided adlibitumthroughout the 
study period, except overnight fasting(18-20hours) prior to dose administration. After 
the substance has been administered, food was withheld for a further 3-4 hours. 
8.4 Water 
The water was offered adlibitum in bottles. There was periodically analyzed to 
detect the presence of possible contaminants 
8.5 Doses 
The doses for the study were selectedbased on literature search and range finding 
study.Following the period offasting, the animals were weighed and then extract 
wasadministered orally as single dose usinga needle fitted onto a disposable syringe 
ofapproximate size at the following different doses. 
Table -7 Dose Level 
TEST GROUP DOSE TO ANIMALS 
(mg/kg body-weight/day) 
NUMBER OFANIMALS 
Group-1 1. CONTROL 10 (5MALE and5 FEMALE) 
Group-II 2. LOW DOSEOF RAJAKESARI 
CHOORANAM 300mg/kg. 
10(5MALE and 5 FEMALE) 
 
Group-III 3. MIDDLEDOSE OFRAJAKESARI 
CHOORANAM 600mg/kg. 
10(5MALE and 5 FEMALE) 
Group-IV 4. HIGH DOSEOF RAJAKESARI 
CHOORANAM 900mg/kg. 
10(5MALE and 5 FEMALE) 
The test item was administered as single dose. After single dose administration 
period, all animals were observed for 28 days. 
Dose Preparation 
 RAJAKESARI CHOORANAM was added in distilled water and completely 
dissolved to for oral foradministration. The dose was prepared of a required 
concentration before dosing bydissolving RAJAKESARI CHOORANAM in distilled 
water. Itwas mixed well. The preparation for differentdoses was vary in concentrations 
to allow a constant dosage volume. 
8.6 Administration 
The test item was administered orally to each   rat as single dose using a 
needlefitted onto adisposable syringe of appropriate size at the following different doses. 
The concentration wasadjusted according to its body weight. The volume was not 
exceeding 10 ml/kg bodyweight. Variability in test volume was minimized by adjusting 
the concentration to ensure aconstant volume at all dose levels. 
9. OBSERVATIONS  
These observations were also performed on week-ends. The observations 
included  but were not limited to changes in skin and fur, in the eyes and mucous 
membranes, in the respiratory, circulatory, central nervous and autonomous systems, 
somatomotor activity and behavior. 
9.1. Clinical signs of toxicity  
 All the rats were observed at least twice daily with the purpose of recording any 
symptoms of ill-health or behavioral changes. Clinical signs of toxicity daily for 28 days. 
9.2. Food intake  
Prior to the beginning of treatment, and daily, the food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
9.3. Water intake 
Water intake was checked by visual observation during the Study. In addition, the 
water consumption in each cage was measured daily for a period of 28 days. 
9.4 Bodyweight: 
The body weight of each rat was recorded one week before the start of treatment, 
and duringthe course of the treatment on the day of initial, 3rd, 7th, 10th, 14th, 17th, 
20th, 24th and 28th days (day of sacrifice). The mean weights for the different groups 
and sexes were calculated from the individual weights. 
 
Blood Collection  
Blood was collected through retro-orbital sinus from all the animals of different 
groups on 28th day. The blood was collected in tubes containing Heparin/EDTA as an 
anticoagulant. Animals were fasted over nightprior to the blood collection. 
LABORATORY STUDIES  
  During the 4th week of treatment, samples of bloodwere withdrawn from the 
orbital sinus of 6 males from each group, underlight etheranesthesia after fasting for 16 
hours. The blood samples are used to evaluate Hematological parameters like RBC, 
WBC, and PLATELETS etc…..Thecollectedblood samples also centrifuged 10000 rpm 
in 10 minutes to separate the serum. The separated serum used to evaluate biochemical 
parameters like SGOT, SGPT, ALP and BILIRUBIN etc., 
Hematology  
The following hematological parameters were analysed using Autoanalyser 
Hb  : Haemoglobin (g %)  
PCV   : Packed Cell Volume 
WBC  : White Blood Corpuscles (x103/cmm)  
RBC  : Red Blood Corpuscles (x106/cmm)  
Blood Platelet count (x103/cmm)  
Differential WBC count:  
N  : Neutrophils (%)  
L  : Lymphocytes (%)  
M  : Monocytes (%)  
E  : Eosinophils (%)  
RDW  : Red Cell Distribution Width. 
MPV  : Mean Platelet Volume 
Clinical Biochemistry:  
The following clinical Bioparameters were analysed using Autoanalyser 
Total serum protein (g/dl)  
ALT/SGPT  : Alanine aminotransferase (U/L)  
AST/SGOT  : Aspartate aminotransferase (U/L)  
ALP    : Alkaline serum phosphatase (U/L)  
CHL    : Cholesterol (mg/dL)  
HDL    : High density lipoprotein 
TG    : Triglyceride 
TERMINAL STUDIES  
 Sacrifice and macroscopic examination 
On completion of the 4 weeks of treatment, 18 Wister rats were sacrificed by 
ether inhalation. A full autopsy was performed on all animals which included 
examination of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents both in situ and after evisceration. As the number of 
animals exceeded the number that could be sacrificed in one day, the autopsies were 
carried out over three consecutive days at the end of the treatment period.  
Organ weights: 
 After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Brain, Heart, Spleen Kidneys, Testes, Liver, Lungs, 
pancreas and stomach. 
HISTOPATHOLOGICAL STUDIES  
 Anatomy of the liver was studied immediately after sacrificing the animals. A 
small portion was fixed in 10% neutral buffered formalin as described by Luna 14 . Thin 
sections of 4-55 µm were taken, stained with Haematoxylin and Eosin and histology was 
studied7 
Luna, LG. Manual of histology, staining methods of Armed Forces Institute of 
Pathology. 3 rdEdn., New York, McGraw Hill, 1968 
  
 
 
 
 
 
 
 
 
 
 
 
 
4.4. PHARMACOLOGICAL STUDY 
4.4.1.EFFECT OF RAJAKESARI CHOORANAM ON BRONCHO-ALVEOLAR 
LEVAGE IN MICE 
PROCEDURE 
 Albino mice of either sex were divided into six groups containing five animals 
each (n=5).All animals were sensitized by an intraperitonial injection of 1ml alum 
precipitate antigen containing 20μg of ova albumin and 8mg of alum suspended in 0.9% 
of sodium chloride solution. A booster injection of this alum-albumin mixture was 
administered 7 days later. Non sensitized animal were injected with alum only (GroupII). 
Seven days after (15 days) the second injection, animal was exposed to aerosolized oval 
albumin (1%) for 30 min. Animals belonging to groups I received orally on distilled 
waterand Group IV, V, VI received orally on RC 0.226mg, 1.134mg and 56.7mg. 
Animals of group III, as positive control group received dexamethasone (0.27mg/kg p.o.) 
5 hr before antigen challenge. The mice were sacrificed at the end of study (24hr after 
sensitization) and trachea catheter was inserted in trachea. Bronchoalveolar lavage fluid 
(BALF) was collected by lavaging the lung with two aliquots 5ml of 0.9% of sodium 
chloride solution. Total recovery volume per mice was approximately 5ml. Total 
leukocyte Eosinophils and Neutrophils were counted under microscope and 
histopathologic evaluation of lung tissue was carried out. [1] 
1. Connett G. J., Warde C., Wooler E.And Lenney W. Arch Dis Childhood 1994; 70: 
170- 173  
DOSAGE SCHEDULE: 
 The required dose for mice/rat will be calculated by using the standard dose 
calculation procedure from recommended clinical dose. 
CONVERSION FORMULA: 
 Human dose is 2100mg,BD 
 Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 200 gm of rat 
 2100 mg x 2(a) x 0.018 (b) = 37.8 (c) /30gms of MICE  
 37.8/1000X30 = 1.134mg/kg 
 
 
 
 
S.No Groups Dose /kg, 
weight 
Dose /200 
gms. 
weight 
Volume of 
administr
ation 
1 Vehicle Control -- -- 0.5 ml 
2 Therapeutic Dose 1.134mg 0.226mg 0.5 ml 
3 Average Dose 5.67mg 1.134mg 0.5 ml 
4 High Dose 11.34mg 56.7mg 0.5 ml 
Table - 8  Experimental Doses Calculated as per the standard procedures 
 
EXPERIMENTAL DESIGN 
GROUP 1: CONTROL (Normal Saline) 
GROUP 2: ONLY ALUM  
GROUP 3: ONLY ALUM + Dexamethazone 
GROUP 4: ONLY ALUM + R.C 0.226mg/kg 
GROUP 5: ONLY ALUM + R.C 1.134 mg/kg 
GROUP 6: ONLY ALUM + R.C 56.7 mg/kg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.2. IN-VITRO ANTISPASMODIC ACTIVITY OF 
RAJAKESARICHOORANAM ON EXCISED RAT ILEUM 
ISOLATION OF RAT ILEUM:-  
 Rats were anesthetized and sacrificed by cervical displacement followed by 
exsanguinations. The ileum was dissected out, immersed in Tyrode’ssolutionand cleaned 
off the mesentery. Respective segments of 2-3cm long were mounted in a 25ml tissue 
organ bath, filled with a mixture of 95% O2 and 5% CO2 and maintained at 37 o C. The 
composition of Tyrode’s solution (in mM for l lit) was 9 mg KCl, 0.1 mg NaCl, 0.1mg 
NaHCO3, 0.42mg NaH2PO4, 0.6 mg Glucose and pH value was 7.4.  
 
ANTI-SPASMODIC ACTIVITY ASSAY PROCEDURE:-  
1. Firstly concentration dependent responses of acetylcholine were recorded (with 
dose of 0.1ml, 0.2ml, 0.4ml, 0.8ml, 1.6ml, 3.2ml) using Sherrington’s recording 
drum with a frontal writing lever. Contact time of 60 sec, and base line of 30sec 
time cycle were opted for proper recording of the responses in presence of plane 
Tyrode’s solution as stock-I solution.  
 
2.  Then same concentration dependent responses of acetylcholine (Ach) using same 
procedure for a mixture of Tyrode’s solution+ Lantana camara extract (with a 
concentration of 1mg/ml) as a stock-II solution were recorded.  
 
3.  Lastly the same concentration dependent responses of Ach for a mixture of 
Tyrode’s solution+ Atropine (as a standard antispasmodic agent) as a stock-III 
solution were recorded. 
 
 
 
 
 
 
 
 
4.4.3. ANTIHISTAMINIC AND ANTIANAPHYLACTIC ACTIVITY 
OF SIDDHA FORMULATION OF RAJAKESARI CHOORANAM 
Introduction 
Allergy is one of the common diseases that affect mankind with diverse 
manifestations. The prevalence of allergy and asthma has risen in the recent years despite 
an improvement in the general health of the population.[1] Allergic diseases are 
responsible for significant morbidity and have severe economic impact.[2] Various 
epidemiological studies have identified the causes for an increase in the prevalence of 
upper and lower respiratory tract allergic diseases. Some of the postulated reasons are 
increasing environmental pollution [3] and increased predisposition of individuals 
producing excessive IgE through a major change in the gene pool, changing lifestyles, and 
an increasing awareness of the disorders.[4] Intensive research during the last several 
decades has highlighted the role of lymphocytes, immunoglobulins, mast cells, and 
various autacoids in the etiopathogenesis of allergic conditions. Inspite of the voluminous 
literature on the subject, the treatment of allergic diseases continues to be far from 
satisfactory. The available treatment options for upper and lower respiratory tract allergic 
diseases have major limitations owing to low efficacy, associated adverse events, and 
compliance issues.[5]  
AYUSH, an Indian system of medicine, has described several drugs from 
indigenous plant sources for use in the treatment of bronchial asthma and allergic 
disorders. In the present study, the effects of Siddha formulation of rajakesari chooranam 
were studied on the active anaphylaxis and mast cell stabilization in rats, and histamine-
induced bronchospasm in guinea pigs.  
Materials and Methods 
Animals 
Inbred Wistar rats (175–200 g) and guinea pigs (400–600g) of either sex housed 
in standard conditions (temperature22 ± 2° C, relative humidity 60 ± 5% and 12 h 
light/dark cycle) were used. They were fed with standard pellet diet and water ad libitum. 
The Institutional Animal Ethics Committee approved the experimental protocol. 
Histamine and horse serum were procured from Sigma Chemicals and toluidine blue from 
Loba-Chemie, Mumbai. Elisa kit for IgE was supplied by Orion diagnostics, Espoc, 
Finland. All other chemicals and reagents were procured from Hi-Media Laboratories 
limited, Mumbai. 
Mast cell stabilizing activity 
Treatment protocol 
Twenty-four rats were divided into four groups of six animals in each group.  
Group I served as control and received vehicle (water). 
Group II (sensitized control group) 
GroupIII served as the treatment control, which was treated with rajakesari 
chooranam at a dose of 200mg/kg body weight, in oral route. 
Group IV served as the treatment control, which was treated with rajakesari 
chooranam 
at a dose of 400 mg/kg body weight, in oral route. 
 In group11 to group 1V were sensitized by injecting 0.5 ml of horse serum 
subcutaneously along with 0.5 ml of triple antigen containing 20,000 million Bordetella 
pertussis organisms (Serum Institute of India Ltd.,Pune), Once a day for 14 days.  
On day 14, the rats were sacrificed 2 h after the treatment and the intestinal 
mesentry was taken out for the study on mast cells. Mesentries along with intestinal 
pieces were excised and kept in Ringer Locke solution (NaCl 154, KCl 5.6, CaCl2 2.2, 
NaHCO3 6.0, glucose 5.55 mM/L of distilled water) at 37oC. The mesenteric pieces were 
challenged with 5% horse serum for 10 min after which the mast cells were stained with 
1.0% toluidine blue and examined microscopically for the number of intact and 
degranulated mast cells.[6] 
Histamine-induced bronchospasm in guinea pigs 
Bronchospasm was induced in guinea pigs by exposing them to 1% histamine 
aerosol under constant pressure (1 kg/cm2) in an aerosol chamber (24 × 14 × 24 cm) 
made of perplex 
Glass,of the three groups of six animals each. 
Group I served as control. 
GroupII served as the treatment control, which was treated with rajakesari 
chooranam 
at a dose of 200 mg/kg body weight, in oral route. 
Group III served as the treatment control, which was treated with rajakesari 
chooranam 
at a dose of 400 mg/kg body weight, in oral route. 
 The animals were exposed to 1% histamine aerosol under constant pressure (1 
kg/cm2) in an aerosol chamber on day 0 without any treatment. The end 
point,preconvulsive dyspnea (PCD) was determined from the time of aerosol exposure to 
the onset of dyspnea leading to the appearance of convulsions.[7] As soon as PCD 
commenced, the animals were removed from the chamber and exposed to fresh air. This 
PCD was taken as day 0 value. On days 1 and 5, 2 h after the administration of the drug, 
the time for the onset of PCD was recorded as on day 0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.4ANTI-INFLAMMATORY ACTIVITYOF SIDDHA 
PREPARATION RAJAKESARI CHOORANAM 
 The anti-inflammatory activities of siddha preparation rajakesari chooranamat a 
dose of 200 and 400mg/kg were evaluated using carrageenan-induced paw edema 
method. The inflammation was readily produced in the form of edema with the help of 
irritant such as carrageenan. Carrageenan is a sulphated polysaccharide obtained from sea 
weed (Rhodophyceae) and when injected cause the release of prostaglandins by the way it 
produces inflammation and edema. 
REQUIREMENTS: 
Animal                                : Albino rat (180-200 g) 
Drugs and chemicals          : Carrageenan (1%w/v), Diclofenac sodium (standard), 
Carboxy methyl cellulose   (1%w/v), 
Digital plethysmo meter.   U G O Basile (Italy) 
Test compounds                :   siddha preparation  rajakesarichooranam 
METHOD: 
Anti-inflammatory activity was performed by the following procedure of Bhandri et 
al(1)The animals were divided into 4 groups each having six animals. A freshly prepared 
suspension of carrageenan (1% w/v , 0.1 ml) was injected to the planter region of left hind 
paw of each rat. One group was kept as control and the animals of the other groups were 
pretreated with the siddha formulation rajakesari chooranamtest Compounds dissolved 
with 2 ml sterile water given through orally 30 min before the carrageenan treatment. The 
paw volumes of the test compounds, standard and control groups were measured at 
60,240,360 minutes of carrageenan treatment with the help of Digital plethysmometer 
(Ugo basile, Italy). Mean increase in paw volume was measured and the percentage of 
inhibition was calculated. 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
Where, Vt-mean increase in paw volume in rats treated with test compounds, 
Vc-mean increase in paw volume in control group of rats. 
 
 
 
 
 
4.5. ANTI MICROBIAL ACTIVITIES BY  
WELL DIFFUSION METHOD 
Aim: 
      The antimicrobial activity of Rajakesari chooranam  was adapted through Well 
diffusion method(Agar diffusion testing).  
PRINCIPLE  
The antimicrobials present in the plant extract are allowed to diffuse out into the 
medium and interact in a plate freshly seeded with the test organisms. The resulting 
zones of inhibition will be uniformly circular as there will be a confluent lawn of growth. 
The diameter of zone of inhibition can be measured in millimeters. 
Components of Muller Hinton agar medium: 
         Beef extract - 2gm/lit 
         Acid Hydrolysate of Casein - 17.5 gm/lit 
         Starch - 1.5 gm/lit 
         Agar – 17gm/lit 
         Distilled water - 1000 ml 
         PH - 7.3  0.1 at 250C 
PROCEDURE (Murray et al., 1995) 
 Petriplates containing 20ml Muller Hinton medium were seeded with 24hr 
culture of bacterial strains. Wells were cut and 20 µl of the plant extracts (aqueous) were 
added. The plates were then incubated at 37°C for 24 hours. The antibacterial activity 
was assayed by measuring the diameter of the inhibition zone formed around the well 
(NCCLS, 1993). Streptomycin was used as a positive control. standard for an In-vitro 
antimicrobial activity of Rajakesari Chooranam was screened against bacteria strains 
such as Klebsiella pneumonia, Streptococcus mutans, Staphylococcus aureus, 
Escherichia coli, Pseudomonas.aerugina, Enterococcus faecalis. 
Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken HR Manual of 
Clinical Microbiology, 6th Ed. ASM Press, Washington DC, 1995; 15-18. 
                            
5. RESULTS AND DISCUSSION 
STANDARDIZATION OF THE TEST DRUG 
 Standardisation of the drug is more essential to derive the efficacy, potency of the 
drug by analysing it by various studies. Following are the results of physicochemical 
and. Physical characterisation and estimation of basic and acidic radicals have been done 
and tabulated.  
 Toxicological results of the drug and pharmacological activity of the drug were 
derived. Its result has been tabulated and interpretation was made below. Thus it is to 
give a complete justification to bring the effectiveness of the trial drug Rajakesari 
Chooranam. 
ORGANOLEPTIC CHARACTER  
 The following characters have been noted in Rajakesari Chooranam.   
S.No.  Organoleptic characters  Result  
1  Appearance   Powder  
2  Touch  Nice  
3  Smell  Pleasant odour  
4  Taste  Bitter,Pungent 
5  Diethel ether  NA  
6  Colour in day light  Brown  
 Table -9 organoleptic characters  
Interpretation: 
The organoleptic characters of the drug Rajakesari Chooranam showed that the 
colour of the chooranam  is Brown in colour since prepared from dry herbs and 
minerals, Bitter, Pungent in taste which might be responsible for the activity 
mentioned earlier and on sight they are fine powder. 
 The fineness of the chooranam represents easy absorption and better 
availability of the drugs. 
 The size of the particle is reduced through various stages like pounding, 
sieving, filtering through white cloth (vasthirakaayam). 
 Only if the size of the particle is reduced to micro and nano particles, the drug 
is easily assimilable in the digestive system. 
 The above processes reduced the size of the particle so that the chooranam 
passes through the sieve. 
  
Table 
S.NO 
Parameter Result 
1  Loss on drying   8.5%  
2  Ash content  5.8%  
3  Acid insoluble ash  0.8%  
4  Water sol.matter  18.4%  
5  Alcohol sol.matter  22.1%  
Micro bial limit test   
6. Microbial contamination 
Total Viable aerobic count  
Total Enterobacteriaceae  
Total fungal count 
1.6x104 coll g  
Nil 
Nil 
7. Test for specific Pathogen  
E.coli 
Salamonella spp.  
S.aureus  
Pseudomonas aeruginosa 
Nill 
 
Table - 10 Physico chemical standards and Micro bial limit test 
INTERPRETATION  
Total Ash: 
  Total ash value of plant material indicated the amount of minerals and earthy 
materials present in the plant material. The total inorganic content (ammonium, 
potassium, calcium, chloride, iron, etc.,) present in the drug is measured through the 
Total ash value and it is of 5.8 % for RC.  
Acid Insoluble Ash: 
  The acid insoluble ash value of the drug denotes the amount of siliceous matter 
present in the plant. The quality of the drug is better if the acid insoluble value is low. It 
is 0.8% for RC.  
Water Soluble Ash:   
 Water-soluble ash is the part of the total ash content, which is soluble in water. It 
is 18.4% for RC  
Alcohol Soluble Ash:   
 Alcohol-soluble ash is the part of the total ash content, which is soluble in alcohol. 
It is 22.1% for RC  
 These are indicating the approximate measure of chemical constituents of 
crude drug. 
 The percentage of soluble matters present in the drug is determined by the 
values of water extractive and ethanol extractive.   
 Based on the extractive value suitable solvent can be selected. It also gives 
the percentage of drug which will correlate with the metabolism reactions.  
 Water-soluble extractive value plays an important role in evaluation of 
crude drugs  
 The alcohol-soluble extractive value was also indicative for the same 
purpose as the water-soluble extractive value 
 Loss on drying :   
 The total of volatile content and moisture present in the drug was 
established in loss on drying.   
 Moisture content of the drug reveals the stability and its shelf-life.   
 High moisture content can adversely affect the active ingredient of the drug.   
Thus low moisture content could get maximum stability and better shelf life 
 
Microbial Limit Tests  
The total bacterial count and the total fungal count of the drug were found to be 
within the WHO prescribed limits which indicate that the drug is free from microbial 
condamination. The other pathogens like Escherichia coli, Salmonella sps, Pseudomonoas 
aeruginosa and Staphylococcus aureus were found to be completely absent in the drugs.   
 
 
 
 
 
 
 
 
TLC Result  
 
 
 
Figure No:5  TLC Result  
INTER PRETATION  TLC principle requiring shorter time and better  resolution.  
The plates are similar to conventional TLC plates.  
 Under UV 254 nm and 366 nm test related to alkaloids, it shows major  spots 
short at Rf 0.90 (Green), 0.89, 0.80,0.71,0.64,0.57 (Violet), and long at Rf 
0.90(Green),0.89,0.80,0.71,0.64,0.57(blue). TLC of RC various Rf values was observed. 
The variation of Rf values indicated the presence of alkaloids, phenols, tannin and some 
unknown compounds in this drug.  
 
 
 
 
 
 
CHEMICAL ANALYSIS:  
Priliminary test for acidic and basic radicles:    
EXPERIMENT   INFERENCE  
Test for Calcium:  Absent 
Test for Sulphate:  Present  
Test for Chloride:  Absent 
Test For Carbonate:  Absent  
Test for Starch:      present 
Test for Iron Ferric:      Absent.  
Test for Iron Ferrous:   Present  
Test for Phosphate:     Absent  
Test for Albumin:  Absent. 
Test for Tannic acid:  Present 
Test for Unsaturation:  present   
Test for the Reducing sugar:  Absent  
Test for the Amino acid:  present   
Test for Zinc:  Absent  
  
Table No: 11 Chemical analysis result 
 The bio-chemical analysis of Rajakesari chooranam contains the following 
chemical constituents FerrousIron, Sulphate, Starch, Unsaturated compounds, Amino 
acids, Tannic acid. 
INTERPRETATION 
 Iron is an essential constituent of Hemoglobin, cytochromes and other 
components of respiratory enzyme systems like cytochrome oxidase, catalase, and 
peroxidase. It enhances the arterial oxygen level. The drug enhances oxygen supply 
and promotes the normal ventilation of the lungs and reduces the dyspnoea. It 
participate the cellular oxidation mechanism.  
Unsaturated fats 
  monounsaturated and polyunsaturated fats can replace saturated fat in the diet, 
trans unsaturated fats should not. Replacing saturated fats with unsaturated fats helps to 
lower levels of total cholesterol and LDL cholesterol in the blood.  
Starch 
 Digestive enzymes have problems digesting crystalline structures. Raw starch will 
digest poorly in the duodenum and small intestine, while bacterial degradation will take 
place mainly in the colon.  
 Amino acids act as neurotransmitters and some act as starting materials for the 
biosynthesis of neurotransmitters, hormones and other important biochemical 
compounds.Amino acids contribute to various anti-oxidant and immunological 
activities relevant to asthma pathogenesis, raising the possibility that differences in 
amino acids may be involved in asthma aetiology.  
 Sulphate has been considered as an adjunct therapy for severe and lifethreatening 
asthma exacerbation.  
Tannins 
 Helps in healing of wounds and inflammation of mucous membrane. 
 They restore the Anti-Oxidant status of the organs to almost normal levels. 
 Increases the cellular Anti-Oxidant enzymes 
 
 
 
 
 
 
 
 
 
 
 
 
 
INSTRUMENTAL ANALYSIS RESULTS 
  
 SEM Results: 
 
Fig No: 6-SEM Picture 650 magnification 
 
 
Fig No: 9-SEM Picture 430 magnification  
 
 
 
INTERPRETATION:  SEM analysis of the RAJAKESARI CHOORANAM shows most 
of the Particles present in the sample is micron size, average particle size is 1 to 5 
microns. So, very minimal quantity of the medicine is enough to treat the disease.The 
morphology of the Rajakesari Chooranam sample can be determined by Environmental 
SEM (FEI Quanta). A representative portion of each sample must be sprinkled onto a 
double side carbon tape and mounted on aluminium stubs, in order to get a higher quality 
secondary electron image for SEM examination. We have observed from SEM 
photographs that particles are elongated in shapes and sizes are in the range from 1 
microns to 5 microns.Although the particle sizes of different batches showed similarity, 
it seems that these particles are aggregates of much smaller particles. When dispersed in 
an aqueous medium, these preparations form a negatively charged hydrophobic particle 
suspension. This hydrophobicity gives these particles a tendency to aggregate together to 
form larger particles. Rajakesari Chooranam exhibited larger sizes and agglomeration of 
the particles. Therefore, the comparatively larger size may be due to the agglomeration 
of the particles by repeated cycles of grinding involved in preparation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICP-OES RESULTS OF RAJAKESARI CHOORANAM 
(wt:0.42115g)  
Elements  Wave Length (nm)  Concentration  
Al  396.152  BDL  
As  188.979  BDL  
Ca  315.807  22.160 mg/L  
Cd  228.802  BDL  
Cu  327.393  BDL  
Fe  238.204  05.346 mg/L  
Hg  253.652  BDL  
K  766.491  13.801 mg/L  
Mg  285.213  01.324 mg/L  
Na  589.592  34.390 mg/L  
Ni  231.604  BDL  
Pb  220.353  BDL  
P  213.617  106.341 mg/L  
S  180.731  01.324 mg/L  
Zn  206.200  03.258 mg/L  
 
Table:12 ICP - OES Result   
INTERPRETATION: 
Emission spectrometry is based on the principle that atoms or ions in an excited state 
tend, to revert back to the ground state and in so doing emit characteristic wavelength 
and intensity of that light is proportional to the concentration of that particular element 
in the sample solution.  
 This technique is used for quantitative and qualitative determination of the 
metals and mettaloids, in the herbo mimeral preparation.  
 This results shows Below detection limit(BDL) of As(arsenic) 
,Hg(Mercury), Cd (Cadmium), Pb(Lead),  Ni(Nikkal), Al(Aluminum), Cu 
(Copper).It is evident that the effectiveness of siddha medicine has been 
proved by the modern scientific way.  
 This result indicates the presence of Iron, Phosphorus, Potassium, 
Magnesium, Sodium, Calcium, Zinc, and Sulphate.  
 In the presence of Magnesium and Sulfate (MgSo 4). - Magnesium 
sulphate has been considered as an adjunct therapy for severe and life 
threatening asthma exacerbation. Theoretically, Magnesium can induce 
bronchial smooth muscle relaxation in a dose dependent manner.  
 By inhibiting calcium influx into cytosol, histamine release from mast 
cell, acetylcholine relase from cholinergic nerve endings.It also may 
increase the bronchodilator effect of beta2-agonist by increasing the 
receptor affinity.  
 Sodium and Potassium: In the presence of Sodium and Potassium regulate 
the acid-base balance of the body fluids.They regulate the water balance 
by maintaining the osmotic pressure of the body fluids.They help to 
preserve the neuromuscular irritability by maintaining a state of 
equilibrium on account of their relative proportion in the ECF and ICF.  
 In the presence of Phosphorus, It is an important constituents of phosphate 
buffers in the blood and urine.It is required for the formation of certain 
physiologically important phosphorus containing compounds like 
phospholipids, coenzymes and enzymes of intermediary metabolism.  
 Zinc is essential for growth.There are conflicting reports about the effect 
of zinc supplements on asthma.Zinc are required for optimal activity of 
the immune system and it has been shown that low levels of these trace 
elements are important factors in acute and chronic inflammatory status 
such as bronchial asthma.  
 Iron supplementation resulted in a significant decreases in airway 
eosinophilia, while systemic iron injections lead to a significant 
suppression of both allergen-induced airway eosinophilia and 
hyperactivity compared to placebo.  
FTIR RESULT  
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Figure No: 8-FTIR Result 
FTIR RESULTS OF RAJAKESARI CHOORANAM 
S.NO Frequency,cm-1 Bond Functional group 
1 3374 (m) N-H Stretch Primary, Secondary, Amines, 
Amides 
2 2923 (m) C-H Stretch Alkenes 
3 2853 (m) C-H Stretch Alkenes 
4 2121 (w) C (Triple bond) N Stretch Nitriles 
5 1736(s) C= O Stretch Esters, Saturated aliphatic 
6 1631 (m) N-H bend Primary amines 
7 1448 (m) C-C Stretch (in -ring) Aromatics 
8 1367 (m) C-H bend Alkanes 
9 1157 (m) C-H wag (-CH2X) Alkyl halides 
10 1032 (m) C-N Stretch Aliphatic amines 
11 867 (s) C-H “ oop” Aromatics 
12 762  (m) C-CI Stretch Alkyl halides 
13 590 (m) C-Br Stretch Alkyl halides 
Table No: 13 FTIR Result 
M=Medium, W= Week, S = Strong 
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INTER PRETATION  
  In FTIR the wavenumbers between 4000cm-1-400cm-1 is known as functional 
group area. <400cm-1 wave number is known as finger print area. The corresponding 
absorbtion frequency by FTIR shows the presence of Alcohol, Alkanes, Amines, 
Aromatics, Ester, Aliphatic amines, Alkyne. The O-H stretch may be due to the presence 
of moisture content. Infrared bonds for inorganic materials appear in the lower wave 
numbers than those observed for organic materials.   In cofirms that Rajakesarii 
chooranam contains Alkanes, Amines, Aromatics, Aliphatic, Nitriles, Primary, 
Secondary, Amides, and Saturated aliphatic, Ester, Alky halides, Alkenes. 
AMINES:  
   The bronchodilator effects of a number of sympathomatic amines were assessed 
in terms of reduction of histamine-induced bronchospasm.  
AROMATICS:  
  The aromatics type of studies may produce valuable information to biochemists 
and pharmacologists in screening of individual species and their phyto-constituents to 
acclelerate the drug discovery and development process for the treatment of asthma. 
Alkyl Halides: 
These are group of compounds derived from alkanes containing one or more halogens. 
Some are used as anesthetics and antiseptic agents. Some of them are used in medicine 
for the elimination of hook worms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TOXICOLOGICAL STUDIES RESULTS: 
ACUTE TOXICITY STUDIES: 
EVALUATION OF ACUTE TOXICITY OF RAJAKESARI 
CHOORANAM 
Effect of Acute Toxicity (14 Days) of RAJAKESARI CHOORANAM 
 
Group no. Dose(mg/kg Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 
Table –14 Physical and behavioral examinations. 
 
Functional and 
Behavioural 
observation 
Observation 5mg/kg 
Group 
(G-I) 
50mg/k
g 
(G-II) 
300mg/k
g 
(G-III) 
 
1000m
g/kg 
(G-IV) 
2000mg
/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Approach response Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch response Normal 3 3 3 3 3 
Table-15 Home cage activity 
 
 
Functional and 
Behavioral 
observation 
Observat
ion 
Control 5 mg/ kg  
(G-I) 
50 
mg/kg 
(G-II) 
300mg/k
g 
(G-III) 
1000mg
/kg 
(G-IV) 
2000m
g/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary reflex Normal 3 3 3 3 3 3 
Abdominal tone Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
Table-16 Hand held observation 
 
 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
Table-17 Mortality 
 
RESULTS 
From acute toxicity study it was observed that the administration of 
RAJAKESARI CHOORANAM at a dose of 2000mg/kg, to a rats. From acute toxicity 
study it was observed that the administration of RAJAKESARI CHOORANAM at a dose 
of 2000 mg/kg to the rats do not produce drug-related toxicity and mortality. So No-
Observed-Adverse-Effect- Level (NOAEL) of RAJAKESARI CHOORANAM is 2000 
mg/kg. 
 
DISCUSSION 
RAJAKESARI CHOORANAM was administered single time at the dose of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot study 
and literature review. All animals were observed daily once for any abnormal clinical 
signs. Weekly body weight and food consumption were recorded. No mortality was 
observed during the entire period of the study. Data obtained in this study indicated no 
significance physical and behavioural signs of any toxicity due to administration of 
RAJAKESARI CHOORANAM at the doses of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg 
and 2000mg/kg to rats.  
At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, Lacrimation, 
Salivation, Piloercetion, Papillary reflex, abdominaltone, Limb tone were observed. 
Functional and behavioral examination was normal in all treated groups.Food 
consumption of all treated animals was found normal as compared to normalgroup. 
Body weight at weekly interval was measured to find out the effect of 
RAJAKESARI CHOORANAM on the growth rate. Body weight change in drug treated 
animals was found normal. 
INTERPRETATION 
The study shows that Rajakesari Chooranam did not produced any toxic effect of dose of 
5mg /kg, 50mg/kg, 300mg/kg, 1000mg/kg, 2000mg/kg to rats. So No-observed - 
Adverse- Effects - level (NOAEL) of Rajakesari Chooranam is 2000mg/kg. 
 
 
 
 
 
 
 
 
 SUB ACUTE TOXICITY   STUDY  RESULT 
Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM On 
Body Weight In gram 
 
Table No. 18 Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI 
CHOORANAM On Body Weight In gram 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
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GROUP CONTROL R C. 300mg/kg R C.600mg/kg R C 900mg/kg 
0,DAY 126.7±1.43 119.8±2.197 129±1.983 128.3±2.275 
7th DAY 132.7±1.43 134.7±1.43 135.7±1.783 135±2.113 
14th DAY 138.5±1.408 141.8±1.302 142.7±1.52 142.8±2.056 
21st  DAY 147.3±2.124 148.7±1.174 150.2±1.905 149±1.571 
28th  DAY 153.3±1.085 156.2±1.4 156.7±1.202 157±2.049 
  
 
 
 
7th DAY
Co
ntr
ol LD MD HD
0
50
100
150
W
ei
gh
t (
g)
 
14th DAY
Co
ntr
ol LD MD HD
0
50
100
150
200
W
eig
ht
 (g
)
 
 
 
 
 
 
21st DAY
Co
ntr
ol LD MD HD
0
50
100
150
200
W
ei
gh
t (
g)
 
 
 
 
28th DAY
Co
ntr
ol LD MD HD
0
50
100
150
200
W
ei
gh
t (
g)
 
 
 
 
 
 
 
 
 
Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM On 
Organ Weight (physical parameter) in gram 
 
 
 
Table No. 19  Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI 
CHOORANAM On Organ Weight (physical parameter) in gram 
 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
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GROUP CONTROL R C. 
300mg/kg 
R 
C.600mg/kg 
R C 
900mg/kg 
BRAIN 1.289±0.1234 1.337±0.08963 1.532±0.114 1.212±0.06309 
HEART 
0.823±0.02989 
0.8145±0.0423
4 0.8245±0.0515 0.808±0.05421 
LIVER 6.345±0.2363 6.764±0.2393 6.733±0.281 6.678±0.5239 
LUNGS 1.355±0.1081 1.088±0.1403 1.25±0.1554 1.202±0.1145 
 
KIDNE
Y 
L 0.8382±0.0241
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0.8557±0.0314
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7 
R 0.8147±0.0245
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4 
0.8273±0.0403
8 
0.8157±0.0327
2 
TESTIS 2.914±0.1975 2.826±0.1422 2.727±0.1444 2.913±0.202 
UTERUS 0.981±0.0877 1.043±0.0886 1.018±0.1147 1.09±0.06846 
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Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM On 
Haematological Parameters.  
 
Table 20. Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM 
On Haematological Parameters. 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
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GROUP CONTROL R C. 300mg/kg R C.600mg/kg R C 900mg/kg 
RBC (X10^6/µL) 5.667±0.201 5.568±0.3231 5.385±0.2607 5.393±0.4832 
WBC(X10^3/µL) 10.52±0.5986 11.15±0.6893 10.82±0.3049 11.3±0.4017 
HB (g/dl) 14.47±0.88 15.02±1.097 13.35±0.6109 14.78±0.54 
PCV % 46±2.603 45.22±2.395 43.25±1.457 44.38±1.441 
POLYMORPHS 
(%) 6±0.8165 6.167±1.078 4±1.095 6±0.6831 
LYMPHOCYTES 
(%) 82.67±1.453 81±1.528 84±1.633 83.17±1.327 
MONOCYTES 
(%) 3±0.3651 2.833±0.4773 3.167±0.6009 2.833±0.7032 
EOSINOPHILS 
(%) 4.167±0.7032 4.667±0.4216 4.667±0.8433 4.833±0.4773 
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Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM On 
Biochemical  Parameters 
 
 
Table No. 21 Effect Of Sub- Acute Dose (28 Days)Of RAJAKESARI 
CHOORANAM On Biochemical  Parameters. 
 
 Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
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GROUP CONTROL R C. 
300mg/kg 
R 
C.600mg/kg 
R C 
900mg/kg 
SGOT(units/min/liter/mg 
protein) 
113.9±3.8 
 
114.9±5.297 
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SGPT 
(units/min/liter/mg 
protein) 
40.75±1.875 
 
40.68±2.912 
 
38.18±1.176 
 
37±1.934 
 
ALP (units/min/liter/mg 
protein) 
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Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM On 
Biochemical  Parameters. 
 
 
 
Table 22 Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAM 
On Biochemical  Parameters. 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
 
 
 
 
 
 
 
 
 
GROUP CONTROL R C. 
300mg/kg 
R 
C.600mg/kg 
R C 
900mg/kg 
 
TOTAL 
BILIRUBIN 
(mg/dl) 
 
1.165±0.09646 
 
1.033±0.1222 
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Table No. 22 Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI 
CHOORANAM On Biochemical  Parameters. 
 
 
 
 
 
Effect Of Sub- Acute Dose (28 Days) Of RAJAKESARI CHOORANAM On 
Biochemical  Parameters. 
 
 
Table 23 Effect Of Sub- Acute Dose (28 Days) Of RAJAKESARI CHOORANAM 
On Biochemical  Parameters 
  
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
 
 
GROUP CONTROL 
R C. 
300mg/kg 
R C.600mg/kg 
R C 
900mg/kg 
CREATINNE 
(mg/dl) 
27.35± 2.11 27.18± 2.678 25.43±1.857 24.65±1.092 
 
URIC ACID (mg/dl) 
 
1.728±0.1619 
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1.663±0.2308 
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Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAMon Food 
Intake in gram. 
 
Table No : 24 Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI 
CHOORANAMon Food Intake in gram 
 
 Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
 
GROUP CONTROL R C. 300mg/kg R C.600mg/kg R C 900mg/kg 
1st DAY 34±1.461 37.83±1.376 36.67±1.585 34.67±1.145 
7th DAY 40.17±0.7923 40.33±1.687 36.5±2.187 38.83±1.973 
14th DAY 36.83±1.641 40.33±2.108 37.67±2.028 37.5±1.875 
21st  DAY 39±0.8944 40±1.932 39±1.125 38.83±2.007 
28th  DAY 39.67±1.333 38.67±1.022 38.17±1.682 40.67±1.022 
 
 
 
 
 
Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAMon Food 
Intake in gram. 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group 
Effect Of Sub- Acute Dose(28 Days)Of RAJAKESARI CHOORANAMOn Water  
Intake in ml 
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RESULTS 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   
period of 28 days. 
Mortality: 
All animals in control and in all the treated dose groups survived throughout the 
dosing period of 28 days. 
Body weight: 
Results of body weight determination of animals Table-1 from control and 
different dose groups exhibited comparable body weight gain throughout the dosing 
period of 28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with that 
by control animals. 
Organ Weight: 
Group Mean Relative Organ Weights (%of body weight) are recorded in Table 
No.4 Comparison of organ weights of treated animals with respective control animals on 
day 29 was found to be comparable similarly. 
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Hematological investigations: 
The results of hematological investigations (Table 4) conducted on day 29 
revealed following significant changes in the values of different parameters investigated 
when compared with those of respective controls; however, the increase or decrease in 
the values obtained was within normal biological and laboratory limits or the effect was 
not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded in 
Table 2 revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and laboratory 
limits. 
DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 900 mg/kg survived 
throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain with 
that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found to 
be comparable with that of respective controls. 
 
INTERPRETATION  
 The Rajakesari Chooranam can be considered safe, as it did not cause any 
rethality or adverse changes with general behavior of rats and also there was no  
observable detrimental effects (300 to 900mg/kg body weight) over a period of 28 days. 
our results have demonstrated that the Rajakesari Chooranam is relatively safe when 
administered orally in rates. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHARMACOLOGICAL RESULTS  
BRONCHODILATOR RESULT  
EFFECT OF RAJAKESARI CHOORANAM ON BRONCHO-ALVEOLAR 
LEVAGE IN MICE 
 
GPS 
 
Eosinophils 
Differential Leukocytes 
 (x10c /µl) 
 
Total Leukocytes 
(per cu.mm) Neutrophils Monocytes 
(Normal ) 
control 
42.6667± 
1.83787 
3.93333± 
0.276486 
42± 
1.46059 
1138.67±1 
3.2531 
(allergic) 
only Alum 
179.333± 
5.67255*** 
15.4667± 
0.256472*** 
61.3333± 
2.56472*** 
1438.67± 
17.7739*** 
Alum + 
dexamethazone 
52.3333± 
1.28236* 
5.4± 
0.0730297* 
36.6667± 
1.83787* 
1024± 
24.133** 
Alum + R 
C.LOW DOSE 
116.667± 
1.83787*** 
7.66667± 
0.787683*** 
49± 
2.39444*** 
1087.33± 
18.2623*** 
Alum + R 
C.MIDLE 
DOSE 
87.3333± 
1.52023*** 
7.1± 
0.0966092*** 
37± 
1.09545*** 
903.333± 
29.2878*** 
Alum + R 
C.HIGH DOSE 
53.3333± 
1.11555*** 
6.36667± 
0.147573*** 
30.3333± 
0.557773*** 
813.333± 
30.4047*** 
     Table No. 25 Effect Of Rajakesari Chooranam On Broncho-Alveolar Levage In Mice 
  
Values are expressed as the mean ± S.D; Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s ns- no significant *P< 0.001, **P < 0.01, ***P < 0.05 
calculate by comparing treated group with CONTROL group.   
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     RESULTS 
 Increased level ofLeucocytes and eosinophils counts in our respiratory system 
play a vital role to induce bronchial hypersensitivity and produces airway inflammation 
in allergic and non-allergic asthma. The inflammatory reaction of bronchial walls in 
asthma is brought about increased level of bronchial eosinophils. It occupied in the later 
phase reaction of bronchial asthma.  
         Subcutaneous administration of boiled and cooled milk into the Wister albino rats 
acts as antigen and produced allergic response in mice increase the total leucocyte and 
eoisinophil count in 24 hour administration (Limbasiya KK. et al, 2012). During 
asthmatic inflammation leukocytes release the following inflammatory mediators are 
cytokines, histamine mainly and basic protein, which promote the endurance of 
inflammation [Brekhman LI et al., 1969]. Eosinophils infiltrating the airway also have 
an effect on mucus secretion by epithelial goblet cells (Shimizu T et al., 2003). 
Eosinophils part in bronchial asthma was quite an active in the development of allergic 
airway inflammation (Elizabeth R. Walsh et al., 2010). Eosinophil creates 
bronchoconstriction through the secretion of mediators such as eosinophil cationic 
protein, eosinophil-derived neurotoxin, and prostaglandin, which results in broncho 
constriction in respiratory tract (Limbasiya KK. et al, 2012).   
         In this study was observed that leukocytes count was decreased in rat treated with 
RAJAKESARI CHOORANAM at doses of 200mg/ kg significantly as compared to 
disease control group. Result suggests that RAJAKESARI CHOORANAM decreases milk 
induced leukocytes count in rat. And this study was observed that RAJAKESARI 
CHOORANAM at doses of 200mg/kg significantly decreased milk induced eosinophils 
count in rat. Eosinophils counts of disease control group was compared with 
RAJAKESARI CHOORANAM treated group results showed the drug reduces eosinophil 
counts in rat. Finally the test drug RAJAKESARICHOORANAM treated group rat 
leucocytes and eosinophils count was considerably reduced.  During bronchial asthma 
broncho construction is developed by inflammatory changes of the airways.   
If a drug reduces or prevents bronchial inflammation of airways bronchodilation 
happens. The effect of RAJAKESARICHOORANAM on reducing bronchial 
inflammation through reducing the increased leucocytes and eosinophils counts in rat. 
Finally the RAJAKESARICHOORANAM results represents reduce bronchial 
inflammation helps airways to dilate. RAJAKESARI CHOORANAM indirectly proves its 
broncho dilator activity in the management of asthma. 
Interpretation 
The test drug Rajakesari Chooranam has got significant Broncodilator Activity. 
 
 
 
 
 
 
 
 
ANTI SPASMODIC ACTIVITY  RESULT 
DoseResponse Relationship Observations of Acetylcholine 
Si.No Concentration/dose Acetylcholine 
Response (cm) 
1 0.1 ml 1.8cm 
2 0.2 ml 2.6cm 
3 0.4 ml 2.9cm 
4 0.8 ml 3.3cm 
5 1.6 ml                      3.7cm 
Table No. 26 Dose Response Relationship Observations of Acetylcholine 
DoseResponse Relationship Observations of Atropine 
Si.No Concentration/dose atropine 
Response (cm) 
1 0.1 ml - 
2 0.2 ml - 
3 0.4 ml - 
4 0.8 ml - 
5 1.6 ml - 
Table No. 27DoseResponse Relationship Observations of Atropine 
Dose Response Relationship Observations of Acetylcholine and 
RAJAKESARICHOORANAM 
Si.No Concentration/dose Acetylcholine + 
Rajakesarichooranam 
Response (cm) 
1 0.1 ml +0.1 ml 3.3 cm 
2 0.2 ml +0.2 ml 3.9 cm 
3 0.4 ml +0.4 ml 4.1 cm 
4 0.8 ml +0.8 ml 4.6cm 
5 1.6 ml + 1.6 ml 5.1cm 
Table  NO. 28 Dose Response Relationship Observations of Acetylcholine and 
RAJAKESARICHOORANAM 
Comparative Dose Response of Ach and Ach followed by Rajakesarichooranam 
Si No Treatment  Dose(ml) response % of response 
1  
Acetylcholine 
0.1 ml 1.8 cm  
2 0.2 ml 2.6 cm  
3 0.4 ml 2.9 cm  
4 0.8 ml 3.3 cm  
5  1.6 ml  3.7 cm  
6  
Acetylcholine + 
Rajakesarichooranam 
0.1 ml +0.1 ml 3.3 cm 12.5 % 
7 0.2 ml +0.2 ml 3.9 cm 15.78 % 
8 0.4 ml +0.4 ml 4.1 cm 24.48 % 
9 0.8 ml +0.8 ml 4.6 cm 23.63 % 
10 1.6 ml + 1.6 ml 5.1 cm 16.94 % 
 
Table No. 29 Comparative Dose Response of Ach and Ach followed by 
Rajakesarichooranam 
 
 
Fig: Comparative dose response relationship of Acetylcholine and Rajakesarichooranam. 
RESULTS 
 Effect of Acetylcholine on excised rat ileum reflected an increase in spasmodic 
activity (response) with an increase in dose 
 
DISCUSSION: 
 From the present study results it was observed that acetylcholine (Ach) alone 
cause’s contraction of excised rat ileum but when acetylcholine was given in presence of 
Rajakesarichooranam there was a marked decrease in contraction of ileum was 
observed.  
 This revealed that Rajakesarichooranam possess a high degree of spasmolytic 
(anti-spasmodic) activity by blocking cholinergic receptors. 
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INTERPRETATION 
The test drug Rajakesari Chooranam has got significant Anti-Spasmodic Activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANTI  HISTAMINE ACTIVITY RESULT  
EFFECT OF  RAJAKESARI CHOORANAM  ON MAST CELL 
STABILIZATION IN SENSITIZED RATS  
 
GROUPS 
                     MAST CELLS 
INTACT DISRUPTED 
NORMAL CONTROL 82.50±3.85 15.90±0.82 
 
TABLE NO:30 EFFECT OF  RAJAKESARI CHOORANAM  ON MAST CELL 
STABILIZATION IN SENSITIZED RATS  
 Values are expressed as Mean±S.E.M 
       *a significantly different from sensitized control at p<0.01 
Effect of  rajakesari chooranam  on histamine induced bronchospasm in guinea pigs. 
 
GROUPS 
PRE-CONVULSION DYSPNEA (PCD)(SEC) 
DAY 0 DAY 1 DAY 5 
GP 1 178.22±7.24 265±9.5 212.25±9.2 
GP 2 (rajakesari chooranam 200mg/kg) 180.25±6.55 220±6.0 412±14.8*a 
GP3 (rajakesari chooranam 400mg/kg 182.30±6.70 222±8.5 405±13.6*a 
TABLE NO 31 : Effect of  rajakesari chooranam  on histamine induced bronchospasm in 
guinea pigs. 
Values are expressed as Mean ±S.E.M 
*a Significantly different from control on day 5 at p<0.001 
RESULTS 
Statistical analysis 
The results of various studies were expressed as mean ± SEM and analyzed 
statistically using one-way ANOVA, followed by Newmann keul’s multiple range tests. 
P<0.05 was considered statistically significant.The analysis was performed using 
Graphpad Prism software package (Version 4.0). 
Mast cell stabilizing potential of rajakesari chooranam Antigen challenge resulted 
in significant degranulation of the mesentric mast cells. Pretreatment of sensitized 
animals with rajakesari chooranam at a dose of 200mg/kg and 400mg/kg, p.o., for 2 
weeks resulted in a significant reduction in the number of disrupted mast cells (P <0.001) 
when challenged with horse serum.  
Effect on histamine-induced bronchospasm 
SENSITIZED RATS 12.60±0.95 88.30±2.45 
rajakesari chooranam 
200mg/kg 
65.80±2.65*a 36.52±1.32*a 
Rajakesari  chooranam 
400mg/kg 
63.50±2.45*a 34.40±1.30*a 
Rajakesari chooranam at a dose of 200mg/kg and 400mg/kg p.o., significantly 
prolonged the latent period of PCD (P <0.001) as compared to control, following 
exposure to histamine aerosols on day 5 [Table no. 2]. 
Discussion 
Experimental animal model of asthma is characterized by allergen-induced 
immediate airway constriction and late airway reactivity to a pharmacological 
vasoconstrictor such as histamine and leukotrienes. Histamine is a central mediator in the 
pathogenesis of allergic and inflammatory disorders. In the present study, rajakesari 
chooranam prolonged the latent period of PCD in guinea pigs following histamine 
aerosol. This may be suggestive of an antihistaminic activity following treatment with 
rajakesari chooranam. 
 Antigen challenge, in sensitized animals, results in the degranulation of mast cells, 
which is an important feature of anaphylaxis. In the present study, rajakesari chooranam 
showed marked protection against the mast cell degranulation following antigen 
challenge in sensitized animals. Mast cell stabilizing activity of rajakesari chooranam 
may be attributed to the presence of active constituents which are known for their mast 
cell stabilizing potential against antigen–antibody reaction and/or due to the suppression 
of IgE antibody production, which is responsible for degranulation mast cells.[8]  
This antianaphylactic and antihistaminic effect may be caused by the stabilization 
of the mast cell membrane, suppression of IgE, and inhibition of pathological effects 
induced by the release of inflammatory mediators in rajakesari chooranam treated 
animals. All the above findings lend credence to the beneficial use of rajakesari 
chooranam in the treatment of asthma and related conditions. 
However, further studies with other experimental models, especially to explore the role of 
cytokines are warranted to substantiate the antiasthmatic and antiallergic activity of 
rajakesari chooranam. 
INTERPRETATION:                                                                                                                                                        
The test drug Rajakesari chooranam has got significant Anti-histaminic activity.  
ANTI-INFLAMMATORY ACTIVITY OF SIDDHA FORMULATION 
 
Treatment Dose (mg/kg) 
Paw volume(ml) as 
measured by mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 10ml/kg orally 5.22±0.75 - 
Group II 
   Std 
10mg/kg 
I.P.Diclofenac 
sodium 
1.68±0.52 67.34%*a 
Group III 
siddha preparation  
rajakesari chooranam 
200mg/kg.Orally. 2.08±0.48 60.52%*a 
Group IV 
siddha preparation  
rajakesari chooranam 
400mg/kg.Orally.  1.98±0.45 63.73%*a 
TABLE No.32 
 
* Data are expressed as Mean ± S.E.M. 
 *Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple 
range tests, to determine the significance of the difference between the control group and 
rats treatedwith the test compounds. 
*a   Values were significantly different from normal control at P< 0.01. 
 
 Both doses of  siddha preparation  rajakesari chooranam   at 200mg/kg and 
400mg/kg were tested for their Anti- inflammatory activity by using carrageenan 
Induced rat paw edema method and the results are tabulated in table no 1.  The results 
reveals that   both doses of siddha preparation  rajakesari chooranam   at 200mg/kg and 
400mg/kg doses possesses significant Anti- inflammatory activity when compared to 
control group at p<0.01. 
INTERPRETATION:  
The test drug Rajakesari chooranam has got significant Anti-Inflammatory 
activity.  
 
 
 
 
ANTI MICROBIAL ACTIDITY RESULTS 
Table No: 15-:  
s.no Organism   Susceptibility Zone inhibition 
(Culture) Streptomycin 
zone size Medicine size 
1. E.coli Sensitive 22mm 13mm 
2. Klebsiella pnemoniae Sensitive 
29mm 18mm 
3. Staphylococcus aureus Sensitive 
24mm 12mm 
4. Streptococcus mutant Sensitive 
22mm 15mm 
5. Enterococcus faecalis Moderate Sensitive 
32mm 22mm 
6. Pseudomonas aeruginosa Resistant 
24mm 18mm 
 
 
 
               KLEBSIELLA 
 
 
 
 
 
 
                           E.COLI 
 
 
  PSEUDOMONAS 
 
 
 
 
                ENTEROCOCCUS 
 
 
                           STAPHYLOCOCCUS 
 
 
INTERPRETATION  
 It was observed that antimicrobial studies of Rajakesari chooranam showed 
that   it is sensitive agent E.Coli, Klebsiella.When compared to the standard drug 
(streptomycin) Which was evident from the zone Inhibition .The herbal drug 
Rajakesari chooranam showed the inhibiton of the growth of the micro organisam at 
100 microgram/ml concentration for the organism.Our results confirmed the 
traditional use of Rajakesari chooranam has anti microbial activity.  
 
 
 
 
 
6. SUMMARY 
        The test drug RAJAKESARI CHOORANAM is selected from the text, 
ANUBOGA VAITHIYA BRAMMA RAGASIYAM (Page no.100) for the evaluation of 
safety, efficacy and therapeutic potency on Bronchial asthma for its Broncho dilator, anti 
spasmodic, anti histamine, and anti inflammatory activities.  
      A  review of the literatures and lateral research works about Piper cubeba,Myristica 
fragrans, Alpinia galanga, Piper longum,Moschus moschiferus, Cinnamomum verum, 
Syzygium aromaticum, Zingiber officinale, Quercus infectoria, Elettaria cardamomum, 
Glycyrrhiza glabra, they are having anti-inflammatory, antispasmodic, anti-asthmatic, 
antihistaminic activity.  
 Physico-chemical analysis shows, it was within acceptable range.So it can be stored for 
a long period and would not easily be attacked by microbes.  
 Total ash value of plant material indicated the amount of minerals and earthy 
materials present in the plant material. The total inorganic content (ammonium, 
potassium, calcium, chloride, iron, etc.,) present in the drug is measured through the 
Total ash value and it is of 5.8 % for RC. 
  The acid insoluble ash value of the drug denotes the amount of siliceous matter 
present in the plant. The quality of the drug is better if the acid insoluble value is low. It 
is 0.8% for RC. 
 Water-soluble ash is the part of the total ash content, which is soluble in water. It 
is 18.4% for RC  
 Alcohol-soluble ash is the part of the total ash content, which is soluble in alcohol. 
It is 22.1% for RC 
 These are indicating the approximate measure of chemical constituents of 
crude  drug. 
 The percentage of soluble matters present in the drug is determined by the 
values  of water extractive and ethanol extractive.   
 Based on the extractive value suitable solvent can be selected. It also gives 
the  percentage of drug which will correlate with the metabolism reactions.  
 Water-soluble extractive value plays an important role in evaluation of 
crude  drugs  
 The alcohol-soluble extractive value was also indicative for the same 
purpose as  the water-soluble extractive valueLoss on drying :   
 The total of volatile content and moisture present in the drug was 
 established in  loss on drying.   
 Moisture content of the drug reveals the stability and its shelf-life.   
 High moisture content can adversely affect the active ingredient of the 
 drug.   
 Thus low moisture content could get maximum stability and better shelf life 
 Water soluble extract shows,water is a better solvent of extraction for the 
formulation.Disintegration time shows, quickly disintegrate with water.TLC result 
shows variation of Rf values indicated the presence of alkaloids,phenols,tannin,and 
some unknown compounds in this drug.  
 Biochemical analysis shows the presence of Sulphate, Starch, Ferrous iron, 
Tannic acid, unsaturated compounds, and aminoacids.  
Iron is an essential constituent of Hemoglobin, cytochromes and other components of 
respiratory enzyme systems like cytochrome oxidase, catalase, and peroxidase. It 
enhances the arterial oxygen level. The drug enhances oxygen supply and promotes the 
normal ventilation of the lungs and reduces the dyspnoea. It participate the cellular 
oxidation mechanism.  
 Amino acids act as neurotransmitters and some act as starting materials for the 
biosynthesis of neurotransmitters, hormones and other important biochemical 
compounds.Amino acids contribute to various anti-oxidant and immunological activities 
relevant to asthma pathogenesis, raising the possibility that differences in amino acids 
may be involved in asthma aetiology.  
 Sulphate has been considered as an adjunct therapy for severe and lifethreatening 
asthma exacerbation.                                                                                                                                                             
Tannins 
Helps in healing of wounds and inflammation of mucous membrane. 
They restore the Anti-Oxidant status of the organs to almost normal levels. 
Increases the cellular Anti-Oxidant enzymes 
ICP-OES results shows below detection limit (BDL) of Arsenic, Mercury, 
Cadmium, Lead, Aluminum, and Copper.It is evident that the effectiveness of 
siddha medicine has been proved by the modern scientific way.  
 Presence of Mg&So4, has been considered as an adjunt therapy for severe and life 
threatening asthma exacerbation. Theoritically, Magnesium can induce bronchial 
smooth muscle relaxation in dose dependent manner. Sodium regulates the body’s acid 
base balance. Iron is essential for may numbers of biological functions such as growth, 
reproduction, healing and immune function. The phosphorus is involved in tissue repair 
and silicon reduce digestive disorders. Sulphate is potent anti oxidant activity in human 
body. Zinc has got potent anti-microbial activity.  
 FTIR results shows It cofirms that Rajakesarii chooranam contains Alkanes, Amines, 
Aromatics, Aliphatic, Nitriles, Primary, Secondary, Amides, and Saturated aliphatic, 
Ester, Alkyl halides, Alkenes. 
TLC results shows under UV 254 nm and 366 nm test related to alkaloids, it shows major  
spots short at Rf 0.90 (Green), 0.89, 0.80,0.71,0.64,0.57 (Violet), and long at Rf 
0.90(Green),0.89,0.80,0.71,0.64,0.57(blue). TLC of RC various Rf values was observed. 
The variation of Rf values indicated the presence of alkaloids, phenols, tannin and some 
unknown compounds in this drug.  
SEM analysis result shows most of the particles present in the sample is,average particle 
size -5  microns.So very minimal quantity of the medicine is enough to treat the 
disease.Target cells takes up these micro particles enhance the bioabsorbtion and 
bioavailability resulting efficacy of the drug will be increased.              
Acute And Sub-Acute Toxicity were carried out in wister albino rats according to 
OECD guidelines(423). This drug has no acute toxicity as there was no mortality seen 
sub-acute toxicity is carried by repeated dose of test drug for 28 days. Mortality, the 
functional observations, haematological and bio-chemical investigations were done. So 
the toxicological study of these test drug, Rajakesari Chooranam establish the safety of 
the drug for long time administration.  
Pharmacological analysis shows that the drug has got significant antispasmodic activity 
and excellent anti-histaminic activity and good anti inflammatory activity and significant 
bronchodilator activity. Hence it can be concluded that this drug may inhibit the tone of 
tracheal and bronchial muscles and thus has a good (Bronchodilator) anti-asthmatic 
action.  
 Antimicrobial studies show, antimicrobial activity against the E.coli, Pseudomonas 
Aeruginesae, Klebisella pneumonia, Streptococcus mutant, Staphylococcus aureus, 
Enterococcus faecalis which compared to standard drug (streptomycin).This is mainly 
due to the phytochemical constituents present in the drug. 
        In Siddha concept if Thee poodha controls deranged kabha poodha which is the one 
of the causative factor of the Bronchial Asthma (Eraippu Noi), thus it relieves 
“Eraippu Noi”.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. CONCLUSION 
             RAJAKESARI CHOORANAM was selected for the elaborate study of its efficacy 
on Eraippu Noi (Bronchial Asthma).  
             From the literature review, Physico-chemical, Pharmacological, 
Microbiological, Biochemical, Instrumental analysis, It has been concluded that RC 
has got a good Bronchodilator, Anti-spasmodic, Anti-histaminic, Antiinflammatory 
activity and hence effective for EraippuNoi.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. FUTURE SCOPE 
  The trial drug Rajakesari chooranam has its own potency in treating 
Bronchial Asthma in animal model which has been established in this 
study.However, the mechanism of action by which Rajakesari chooranam produced 
its effect on the Bronchial Asthma in experimental animal models and also 
multicentre clinical trials are required to understand the exact molecular mechanisms 
of action.So it could be used worldwide in treatment of Bronchial Asthma.  
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